"","id","reference","authors","consortium","title","journal","pubmed","remark"
"1",2001,"1  (bases 1 to 194)","Auerswald,E.A., Schroeder,W., Schnabel,E., Bruns,W., Reinhardt,G.	and Kotick,M.",NA,"Aprotinin homologues produced by genetic engineering","Patent: EP 0238993-A2 1 30-SEP-1987;	BAYER AG",NA,NA
"2",3001,"1  (bases 1 to 194)","Auerswald,E.A., Schroeder,W., Schnabel,E., Bruns,W., Reinhardt,G.	and Kotick,M.",NA,"Aprotinin homologues produced by genetic engineering","Patent: EP 0238993-A2 2 30-SEP-1987;	BAYER AG",NA,NA
"3",2284001,"1  (bases 1 to 378)","Sanchez,F.S., Susan,V.R., Carramolino-Fitera,L. and Ortega,A.P.A.",NA,"Fungal resistance markers","Patent: EP 0240250-A1 1 07-OCT-1987;	Antibioticos, S.A",NA,NA
"4",14406001,"1  (bases 1 to 45)","Auerswald,E.A., Schroeder,W., Schnabel,E., Bruns,W., Reinhardt,G.	and Kotick,M.",NA,"Aprotinin homologues produced by genetic engineering","Patent: EP 0238993-A2 20 30-SEP-1987;	BAYER AG",NA,NA
"5",14407001,"1  (bases 1 to 45)","Auerswald,E.A., Schroeder,W., Schnabel,E., Bruns,W., Reinhardt,G.	and Kotick,M.",NA,"Aprotinin homologues produced by genetic engineering","Patent: EP 0238993-A2 23 30-SEP-1987;	BAYER AG",NA,NA
"6",14408001,"1  (bases 1 to 45)","Auerswald,E.A., Schroeder,W., Schnabel,E., Bruns,W., Reinhardt,G.	and Kotick,M.",NA,"Aprotinin homologues produced by genetic engineering","Patent: EP 0238993-A2 26 30-SEP-1987;	BAYER AG",NA,NA
"7",14409001,"1  (bases 1 to 194)","Auerswald,E.A., Schroeder,W., Schnabel,E., Bruns,W., Reinhardt,G.	and Kotick,M.",NA,"Aprotinin homologues produced by genetic engineering","Patent: EP 0238993-A2 29 30-SEP-1987;	BAYER AG",NA,NA
"8",14410001,"1  (bases 1 to 1900)","Warne,S.",NA,"","Patent: GB 2220942-A 1 24-JAN-1990;	The Secretary of State of Trade and Industry",NA,NA
"9",14412001,"1  (bases 1 to 2368)","Brown,J.P., Plowman,G.D., Hellstrom,K.E., Purchio,A.F.,	Pennathur,S., Estin,C.D., Rose,T.M., Hellstrom,I. and Hu,S.L.",NA,"","Patent: GB 2188637-A 1 07-OCT-1987;	Oncogen",NA,NA
"10",14414001,"1  (bases 1 to 252)","Brown,J.P., Plowman,G.D., Hellstrom,K.E., Purchio,A.F.,	Pennathur,S., Estin,C.D., Rose,T.M., Hellstrom,I. and Hu,S.L.",NA,"","Patent: GB 2188637-A 3 07-OCT-1987;	Oncogen",NA,NA
"11",14415001,"1  (bases 1 to 49)","Bishop,C., Cotinot,C., Fellous,M., Kirszenbaum,M. and Vaiman,M.",NA,"DNA probe specific for the male genomes of ruminants, their	preparation and use","Patent: EP 0235046-A1 1 02-SEP-1987;	INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE, Etablissement public	dit:; INSTITUT PASTEUR; COMMISSARIAT A L'ENERGIE ATOMIQUE	Etablissement de Caractere Scientifique Technique et Industriel",NA,NA
"12",14416001,"1  (bases 1 to 13)","Mattes,R.",NA,"Tissue plasminogen activator (tPA) derivative and its production","Patent: EP 0242836-A1 1 28-OCT-1987;	BOEHRINGER MANNHEIM GMBH",NA,NA
"13",14417001,"1  (bases 1 to 21)","Mattes,R.",NA,"Tissue plasminogen activator (tPA) derivative and its production","Patent: EP 0242836-A1 2 28-OCT-1987;	BOEHRINGER MANNHEIM GMBH",NA,NA
"14",14418001,"1  (bases 1 to 19)","Mattes,R.",NA,"Tissue plasminogen activator (tPA) derivative and its production","Patent: EP 0242836-A1 3 28-OCT-1987;	BOEHRINGER MANNHEIM GMBH",NA,NA
"15",14419001,"1  (bases 1 to 13)","Mattes,R.",NA,"Method for preparing plasminogen activators in procaryotes","Patent: EP 0242835-A1 1 28-OCT-1987;	BOEHRINGER MANNHEIM GMBH",NA,NA
"16",14420001,"1  (bases 1 to 634)","Hercend,T.",NA,"NEW LIMPHOKINES, DNA SEQUENCES CODING FOR SAID LIMPHOKINES AND	PHARMACEUTICAL COMPOSITIONS CONTAINING SAID LIMPHOKINES","Patent: WO 9003394-A2 1 05-APR-1990;	Roussel UCLAF",NA,NA
"17",14422001,"1  (bases 1 to 705)","Hercend,T.",NA,"NEW LIMPHOKINES, DNA SEQUENCES CODING FOR SAID LIMPHOKINES AND	PHARMACEUTICAL COMPOSITIONS CONTAINING SAID LIMPHOKINES","Patent: WO 9003394-A2 3 05-APR-1990;	Roussel UCLAF",NA,NA
"18",14423001,"1  (bases 1 to 576)","Palva,I.",NA,"","Patent: GB 2133408-A 1 25-JUL-1984;	Ikka Palva",NA,NA
"19",14424001,"1  (bases 1 to 576)","Palva,I.",NA,"","Patent: GB 2133408-A 2 25-JUL-1984;	Ikka Palva",NA,NA
"20",14425001,"1  (bases 1 to 576)","Palva,I.",NA,"","Patent: GB 2133408-A 3 25-JUL-1984;	Ikka Palva",NA,NA
"21",14426001,"1  (bases 1 to 576)","Palva,I.",NA,"","Patent: GB 2133408-A 4 25-JUL-1984;	Ikka Palva",NA,NA
"22",14427001,"1  (bases 1 to 20)","Huber,M., Gitler,C., Revel,M., Mirelman,D., Garfinkel,L.I. and	Giladi,M.",NA,"","Patent: GB 2223307-A 1 04-APR-1990;	Yeda Res. and Dev. Company Limited",NA,NA
"23",14428001,"1  (bases 1 to 20)","Huber,M., Gitler,C., Revel,M., Mirelman,D., Garfinkel,L.I. and	Giladi,M.",NA,"","Patent: GB 2223307-A 2 04-APR-1990;	Yeda Res. and Dev. Company Limited",NA,NA
"24",14429001,"1  (bases 1 to 20)","Huber,M., Gitler,C., Revel,M., Mirelman,D., Garfinkel,L.I. and	Giladi,M.",NA,"","Patent: GB 2223307-A 3 04-APR-1990;	Yeda Res. and Dev. Company Limited",NA,NA
"25",14430001,"1  (bases 1 to 21)","Huber,M., Gitler,C., Revel,M., Mirelman,D., Garfinkel,L.I. and	Giladi,M.",NA,"","Patent: GB 2223307-A 4 04-APR-1990;	Yeda Res. and Dev. Company Limited",NA,NA
"26",14431001,"1  (bases 1 to 58)","Kang,C.Y.",NA,"","Patent: GB 2228486-A 1 29-AUG-1990;	Univesity of Ottawa",NA,NA
"27",14432001,"1  (bases 1 to 28)","Kang,C.Y.",NA,"","Patent: GB 2228486-A 2 29-AUG-1990;	Univesity of Ottawa",NA,NA
"28",14433001,"1  (bases 1 to 21)","Kang,C.Y.",NA,"","Patent: GB 2228486-A 3 29-AUG-1990;	Univesity of Ottawa",NA,NA
"29",14434001,"1  (bases 1 to 22)","Kang,C.Y.",NA,"","Patent: GB 2228486-A 4 29-AUG-1990;	Univesity of Ottawa",NA,NA
"30",14435001,"1  (bases 1 to 23)","Kang,C.Y.",NA,"","Patent: GB 2228486-A 5 29-AUG-1990;	Univesity of Ottawa",NA,NA
"31",14436001,"1  (bases 1 to 27)","Kang,C.Y.",NA,"","Patent: GB 2228486-A 6 29-AUG-1990;	Univesity of Ottawa",NA,NA
"32",14437001,"1  (bases 1 to 20)","Kang,C.Y.",NA,"","Patent: GB 2228486-A 7 29-AUG-1990;	Univesity of Ottawa",NA,NA
"33",14438001,"1  (bases 1 to 21)","Kang,C.Y.",NA,"","Patent: GB 2228486-A 8 29-AUG-1990;	Univesity of Ottawa",NA,NA
"34",14439001,"1  (bases 1 to 22)","Kang,C.Y.",NA,"","Patent: GB 2228486-A 9 29-AUG-1990;	Univesity of Ottawa",NA,NA
"35",14440001,"1  (bases 1 to 29)","Kang,C.Y.",NA,"","Patent: GB 2228486-A 10 29-AUG-1990;	Univesity of Ottawa",NA,NA
"36",14441001,"1  (bases 1 to 30)","Kang,C.Y.",NA,"","Patent: GB 2228486-A 11 29-AUG-1990;	Univesity of Ottawa",NA,NA
"37",14442001,"1  (bases 1 to 25)","Kang,C.Y.",NA,"","Patent: GB 2228486-A 12 29-AUG-1990;	Univesity of Ottawa",NA,NA
"38",14443001,"1  (bases 1 to 504)","Kozlov,J.I., Naroditskaya,V.A., Eremashvill,M.R., Strongin,A.Y.,	Skvortsova,M.A., Chistoserdov,A.J., Tsygankov,J.D., Evdonina,L.V.,	Jurin,V.L., Monastyrskaya,G.S., Sverdlov,E.D., Dolganov,G.M. and	Tsarev,S.A.",NA,"","Patent: GB 2199830-A 1 20-JUL-1988;	Vsesojuzny Nauchno-Issledovatelsky Inst. Genetiki",NA,NA
"39",14445001,"1  (bases 1 to 2439)","Jefferson,R.A.",NA,"","Patent: GB 2197653-A 1 25-MAY-1988;	Richard Anthony Jefferson",NA,NA
"40",14447001,"1  (bases 1 to 1496)","Rogers,G.E.",NA,"","Patent: GB 2227243-A 1 25-JUL-1990;	Luminis Pty Ltd",NA,NA
"41",14449001,"1  (bases 1 to 1350)","Rogers,G.E.",NA,"","Patent: GB 2227243-A 3 25-JUL-1990;	Luminis Pty Ltd",NA,NA
"42",14451001,"1  (bases 1 to 318)","Gutmann,E.",NA,"PEPTIDES COMPRISING AN IMMUNOGEN SITE OF THE POLIOVIRUS AND DNAs	CONTAINING NUCLEOTIDIC SEQUENCES CODING FOR SAID PEPTIDES","Patent: WO 8803950-A1 1 02-JUN-1988;	Girard M",NA,NA
"43",14452001,"1  (bases 1 to 1181)","Gutmann,E.",NA,"PEPTIDES COMPRISING AN IMMUNOGEN SITE OF THE POLIOVIRUS AND DNAs	CONTAINING NUCLEOTIDIC SEQUENCES CODING FOR SAID PEPTIDES","Patent: WO 8803950-A1 3 02-JUN-1988;	Girard M",NA,NA
"44",14453001,"1  (bases 1 to 939)","Sanchis,V.",NA,"NUCLEOTIDE SEQUENCES CODING FOR POLYPEPTIDES EXERCISING A	LARVICIDAL EFFECT IN LEPIDOPTERA","Patent: WO 8809812-A1 1 15-DEC-1988;	Institut Pasteur",NA,NA
"45",14454001,"1  (bases 1 to 2711)","Sanchis,V.",NA,"NUCLEOTIDE SEQUENCES CODING FOR POLYPEPTIDES EXERCISING A	LARVICIDAL EFFECT IN LEPIDOPTERA","Patent: WO 8809812-A1 3 15-DEC-1988;	Institut Pasteur",NA,NA
"46",14455001,"1  (bases 1 to 480)","Armau,E.",NA,"APPLICATION OF ANTIBIOTICS OF THE PHLEOMYCINE FAMILY AS SELECTION	AGENT IN THE FIELD OF GENETIC ENGINEERING","Patent: WO 8601537-A1 1 13-MAR-1986;	CNRS",NA,NA
"47",14456001,"1  (bases 1 to 480)","Armau,E.",NA,"APPLICATION OF ANTIBIOTICS OF THE PHLEOMYCINE FAMILY AS SELECTION	AGENT IN THE FIELD OF GENETIC ENGINEERING","Patent: WO 8601537-A1 2 13-MAR-1986;	CNRS",NA,NA
"48",14457001,"1  (bases 1 to 158)","Grandi,G.",NA,"","Patent: GB 2126590-A 1 28-MAR-1984;	ENI-Ente Nayionale",NA,NA
"49",14458001,"1  (bases 1 to 29)","Grandi,G.",NA,"","Patent: GB 2126590-A 2 28-MAR-1984;	ENI-Ente Nayionale",NA,NA
"50",14459001,"1  (bases 1 to 32)","Grandi,G.",NA,"","Patent: GB 2126590-A 3 28-MAR-1984;	ENI-Ente Nayionale",NA,NA
"51",14460001,"1  (bases 1 to 33)","Grandi,G.",NA,"","Patent: GB 2126590-A 4 28-MAR-1984;	ENI-Ente Nayionale",NA,NA
"52",14461001,"1  (bases 1 to 63)","Nofschneider,P.H., Schaller,H., Kupper,H.A. and Keller.",NA,"","Patent: GB 2079288-A 5 20-JAN-1982;	Biogen N.V",NA,NA
"53",14462001,"1  (bases 1 to 961)","Nofschneider,P.H., Schaller,H., Kupper,H.A. and Keller.",NA,"","Patent: GB 2079288-A 2 20-JAN-1982;	Biogen N.V",NA,NA
"54",14463001,"1  (bases 1 to 662)","Nofschneider,P.H., Schaller,H., Kupper,H.A. and Keller.",NA,"","Patent: GB 2079288-A 3 20-JAN-1982;	Biogen N.V",NA,NA
"55",14464001,"1  (bases 1 to 1761)","Aberg,B.",NA,"","Patent: WO 8902467-A1 1 23-MAR-1989;	Skandigen AB",NA,NA
"56",14466001,"1  (bases 1 to 76)","Aberg,B.",NA,"","Patent: WO 8902467-A1 2 23-MAR-1989;	Skandigen AB",NA,NA
"57",14467001,"1  (bases 1 to 77)","Aberg,B.",NA,"","Patent: WO 8902467-A1 3 23-MAR-1989;	Skandigen AB",NA,NA
"58",14468001,"1  (bases 1 to 75)","Aberg,B.",NA,"","Patent: WO 8902467-A1 4 23-MAR-1989;	Skandigen AB",NA,NA
"59",14469001,"1  (bases 1 to 70)","Aberg,B.",NA,"","Patent: WO 8902467-A1 5 23-MAR-1989;	Skandigen AB",NA,NA
"60",14470001,"1  (bases 1 to 76)","Aberg,B.",NA,"","Patent: WO 8902467-A1 6 23-MAR-1989;	Skandigen AB",NA,NA
"61",14471001,"1  (bases 1 to 82)","Aberg,B.",NA,"","Patent: WO 8902467-A1 7 23-MAR-1989;	Skandigen AB",NA,NA
"62",14472001,"1  (bases 1 to 74)","Aberg,B.",NA,"","Patent: WO 8902467-A1 8 23-MAR-1989;	Skandigen AB",NA,NA
"63",14473001,"1  (bases 1 to 76)","Aberg,B.",NA,"","Patent: WO 8902467-A1 9 23-MAR-1989;	Skandigen AB",NA,NA
"64",14474001,"1  (bases 1 to 74)","Aberg,B.",NA,"","Patent: WO 8902467-A1 10 23-MAR-1989;	Skandigen AB",NA,NA
"65",14475001,"1  (bases 1 to 18)","Kang,C.Y.",NA,"","Patent: GB 2228486-A 13 29-AUG-1990;	Univesity of Ottawa",NA,NA
"66",14476001,"1  (bases 1 to 14)","Sanchez,F.S., Susan,V.R., Carramolino-Fitera,L. and Ortega,A.P.A.",NA,"Fungal resistance markers","Patent: EP 0240250-A1 2 07-OCT-1987;	Antibioticos, S.A",NA,NA
"67",14477001,"1  (bases 1 to 12)","Sanchez,F.S., Susan,V.R., Carramolino-Fitera,L. and Ortega,A.P.A.",NA,"Fungal resistance markers","Patent: EP 0240250-A1 3 07-OCT-1987;	Antibioticos, S.A",NA,NA
"68",14478001,"1  (bases 1 to 33)","Vega,D.P., Martinez,A.G., Falgueras,M.S., Mellado,R.P. and	Redondo,A.M.",NA,"Streptomyces expression vectors","Patent: EP 0310436-A2 2 05-APR-1989;	Antibioticos, S.A",NA,NA
"69",14479001,"1  (bases 1 to 39)","Hofnung,M., Charbit,A. and Boulain,J.C.",NA,"Procedure for exposing an epitope within a protein possessing a	distinct polypeptide structure, and the products obtained","Patent: EP 0242243-A1 2 21-OCT-1987;	INSTITUT PASTEUR; CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE	(CNRS); INSTITUT PASTEUR; CENTRE NATIONAL DE LA RECHERCHE	SCIENTIFIQUE (CNRS)",NA,NA
"70",14480001,"1  (bases 1 to 39)","Hofnung,M., Charbit,A. and Boulain,J.C.",NA,"Procedure for exposing an epitope within a protein possessing a	distinct polypeptide structure, and the products obtained","Patent: EP 0242243-A1 3 21-OCT-1987;	INSTITUT PASTEUR; CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE	(CNRS); INSTITUT PASTEUR; CENTRE NATIONAL DE LA RECHERCHE	SCIENTIFIQUE (CNRS)",NA,NA
"71",14481001,"1  (bases 1 to 24)","Hofnung,M., Charbit,A. and Boulain,J.C.",NA,"Procedure for exposing an epitope within a protein possessing a	distinct polypeptide structure, and the products obtained","Patent: EP 0242243-A1 4 21-OCT-1987;	INSTITUT PASTEUR; CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE	(CNRS); INSTITUT PASTEUR; CENTRE NATIONAL DE LA RECHERCHE	SCIENTIFIQUE (CNRS)",NA,NA
"72",14482001,"1  (bases 1 to 24)","Hofnung,M., Charbit,A. and Boulain,J.C.",NA,"Procedure for exposing an epitope within a protein possessing a	distinct polypeptide structure, and the products obtained","Patent: EP 0242243-A1 6 21-OCT-1987;	INSTITUT PASTEUR; CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE	(CNRS); INSTITUT PASTEUR; CENTRE NATIONAL DE LA RECHERCHE	SCIENTIFIQUE (CNRS)",NA,NA
"73",14483001,"1  (bases 1 to 27)","Hofnung,M., Charbit,A. and Boulain,J.C.",NA,"Procedure for exposing an epitope within a protein possessing a	distinct polypeptide structure, and the products obtained","Patent: EP 0242243-A1 8 21-OCT-1987;	INSTITUT PASTEUR; CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE	(CNRS); INSTITUT PASTEUR; CENTRE NATIONAL DE LA RECHERCHE	SCIENTIFIQUE (CNRS)",NA,NA
"74",14484001,"1  (bases 1 to 24)","Hofnung,M., Charbit,A. and Boulain,J.C.",NA,"Procedure for exposing an epitope within a protein possessing a	distinct polypeptide structure, and the products obtained","Patent: EP 0242243-A1 10 21-OCT-1987;	INSTITUT PASTEUR; CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE	(CNRS); INSTITUT PASTEUR; CENTRE NATIONAL DE LA RECHERCHE	SCIENTIFIQUE (CNRS)",NA,NA
"75",14485001,"1  (bases 1 to 24)","Hofnung,M., Charbit,A. and Boulain,J.C.",NA,"Procedure for exposing an epitope within a protein possessing a	distinct polypeptide structure, and the products obtained","Patent: EP 0242243-A1 12 21-OCT-1987;	INSTITUT PASTEUR; CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE	(CNRS); INSTITUT PASTEUR; CENTRE NATIONAL DE LA RECHERCHE	SCIENTIFIQUE (CNRS)",NA,NA
"76",14486001,"1  (bases 1 to 39)","Nigon,V.M.",NA,"INTEGRATION AND EXPRESSION VIRAL VECTORS","Patent: WO 8903877-A1 1 05-MAY-1989;	Institut de la Recherche Agronomique",NA,NA
"77",14487001,"1  (bases 1 to 28)","Nigon,V.M.",NA,"INTEGRATION AND EXPRESSION VIRAL VECTORS","Patent: WO 8903877-A1 2 05-MAY-1989;	Institut de la Recherche Agronomique",NA,NA
"78",14488001,"1  (bases 1 to 813)","Nigon,V.M.",NA,"INTEGRATION AND EXPRESSION VIRAL VECTORS","Patent: WO 8903877-A1 3 05-MAY-1989;	Institut de la Recherche Agronomique",NA,NA
"79",14489001,"1  (bases 1 to 267)","Nigon,V.M.",NA,"INTEGRATION AND EXPRESSION VIRAL VECTORS","Patent: WO 8903877-A1 4 05-MAY-1989;	Institut de la Recherche Agronomique",NA,NA
"80",14490001,"1  (bases 1 to 276)","Nigon,V.M.",NA,"INTEGRATION AND EXPRESSION VIRAL VECTORS","Patent: WO 8903877-A1 5 05-MAY-1989;	Institut de la Recherche Agronomique",NA,NA
"81",14491001,"1  (bases 1 to 108)","Nigon,V.M.",NA,"INTEGRATION AND EXPRESSION VIRAL VECTORS","Patent: WO 8903877-A1 6 05-MAY-1989;	Institut de la Recherche Agronomique",NA,NA
"82",14492001,"1  (bases 1 to 42)","Nigon,V.M.",NA,"INTEGRATION AND EXPRESSION VIRAL VECTORS","Patent: WO 8903877-A1 7 05-MAY-1989;	Institut de la Recherche Agronomique",NA,NA
"83",14493001,"1  (bases 1 to 350)","Nigon,V.M.",NA,"INTEGRATION AND EXPRESSION VIRAL VECTORS","Patent: WO 8903877-A1 8 05-MAY-1989;	Institut de la Recherche Agronomique",NA,NA
"84",14494001,"1  (bases 1 to 16)","Nigon,V.M.",NA,"INTEGRATION AND EXPRESSION VIRAL VECTORS","Patent: WO 8903877-A1 9 05-MAY-1989;	Institut de la Recherche Agronomique",NA,NA
"85",14495001,"1  (bases 1 to 22)","Nigon,V.M.",NA,"INTEGRATION AND EXPRESSION VIRAL VECTORS","Patent: WO 8903877-A1 10 05-MAY-1989;	Institut de la Recherche Agronomique",NA,NA
"86",14496001,"1  (bases 1 to 60)","Nigon,V.M.",NA,"INTEGRATION AND EXPRESSION VIRAL VECTORS","Patent: WO 8903877-A1 11 05-MAY-1989;	Institut de la Recherche Agronomique",NA,NA
"87",14497001,"1  (bases 1 to 19)","Nigon,V.M.",NA,"INTEGRATION AND EXPRESSION VIRAL VECTORS","Patent: WO 8903877-A1 12 05-MAY-1989;	Institut de la Recherche Agronomique",NA,NA
"88",14498001,"1  (bases 1 to 15)","Meneguzzi,G.",NA,"PHARMACEUTICAL COMPOSITION USEFUL IN THE PREVENTION OR TREATMENT OF	PAPILLOMAVIRUS-INDUCED TUMOURS","Patent: WO 9010459-A1 1 20-SEP-1990;	Transgene S.A",NA,NA
"89",14499001,"1  (bases 1 to 20)","Meneguzzi,G.",NA,"PHARMACEUTICAL COMPOSITION USEFUL IN THE PREVENTION OR TREATMENT OF	PAPILLOMAVIRUS-INDUCED TUMOURS","Patent: WO 9010459-A1 2 20-SEP-1990;	Transgene S.A",NA,NA
"90",14500001,"1  (bases 1 to 18)","Meneguzzi,G.",NA,"PHARMACEUTICAL COMPOSITION USEFUL IN THE PREVENTION OR TREATMENT OF	PAPILLOMAVIRUS-INDUCED TUMOURS","Patent: WO 9010459-A1 3 20-SEP-1990;	Transgene S.A",NA,NA
"91",14501001,"1  (bases 1 to 24)","Meneguzzi,G.",NA,"PHARMACEUTICAL COMPOSITION USEFUL IN THE PREVENTION OR TREATMENT OF	PAPILLOMAVIRUS-INDUCED TUMOURS","Patent: WO 9010459-A1 4 20-SEP-1990;	Transgene S.A",NA,NA
"92",14502001,"1  (bases 1 to 11)","Meneguzzi,G.",NA,"PHARMACEUTICAL COMPOSITION USEFUL IN THE PREVENTION OR TREATMENT OF	PAPILLOMAVIRUS-INDUCED TUMOURS","Patent: WO 9010459-A1 5 20-SEP-1990;	Transgene S.A",NA,NA
"93",14503001,"1  (bases 1 to 25)","Meneguzzi,G.",NA,"PHARMACEUTICAL COMPOSITION USEFUL IN THE PREVENTION OR TREATMENT OF	PAPILLOMAVIRUS-INDUCED TUMOURS","Patent: WO 9010459-A1 6 20-SEP-1990;	Transgene S.A",NA,NA
"94",14504001,"1  (bases 1 to 13)","Meneguzzi,G.",NA,"PHARMACEUTICAL COMPOSITION USEFUL IN THE PREVENTION OR TREATMENT OF	PAPILLOMAVIRUS-INDUCED TUMOURS","Patent: WO 9010459-A1 7 20-SEP-1990;	Transgene S.A",NA,NA
"95",14505001,"1  (bases 1 to 27)","Meneguzzi,G.",NA,"PHARMACEUTICAL COMPOSITION USEFUL IN THE PREVENTION OR TREATMENT OF	PAPILLOMAVIRUS-INDUCED TUMOURS","Patent: WO 9010459-A1 8 20-SEP-1990;	Transgene S.A",NA,NA
"96",14506001,"1  (bases 1 to 15)","Meneguzzi,G.",NA,"PHARMACEUTICAL COMPOSITION USEFUL IN THE PREVENTION OR TREATMENT OF	PAPILLOMAVIRUS-INDUCED TUMOURS","Patent: WO 9010459-A1 9 20-SEP-1990;	Transgene S.A",NA,NA
"97",14507001,"1  (bases 1 to 9)","Meneguzzi,G.",NA,"PHARMACEUTICAL COMPOSITION USEFUL IN THE PREVENTION OR TREATMENT OF	PAPILLOMAVIRUS-INDUCED TUMOURS","Patent: WO 9010459-A1 10 20-SEP-1990;	Transgene S.A",NA,NA
"98",14508001,"1  (bases 1 to 25)","Meneguzzi,G.",NA,"PHARMACEUTICAL COMPOSITION USEFUL IN THE PREVENTION OR TREATMENT OF	PAPILLOMAVIRUS-INDUCED TUMOURS","Patent: WO 9010459-A1 11 20-SEP-1990;	Transgene S.A",NA,NA
"99",14509001,"1  (bases 1 to 25)","Meneguzzi,G.",NA,"PHARMACEUTICAL COMPOSITION USEFUL IN THE PREVENTION OR TREATMENT OF	PAPILLOMAVIRUS-INDUCED TUMOURS","Patent: WO 9010459-A1 12 20-SEP-1990;	Transgene S.A",NA,NA
"100",14510001,"1  (bases 1 to 15)","Meneguzzi,G.",NA,"PHARMACEUTICAL COMPOSITION USEFUL IN THE PREVENTION OR TREATMENT OF	PAPILLOMAVIRUS-INDUCED TUMOURS","Patent: WO 9010459-A1 13 20-SEP-1990;	Transgene S.A",NA,NA
"101",14511001,"1  (bases 1 to 15)","Meneguzzi,G.",NA,"PHARMACEUTICAL COMPOSITION USEFUL IN THE PREVENTION OR TREATMENT OF	PAPILLOMAVIRUS-INDUCED TUMOURS","Patent: WO 9010459-A1 14 20-SEP-1990;	Transgene S.A",NA,NA
"102",14512001,"1  (bases 1 to 16)","Meneguzzi,G.",NA,"PHARMACEUTICAL COMPOSITION USEFUL IN THE PREVENTION OR TREATMENT OF	PAPILLOMAVIRUS-INDUCED TUMOURS","Patent: WO 9010459-A1 15 20-SEP-1990;	Transgene S.A",NA,NA
"103",14513001,"1  (bases 1 to 37)","Meneguzzi,G.",NA,"PHARMACEUTICAL COMPOSITION USEFUL IN THE PREVENTION OR TREATMENT OF	PAPILLOMAVIRUS-INDUCED TUMOURS","Patent: WO 9010459-A1 16 20-SEP-1990;	Transgene S.A",NA,NA
"104",14514001,"1  (bases 1 to 18)","Meneguzzi,G.",NA,"PHARMACEUTICAL COMPOSITION USEFUL IN THE PREVENTION OR TREATMENT OF	PAPILLOMAVIRUS-INDUCED TUMOURS","Patent: WO 9010459-A1 17 20-SEP-1990;	Transgene S.A",NA,NA
"105",14515001,"1  (bases 1 to 32)","Meneguzzi,G.",NA,"PHARMACEUTICAL COMPOSITION USEFUL IN THE PREVENTION OR TREATMENT OF	PAPILLOMAVIRUS-INDUCED TUMOURS","Patent: WO 9010459-A1 18 20-SEP-1990;	Transgene S.A",NA,NA
"106",14516001,"1  (bases 1 to 36)","Meneguzzi,G.",NA,"PHARMACEUTICAL COMPOSITION USEFUL IN THE PREVENTION OR TREATMENT OF	PAPILLOMAVIRUS-INDUCED TUMOURS","Patent: WO 9010459-A1 19 20-SEP-1990;	Transgene S.A",NA,NA
"107",14517001,"1  (bases 1 to 37)","Meneguzzi,G.",NA,"PHARMACEUTICAL COMPOSITION USEFUL IN THE PREVENTION OR TREATMENT OF	PAPILLOMAVIRUS-INDUCED TUMOURS","Patent: WO 9010459-A1 20 20-SEP-1990;	Transgene S.A",NA,NA
"108",14518001,"1  (bases 1 to 252)","Meneguzzi,G.",NA,"PHARMACEUTICAL COMPOSITION USEFUL IN THE PREVENTION OR TREATMENT OF	PAPILLOMAVIRUS-INDUCED TUMOURS","Patent: WO 9010459-A1 21 20-SEP-1990;	Transgene S.A",NA,NA
"109",14520001,"1  (bases 1 to 731)","Tandeau de Marsac,N.",NA,"EXPRESSION OF SEQUENCES OF NUCLEOTIDES CODING FOR GAS VESICLES","Patent: WO 9010071-A1 1 07-SEP-1990;	Institut Pasteur",NA,NA
"110",14522001,"1  (bases 1 to 51)","Marchand,C.",NA,"MOLECULES COMPRISING AT LEAST ONE PEPTIDIC SEQUENCE CARRYING ONE OR	A PLURALITY OF EPITOPES CHARACTERIZING A PROTEIN PRODUCED BY P.	FALCIPARUM IN HEPATOCYTES AND COMPOSITIONS CONTAINING THEM","Patent: WO 8805785-A1 17 11-AUG-1988;	Institut Pasteur",NA,NA
"111",14523001,"1  (bases 1 to 210)","Marchand,C.",NA,"MOLECULES COMPRISING AT LEAST ONE PEPTIDIC SEQUENCE CARRYING ONE OR	A PLURALITY OF EPITOPES CHARACTERIZING A PROTEIN PRODUCED BY P.	FALCIPARUM IN HEPATOCYTES AND COMPOSITIONS CONTAINING THEM","Patent: WO 8805785-A1 18 11-AUG-1988;	Institut Pasteur",NA,NA
"112",14524001,"1  (bases 1 to 354)",".",NA,"PROTEINS FOR FUSING THE SUB-UNIT B OF THE CHOLERAIC TOXIN AND	HETEROLOGOUS ANTIGEN, AND NUCLEIC ACIDS ENCODING THEM","Patent: WO 9003437-A1 2 05-APR-1990;",NA,NA
"113",14526001,"1  (bases 1 to 354)",".",NA,"PROTEINS FOR FUSING THE SUB-UNIT B OF THE CHOLERAIC TOXIN AND	HETEROLOGOUS ANTIGEN, AND NUCLEIC ACIDS ENCODING THEM","Patent: WO 9003437-A1 3 05-APR-1990;",NA,NA
"114",14527001,"1  (bases 1 to 32)",".",NA,"PROTEINS FOR FUSING THE SUB-UNIT B OF THE CHOLERAIC TOXIN AND	HETEROLOGOUS ANTIGEN, AND NUCLEIC ACIDS ENCODING THEM","Patent: WO 9003437-A1 4 05-APR-1990;",NA,NA
"115",14528001,"1  (bases 1 to 32)",".",NA,"PROTEINS FOR FUSING THE SUB-UNIT B OF THE CHOLERAIC TOXIN AND	HETEROLOGOUS ANTIGEN, AND NUCLEIC ACIDS ENCODING THEM","Patent: WO 9003437-A1 5 05-APR-1990;",NA,NA
"116",14529001,"1  (bases 1 to 46)",".",NA,"PROTEINS FOR FUSING THE SUB-UNIT B OF THE CHOLERAIC TOXIN AND	HETEROLOGOUS ANTIGEN, AND NUCLEIC ACIDS ENCODING THEM","Patent: WO 9003437-A1 8 05-APR-1990;",NA,NA
"117",14530001,"1  (bases 1 to 10)",".",NA,"PROTEINS FOR FUSING THE SUB-UNIT B OF THE CHOLERAIC TOXIN AND	HETEROLOGOUS ANTIGEN, AND NUCLEIC ACIDS ENCODING THEM","Patent: WO 9003437-A1 9 05-APR-1990;",NA,NA
"118",14531001,"1  (bases 1 to 18)",".",NA,"PROTEINS FOR FUSING THE SUB-UNIT B OF THE CHOLERAIC TOXIN AND	HETEROLOGOUS ANTIGEN, AND NUCLEIC ACIDS ENCODING THEM","Patent: WO 9003437-A1 10 05-APR-1990;",NA,NA
"119",14532001,"1  (bases 1 to 83)",".",NA,"PROTEINS FOR FUSING THE SUB-UNIT B OF THE CHOLERAIC TOXIN AND	HETEROLOGOUS ANTIGEN, AND NUCLEIC ACIDS ENCODING THEM","Patent: WO 9003437-A1 12 05-APR-1990;",NA,NA
"120",14533001,"1  (bases 1 to 83)",".",NA,"PROTEINS FOR FUSING THE SUB-UNIT B OF THE CHOLERAIC TOXIN AND	HETEROLOGOUS ANTIGEN, AND NUCLEIC ACIDS ENCODING THEM","Patent: WO 9003437-A1 13 05-APR-1990;",NA,NA
"121",14534001,"1  (bases 1 to 56)",".",NA,"PROTEINS FOR FUSING THE SUB-UNIT B OF THE CHOLERAIC TOXIN AND	HETEROLOGOUS ANTIGEN, AND NUCLEIC ACIDS ENCODING THEM","Patent: WO 9003437-A1 15 05-APR-1990;",NA,NA
"122",14535001,"1  (bases 1 to 83)","Goeddel,D.V. and Heyneker,H.L.",NA,"","Patent: GB 2121048-A 2 14-DEC-1983;	Genentech Inc",NA,NA
"123",14537001,"1  (bases 1 to 83)","Goeddel,D.V. and Heyneker,H.L.",NA,"","Patent: GB 2121048-A 3 14-DEC-1983;	Genentech Inc",NA,NA
"124",14538001,"1  (bases 1 to 556)","Goeddel,D.V. and Heyneker,H.L.",NA,"","Patent: GB 2121048-A 5 14-DEC-1983;	Genentech Inc",NA,NA
"125",14540001,"1  (bases 1 to 576)",".",NA,"","Patent: GB 2091268-A 1 28-JUL-1982;",NA,NA
"126",14541001,"1  (bases 1 to 576)",".",NA,"","Patent: GB 2091268-A 2 28-JUL-1982;",NA,NA
"127",14542001,"1  (bases 1 to 465)",".",NA,"","Patent: GB 2091268-A 4 28-JUL-1982;",NA,NA
"128",14544001,"1  (bases 1 to 465)",".",NA,"","Patent: GB 2091268-A 5 28-JUL-1982;",NA,NA
"129",14546001,"1  (bases 1 to 39)",".",NA,"","Patent: GB 2091268-A 6 28-JUL-1982;",NA,NA
"130",14547001,"1  (bases 1 to 40)",".",NA,"","Patent: GB 2091268-A 8 28-JUL-1982;",NA,NA
"131",14548001,"1  (bases 1 to 41)",".",NA,"","Patent: GB 2091268-A 9 28-JUL-1982;",NA,NA
"132",14549001,"1  (bases 1 to 42)",".",NA,"","Patent: GB 2091268-A 10 28-JUL-1982;",NA,NA
"133",14550001,"1  (bases 1 to 39)",".",NA,"","Patent: GB 2091268-A 11 28-JUL-1982;",NA,NA
"134",14551001,"1  (bases 1 to 40)",".",NA,"","Patent: GB 2091268-A 12 28-JUL-1982;",NA,NA
"135",14552001,"1  (bases 1 to 41)",".",NA,"","Patent: GB 2091268-A 13 28-JUL-1982;",NA,NA
"136",14553001,"1  (bases 1 to 42)",".",NA,"","Patent: GB 2091268-A 14 28-JUL-1982;",NA,NA
"137",14554001,"1  (bases 1 to 43)",".",NA,"","Patent: GB 2091268-A 15 28-JUL-1982;",NA,NA
"138",14555001,"1  (bases 1 to 43)",".",NA,"","Patent: GB 2091268-A 16 28-JUL-1982;",NA,NA
"139",14556001,"1  (bases 1 to 44)",".",NA,"","Patent: GB 2091268-A 17 28-JUL-1982;",NA,NA
"140",14557001,"1  (bases 1 to 44)",".",NA,"","Patent: GB 2091268-A 18 28-JUL-1982;",NA,NA
"141",14558001,"1  (bases 1 to 754)","Mattick,J.",NA,"IMPROVED ANTIGENIC PREPARATION","Patent: WO 8602557-A1 8 09-MAY-1986;	Commonwealth Scientificand Industrial Res. Organization",NA,NA
"142",14560001,"1  (bases 1 to 224)",".",NA,"DNA SEQUENCE ENCODING A HIRUDIN-LIKE PROTEIN AND PROCESS FOR	PREPARING SUCH PROTEIN","Patent: WO 8603517-A1 15 19-JUN-1986;",NA,NA
"143",14562001,"1  (bases 1 to 224)",".",NA,"DNA SEQUENCE ENCODING A HIRUDIN-LIKE PROTEIN AND PROCESS FOR	PREPARING SUCH PROTEIN","Patent: WO 8603517-A1 16 19-JUN-1986;",NA,NA
"144",14563001,"1  (bases 1 to 33)",".",NA,"DNA SEQUENCE ENCODING A HIRUDIN-LIKE PROTEIN AND PROCESS FOR	PREPARING SUCH PROTEIN","Patent: WO 8603517-A1 1 19-JUN-1986;",NA,NA
"145",14564001,"1  (bases 1 to 34)",".",NA,"DNA SEQUENCE ENCODING A HIRUDIN-LIKE PROTEIN AND PROCESS FOR	PREPARING SUCH PROTEIN","Patent: WO 8603517-A1 2 19-JUN-1986;",NA,NA
"146",14565001,"1  (bases 1 to 35)",".",NA,"DNA SEQUENCE ENCODING A HIRUDIN-LIKE PROTEIN AND PROCESS FOR	PREPARING SUCH PROTEIN","Patent: WO 8603517-A1 3 19-JUN-1986;",NA,NA
"147",14566001,"1  (bases 1 to 35)",".",NA,"DNA SEQUENCE ENCODING A HIRUDIN-LIKE PROTEIN AND PROCESS FOR	PREPARING SUCH PROTEIN","Patent: WO 8603517-A1 4 19-JUN-1986;",NA,NA
"148",14567001,"1  (bases 1 to 32)",".",NA,"DNA SEQUENCE ENCODING A HIRUDIN-LIKE PROTEIN AND PROCESS FOR	PREPARING SUCH PROTEIN","Patent: WO 8603517-A1 5 19-JUN-1986;",NA,NA
"149",14568001,"1  (bases 1 to 32)",".",NA,"DNA SEQUENCE ENCODING A HIRUDIN-LIKE PROTEIN AND PROCESS FOR	PREPARING SUCH PROTEIN","Patent: WO 8603517-A1 6 19-JUN-1986;",NA,NA
"150",14569001,"1  (bases 1 to 36)",".",NA,"DNA SEQUENCE ENCODING A HIRUDIN-LIKE PROTEIN AND PROCESS FOR	PREPARING SUCH PROTEIN","Patent: WO 8603517-A1 7 19-JUN-1986;",NA,NA
"151",14570001,"1  (bases 1 to 36)",".",NA,"DNA SEQUENCE ENCODING A HIRUDIN-LIKE PROTEIN AND PROCESS FOR	PREPARING SUCH PROTEIN","Patent: WO 8603517-A1 8 19-JUN-1986;",NA,NA
"152",14571001,"1  (bases 1 to 37)",".",NA,"DNA SEQUENCE ENCODING A HIRUDIN-LIKE PROTEIN AND PROCESS FOR	PREPARING SUCH PROTEIN","Patent: WO 8603517-A1 9 19-JUN-1986;",NA,NA
"153",14572001,"1  (bases 1 to 37)",".",NA,"DNA SEQUENCE ENCODING A HIRUDIN-LIKE PROTEIN AND PROCESS FOR	PREPARING SUCH PROTEIN","Patent: WO 8603517-A1 10 19-JUN-1986;",NA,NA
"154",14573001,"1  (bases 1 to 29)",".",NA,"DNA SEQUENCE ENCODING A HIRUDIN-LIKE PROTEIN AND PROCESS FOR	PREPARING SUCH PROTEIN","Patent: WO 8603517-A1 11 19-JUN-1986;",NA,NA
"155",14574001,"1  (bases 1 to 29)",".",NA,"DNA SEQUENCE ENCODING A HIRUDIN-LIKE PROTEIN AND PROCESS FOR	PREPARING SUCH PROTEIN","Patent: WO 8603517-A1 12 19-JUN-1986;",NA,NA
"156",14575001,"1  (bases 1 to 18)",".",NA,"DNA SEQUENCE ENCODING A HIRUDIN-LIKE PROTEIN AND PROCESS FOR	PREPARING SUCH PROTEIN","Patent: WO 8603517-A1 13 19-JUN-1986;",NA,NA
"157",14576001,"1  (bases 1 to 17)",".",NA,"DNA SEQUENCE ENCODING A HIRUDIN-LIKE PROTEIN AND PROCESS FOR	PREPARING SUCH PROTEIN","Patent: WO 8603517-A1 14 19-JUN-1986;",NA,NA
"158",14577001,"1  (bases 1 to 878)",".",NA,"RECOMBINANT DNA AND ITS USE","Patent: WO 8601534-A1 1 13-MAR-1986;",NA,NA
"159",14579001,"1  (bases 1 to 860)",".",NA,"RECOMBINANT DNA AND ITS USE","Patent: WO 8601534-A1 2 13-MAR-1986;",NA,NA
"160",14581001,"1  (bases 1 to 580)","Molin,S.",NA,"","Patent: WO 8607608-A1 1 31-DEC-1986;	Alfred Benzon",NA,NA
"161",14582001,"1  (bases 1 to 580)","Molin,S.",NA,"","Patent: WO 8607608-A1 2 31-DEC-1986;	Alfred Benzon",NA,NA
"162",14583001,"1  (bases 1 to 330)","Molin,S.",NA,"","Patent: WO 8607608-A1 9 31-DEC-1986;	Alfred Benzon",NA,NA
"163",14585001,"1  (bases 1 to 327)","Molin,S.",NA,"","Patent: WO 8607608-A1 10 31-DEC-1986;	Alfred Benzon",NA,NA
"164",14587001,"1  (bases 1 to 45)","Neuberger,M.S.",NA,"PRODUCTION OF CHIMERIC ANTIBODIES","Patent: WO 8601533-A1 2 13-MAR-1986;	CellTech Ltd",NA,NA
"165",14588001,"1  (bases 1 to 6)","Neuberger,M.S.",NA,"PRODUCTION OF CHIMERIC ANTIBODIES","Patent: WO 8601533-A1 3 13-MAR-1986;	CellTech Ltd",NA,NA
"166",14589001,"1  (bases 1 to 15)","Neuberger,M.S.",NA,"PRODUCTION OF CHIMERIC ANTIBODIES","Patent: WO 8601533-A1 4 13-MAR-1986;	CellTech Ltd",NA,NA
"167",14590001,"1  (bases 1 to 878)",".",NA,"RECOMBINANT DNA AND ITS USE","Patent: WO 8600640-A1 1 30-JAN-1986;",NA,NA
"168",14592001,"1  (bases 1 to 860)",".",NA,"RECOMBINANT DNA AND ITS USE","Patent: WO 8600640-A1 3 30-JAN-1986;",NA,NA
"169",14594001,"1  (bases 1 to 22)","Hinnen,A.",NA,"EUKARYGOTIC HYBRID VECTORS AND PREPARATION OF POLYPEPTIDES","Patent: WO 8600089-A1 1 03-JAN-1986;	CIBA-GEIGY",NA,NA
"170",14595001,"1  (bases 1 to 22)","Hinnen,A.",NA,"EUKARYGOTIC HYBRID VECTORS AND PREPARATION OF POLYPEPTIDES","Patent: WO 8600089-A1 6 03-JAN-1986;	CIBA-GEIGY",NA,NA
"171",14596001,"1  (bases 1 to 18)","Hinnen,A.",NA,"EUKARYGOTIC HYBRID VECTORS AND PREPARATION OF POLYPEPTIDES","Patent: WO 8600089-A1 7 03-JAN-1986;	CIBA-GEIGY",NA,NA
"172",14597001,"1  (bases 1 to 66)","Hinnen,A.",NA,"EUKARYGOTIC HYBRID VECTORS AND PREPARATION OF POLYPEPTIDES","Patent: WO 8600089-A1 8 03-JAN-1986;	CIBA-GEIGY",NA,NA
"173",14598001,"1  (bases 1 to 377)","Hinnen,A.",NA,"EUKARYGOTIC HYBRID VECTORS AND PREPARATION OF POLYPEPTIDES","Patent: WO 8600089-A1 9 03-JAN-1986;	CIBA-GEIGY",NA,NA
"174",14600001,"1  (bases 1 to 221)","Edwards,R.",NA,"SYNTHETIC DNA SEQUENCE CODING FOR HUMAN INSULIN-LIKE GROWTH FACTOR	II","Patent: WO 8903423-A1 2 20-APR-1989;	British Bio-Technology Ltd",NA,NA
"175",14602001,"1  (bases 1 to 955)","Edwards,R.",NA,"SYNTHETIC GENE","Patent: WO 8903424-A1 2 20-APR-1989;	British Bio-Technology Ltd",NA,NA
"176",14604001,"1  (bases 1 to 955)","Edwards,R.",NA,"SYNTHETIC GENE","Patent: WO 8903424-A1 3 20-APR-1989;	British Bio-Technology Ltd",NA,NA
"177",14605001,"1  (bases 1 to 507)","Edwards,R.",NA,"SYNTHETIC GENE","Patent: WO 8903422-A1 2 20-APR-1989;	British Bio-Technology Ltd",NA,NA
"178",14607001,"1  (bases 1 to 507)","Edwards,R.",NA,"SYNTHETIC GENE","Patent: WO 8903422-A1 3 20-APR-1989;	British Bio-Technology Ltd",NA,NA
"179",14608001,"1  (bases 1 to 1068)","Stern,A.",NA,"TISSUE PLASMINOGENE ACTIVATOR DERIVATIVE","Patent: WO 9009437-A1 2 23-AUG-1990;	Boehringer Mannheim GMBH",NA,NA
"180",14610001,"1  (bases 1 to 1890)","Chakrabory,T.",NA,"PROCESS FOR TESTING FOR PATHOGENIC LISTERIA BACTERIA","Patent: WO 9008197-A1 1 26-JUL-1990;	Boehringer Mannheim GMBH",NA,NA
"181",14614001,"1  (bases 1 to 1704)","Schroeder,G., Schroeder,J., Hain,R. and Schreier,P.H.",NA,"Stilbene synthase gene","Patent: EP 0309862-A1 2 05-APR-1989;	BAYER AG",NA,NA
"182",14615001,"1  (bases 1 to 4068)","Certa,U.",NA,"Antimalaria vaccines","Patent: EP 0309746-A1 10 05-APR-1989;	F. HOFFMANN-LA ROCHE AG",NA,NA
"183",14616001,"1  (bases 1 to 3740)","Certa,U.",NA,"Antimalaria vaccines","Patent: EP 0309746-A1 11 05-APR-1989;	F. HOFFMANN-LA ROCHE AG",NA,NA
"184",14617001,"1  (bases 1 to 5376)","Certa,U.",NA,"Antimalaria vaccines","Patent: EP 0309746-A1 12 05-APR-1989;	F. HOFFMANN-LA ROCHE AG",NA,NA
"185",14618001,"1  (bases 1 to 5376)","Certa,U.",NA,"Antimalaria vaccines","Patent: EP 0309746-A1 13 05-APR-1989;	F. HOFFMANN-LA ROCHE AG",NA,NA
"186",14619001,"1  (bases 1 to 1599)","Certa,U.",NA,"Antimalaria vaccines","Patent: EP 0309746-A1 14 05-APR-1989;	F. HOFFMANN-LA ROCHE AG",NA,NA
"187",14621001,"1  (bases 1 to 75)","Aberg,B.",NA,"","Patent: WO 8902467-A1 11 23-MAR-1989;	Skandigen AB",NA,NA
"188",14622001,"1  (bases 1 to 76)","Aberg,B.",NA,"","Patent: WO 8902467-A1 12 23-MAR-1989;	Skandigen AB",NA,NA
"189",14623001,"1  (bases 1 to 76)","Aberg,B.",NA,"","Patent: WO 8902467-A1 13 23-MAR-1989;	Skandigen AB",NA,NA
"190",14624001,"1  (bases 1 to 79)","Aberg,B.",NA,"","Patent: WO 8902467-A1 14 23-MAR-1989;	Skandigen AB",NA,NA
"191",14625001,"1  (bases 1 to 81)","Aberg,B.",NA,"","Patent: WO 8902467-A1 15 23-MAR-1989;	Skandigen AB",NA,NA
"192",14626001,"1  (bases 1 to 79)","Aberg,B.",NA,"","Patent: WO 8902467-A1 16 23-MAR-1989;	Skandigen AB",NA,NA
"193",14627001,"1  (bases 1 to 76)","Aberg,B.",NA,"","Patent: WO 8902467-A1 17 23-MAR-1989;	Skandigen AB",NA,NA
"194",14628001,"1  (bases 1 to 85)","Aberg,B.",NA,"","Patent: WO 8902467-A1 18 23-MAR-1989;	Skandigen AB",NA,NA
"195",14629001,"1  (bases 1 to 73)","Aberg,B.",NA,"","Patent: WO 8902467-A1 19 23-MAR-1989;	Skandigen AB",NA,NA
"196",14630001,"1  (bases 1 to 69)","Aberg,B.",NA,"","Patent: WO 8902467-A1 20 23-MAR-1989;	Skandigen AB",NA,NA
"197",14631001,"1  (bases 1 to 74)","Aberg,B.",NA,"","Patent: WO 8902467-A1 21 23-MAR-1989;	Skandigen AB",NA,NA
"198",14632001,"1  (bases 1 to 77)","Aberg,B.",NA,"","Patent: WO 8902467-A1 22 23-MAR-1989;	Skandigen AB",NA,NA
"199",14633001,"1  (bases 1 to 77)","Aberg,B.",NA,"","Patent: WO 8902467-A1 23 23-MAR-1989;	Skandigen AB",NA,NA
"200",14634001,"1  (bases 1 to 77)","Aberg,B.",NA,"","Patent: WO 8902467-A1 24 23-MAR-1989;	Skandigen AB",NA,NA
"201",14635001,"1  (bases 1 to 78)","Aberg,B.",NA,"","Patent: WO 8902467-A1 25 23-MAR-1989;	Skandigen AB",NA,NA
"202",14636001,"1  (bases 1 to 25)","Aberg,B.",NA,"","Patent: WO 8902467-A1 26 23-MAR-1989;	Skandigen AB",NA,NA
"203",14637001,"1  (bases 1 to 34)","Aberg,B.",NA,"","Patent: WO 8902467-A1 27 23-MAR-1989;	Skandigen AB",NA,NA
"204",14638001,"1  (bases 1 to 18)","Aberg,B.",NA,"","Patent: WO 8902467-A1 28 23-MAR-1989;	Skandigen AB",NA,NA
"205",14639001,"1  (bases 1 to 27)","Aberg,B.",NA,"","Patent: WO 8902467-A1 29 23-MAR-1989;	Skandigen AB",NA,NA
"206",14640001,"1  (bases 1 to 1456)","Woeldike,H.",NA,"PROCESS FOR THE PRODUCTION OF PROTEIN PRODUCTS IN ASPERGILLUS AND	PROMOTERS FOR USE IN ASPERGILLUS","Patent: WO 8901969-A1 1 09-MAR-1989;	Novo Industries",NA,NA
"207",14641001,"1  (bases 1 to 140)","Woeldike,H.",NA,"PROCESS FOR THE PRODUCTION OF PROTEIN PRODUCTS IN ASPERGILLUS AND	PROMOTERS FOR USE IN ASPERGILLUS","Patent: WO 8901969-A1 2 09-MAR-1989;	Novo Industries",NA,NA
"208",14643001,"1  (bases 1 to 927)","Woeldike,H.",NA,"PROCESS FOR THE PRODUCTION OF PROTEIN PRODUCTS IN ASPERGILLUS AND	PROMOTERS FOR USE IN ASPERGILLUS","Patent: WO 8901969-A1 4 09-MAR-1989;	Novo Industries",NA,NA
"209",14644001,"1  (bases 1 to 1276)","Woeldike,H.",NA,"PROCESS FOR THE PRODUCTION OF PROTEIN PRODUCTS IN ASPERGILLUS AND	PROMOTERS FOR USE IN ASPERGILLUS","Patent: WO 8901969-A1 5 09-MAR-1989;	Novo Industries",NA,NA
"210",14645001,"1  (bases 1 to 162)","Woeldike,H.",NA,"PROCESS FOR THE PRODUCTION OF PROTEIN PRODUCTS IN ASPERGILLUS AND	PROMOTERS FOR USE IN ASPERGILLUS","Patent: WO 8901969-A1 6 09-MAR-1989;	Novo Industries",NA,NA
"211",14647001,"1  (bases 1 to 1800)","Woeldike,H.",NA,"PROCESS FOR THE PRODUCTION OF PROTEIN PRODUCTS IN ASPERGILLUS AND	PROMOTERS FOR USE IN ASPERGILLUS","Patent: WO 8901969-A1 9 09-MAR-1989;	Novo Industries",NA,NA
"212",14649001,"1  (bases 1 to 1240)","Borriss,R.",NA,"A THERMOSTABLE (1,3-1,4)- beta -GLUCANASE","Patent: WO 9009436-A1 3 23-AUG-1990;	Carlsberg",NA,NA
"213",14651001,"1  (bases 1 to 26)","Soubrier,F.",NA,"NUCLEIC ACID CODING FOR THE HUMAN ANGIOTENSINE CONVERSION ENZYME	(ACE), AND ITS APPLICATIONS PARTICULARLY FOR THE IN VITRO DIAGNOSIS	OF HIGH BLOOD PRESSURE","Patent: WO 9003435-A2 4 05-APR-1990;	Institut National de la Sante et de la Recherche Med",NA,NA
"214",14652001,"1  (bases 1 to 4024)","Soubrier,F.",NA,"NUCLEIC ACID CODING FOR THE HUMAN ANGIOTENSINE CONVERSION ENZYME	(ACE), AND ITS APPLICATIONS PARTICULARLY FOR THE IN VITRO DIAGNOSIS	OF HIGH BLOOD PRESSURE","Patent: WO 9003435-A2 18 05-APR-1990;	Institut National de la Sante et de la Recherche Med",NA,NA
"215",14654001,"1  (bases 1 to 56)",".",NA,"PROTEINS FOR FUSING THE SUB-UNIT B OF THE CHOLERAIC TOXIN AND	HETEROLOGOUS ANTIGEN, AND NUCLEIC ACIDS ENCODING THEM","Patent: WO 9003437-A1 17 05-APR-1990;",NA,NA
"216",14655001,"1  (bases 1 to 26)",".",NA,"PROTEINS FOR FUSING THE SUB-UNIT B OF THE CHOLERAIC TOXIN AND	HETEROLOGOUS ANTIGEN, AND NUCLEIC ACIDS ENCODING THEM","Patent: WO 9003437-A1 18 05-APR-1990;",NA,NA
"217",14656001,"1  (bases 1 to 28)",".",NA,"PROTEINS FOR FUSING THE SUB-UNIT B OF THE CHOLERAIC TOXIN AND	HETEROLOGOUS ANTIGEN, AND NUCLEIC ACIDS ENCODING THEM","Patent: WO 9003437-A1 19 05-APR-1990;",NA,NA
"218",14657001,"1  (bases 1 to 44)",".",NA,"PROTEINS FOR FUSING THE SUB-UNIT B OF THE CHOLERAIC TOXIN AND	HETEROLOGOUS ANTIGEN, AND NUCLEIC ACIDS ENCODING THEM","Patent: WO 9003437-A1 21 05-APR-1990;",NA,NA
"219",14658001,"1  (bases 1 to 32)",".",NA,"PROTEINS FOR FUSING THE SUB-UNIT B OF THE CHOLERAIC TOXIN AND	HETEROLOGOUS ANTIGEN, AND NUCLEIC ACIDS ENCODING THEM","Patent: WO 9003437-A1 23 05-APR-1990;",NA,NA
"220",14659001,"1  (bases 1 to 42)",".",NA,"PROTEINS FOR FUSING THE SUB-UNIT B OF THE CHOLERAIC TOXIN AND	HETEROLOGOUS ANTIGEN, AND NUCLEIC ACIDS ENCODING THEM","Patent: WO 9003437-A1 25 05-APR-1990;",NA,NA
"221",14660001,"1  (bases 1 to 37)",".",NA,"PROTEINS FOR FUSING THE SUB-UNIT B OF THE CHOLERAIC TOXIN AND	HETEROLOGOUS ANTIGEN, AND NUCLEIC ACIDS ENCODING THEM","Patent: WO 9003437-A1 27 05-APR-1990;",NA,NA
"222",14661001,"1  (bases 1 to 42)",".",NA,"PROTEINS FOR FUSING THE SUB-UNIT B OF THE CHOLERAIC TOXIN AND	HETEROLOGOUS ANTIGEN, AND NUCLEIC ACIDS ENCODING THEM","Patent: WO 9003437-A1 29 05-APR-1990;",NA,NA
"223",14662001,"1  (bases 1 to 375)",".",NA,"PROTEINS FOR FUSING THE SUB-UNIT B OF THE CHOLERAIC TOXIN AND	HETEROLOGOUS ANTIGEN, AND NUCLEIC ACIDS ENCODING THEM","Patent: WO 9003437-A1 31 05-APR-1990;",NA,NA
"224",14664001,"1  (bases 1 to 46)",".",NA,"PROTEINS FOR FUSING THE SUB-UNIT B OF THE CHOLERAIC TOXIN AND	HETEROLOGOUS ANTIGEN, AND NUCLEIC ACIDS ENCODING THEM","Patent: WO 9003437-A1 32 05-APR-1990;",NA,NA
"225",14665001,"1  (bases 1 to 10)",".",NA,"PROTEINS FOR FUSING THE SUB-UNIT B OF THE CHOLERAIC TOXIN AND	HETEROLOGOUS ANTIGEN, AND NUCLEIC ACIDS ENCODING THEM","Patent: WO 9003437-A1 33 05-APR-1990;",NA,NA
"226",14666001,"1  (bases 1 to 18)",".",NA,"PROTEINS FOR FUSING THE SUB-UNIT B OF THE CHOLERAIC TOXIN AND	HETEROLOGOUS ANTIGEN, AND NUCLEIC ACIDS ENCODING THEM","Patent: WO 9003437-A1 34 05-APR-1990;",NA,NA
"227",14667001,"1  (bases 1 to 51)",".",NA,"PROTEINS FOR FUSING THE SUB-UNIT B OF THE CHOLERAIC TOXIN AND	HETEROLOGOUS ANTIGEN, AND NUCLEIC ACIDS ENCODING THEM","Patent: WO 9003437-A1 36 05-APR-1990;",NA,NA
"228",14668001,"1  (bases 1 to 51)",".",NA,"PROTEINS FOR FUSING THE SUB-UNIT B OF THE CHOLERAIC TOXIN AND	HETEROLOGOUS ANTIGEN, AND NUCLEIC ACIDS ENCODING THEM","Patent: WO 9003437-A1 37 05-APR-1990;",NA,NA
"229",14669001,"1  (bases 1 to 420)","Bodmer,M.W.",NA,"RECOMBINANT ANTIBODY AND METHOD","Patent: WO 8901783-A2 1 09-MAR-1989;	CellTech Ltd",NA,NA
"230",14671001,"1  (bases 1 to 420)","Bodmer,M.W.",NA,"RECOMBINANT ANTIBODY AND METHOD","Patent: WO 8901783-A2 3 09-MAR-1989;	CellTech Ltd",NA,NA
"231",14673001,"1  (bases 1 to 177)","Norris,K.",NA,"APROTININ HOMOLOGUES AND PROCESS FOR THE PRODUCTION OF APROTININ	AND APROTININ HOMOLOGUES IN YEAST","Patent: WO 8901968-A1 2 09-MAR-1989;	Novo Industries",NA,NA
"232",14674001,"1  (bases 1 to 176)","Norris,K.",NA,"APROTININ HOMOLOGUES AND PROCESS FOR THE PRODUCTION OF APROTININ	AND APROTININ HOMOLOGUES IN YEAST","Patent: WO 8901968-A1 3 09-MAR-1989;	Novo Industries",NA,NA
"233",14675001,"1  (bases 1 to 177)","Norris,K.",NA,"APROTININ HOMOLOGUES AND PROCESS FOR THE PRODUCTION OF APROTININ	AND APROTININ HOMOLOGUES IN YEAST","Patent: WO 8901968-A1 5 09-MAR-1989;	Novo Industries",NA,NA
"234",14677001,"1  (bases 1 to 176)","Norris,K.",NA,"APROTININ HOMOLOGUES AND PROCESS FOR THE PRODUCTION OF APROTININ	AND APROTININ HOMOLOGUES IN YEAST","Patent: WO 8901968-A1 6 09-MAR-1989;	Novo Industries",NA,NA
"235",14678001,"1  (bases 1 to 1054)","Radford,A.J.",NA,"EXPRESSION SYSTEM FOR ACTINOMYCETES AND RELATED ORGANISMS","Patent: WO 9010701-A1 1 20-SEP-1990;	Commonwealth Scientific and Industrial Res. Organisation",NA,NA
"236",14680001,"1  (bases 1 to 1559)","McAdam,R.A.",NA,"PROBES, KITS AND METHODS FOR THE DETECTION AND DIFFERENTIATION OF	MYCOBACTERIA","Patent: WO 9010085-A1 2 07-SEP-1990;	Cogent Ltd",NA,NA
"237",14682001,"1  (bases 1 to 3192)","Hartley,B.S.",NA,"DNA CONSTRUCT AND MODIFIED YEAST","Patent: WO 9010703-A1 1 20-SEP-1990;	Imperial College of Science, Tech. and Medicine",NA,NA
"238",14684001,"1  (bases 1 to 4998)","Seelig,R. and Seelig,H.P.",NA,"VIRAL ANTIGEN, PROCESS FOR ITS PRODUCTION, AND APPLICATION IN	DIAGNOSIS AND THERAPY (VACCINE)","Patent: WO 8806184-A1 1 25-AUG-1988;	Seelig R.; Seelig H.P",NA,NA
"239",14685001,"1  (bases 1 to 4998)","Seelig,R. and Seelig,H.P.",NA,"VIRAL ANTIGEN, PROCESS FOR ITS PRODUCTION, AND APPLICATION IN	DIAGNOSIS AND THERAPY (VACCINE)","Patent: WO 8806184-A1 2 25-AUG-1988;	Seelig R.; Seelig H.P",NA,NA
"240",14686001,"1  (bases 1 to 301)","Seelig,R. and Seelig,H.P.",NA,"VIRAL ANTIGEN, PROCESS FOR ITS PRODUCTION, AND APPLICATION IN	DIAGNOSIS AND THERAPY (VACCINE)","Patent: WO 8806184-A1 3 25-AUG-1988;	Seelig R.; Seelig H.P",NA,NA
"241",14691001,"1  (bases 1 to 301)","Seelig,R. and Seelig,H.P.",NA,"VIRAL ANTIGEN, PROCESS FOR ITS PRODUCTION, AND APPLICATION IN	DIAGNOSIS AND THERAPY (VACCINE)","Patent: WO 8806184-A1 4 25-AUG-1988;	Seelig R.; Seelig H.P",NA,NA
"242",14694001,"1  (bases 1 to 1121)","De,Geus.",NA,"CUTINASE","Patent: WO 9009446-A1 1 23-AUG-1990;	Plant Genetics Systems",NA,NA
"243",14696001,"1  (bases 1 to 178)","Norris,K.",NA,"APROTININ HOMOLOGUES AND PROCESS FOR THE PRODUCTION OF APROTININ	AND APROTININ HOMOLOGUES IN YEAST","Patent: WO 8901968-A1 8 09-MAR-1989;	Novo Industries",NA,NA
"244",14698001,"1  (bases 1 to 182)","Norris,K.",NA,"APROTININ HOMOLOGUES AND PROCESS FOR THE PRODUCTION OF APROTININ	AND APROTININ HOMOLOGUES IN YEAST","Patent: WO 8901968-A1 9 09-MAR-1989;	Novo Industries",NA,NA
"245",14699001,"1  (bases 1 to 178)","Norris,K.",NA,"APROTININ HOMOLOGUES AND PROCESS FOR THE PRODUCTION OF APROTININ	AND APROTININ HOMOLOGUES IN YEAST","Patent: WO 8901968-A1 11 09-MAR-1989;	Novo Industries",NA,NA
"246",14700001,"1  (bases 1 to 182)","Norris,K.",NA,"APROTININ HOMOLOGUES AND PROCESS FOR THE PRODUCTION OF APROTININ	AND APROTININ HOMOLOGUES IN YEAST","Patent: WO 8901968-A1 12 09-MAR-1989;	Novo Industries",NA,NA
"247",14701001,"1  (bases 1 to 29)","Bishop,D.",NA,"EXPRESSION VECTORS FOR THE SYNTHESIS OF PROTEINS AND PLASMID	REPLICONS AND SEQUENCE CASSETTES FOR USE IN CONSTRUCTING SUCH	VECTORS","Patent: WO 8901518-A1 1 23-FEB-1989;	Natural Environment Res. Council",NA,NA
"248",14702001,"1  (bases 1 to 35)","Bishop,D.",NA,"EXPRESSION VECTORS FOR THE SYNTHESIS OF PROTEINS AND PLASMID	REPLICONS AND SEQUENCE CASSETTES FOR USE IN CONSTRUCTING SUCH	VECTORS","Patent: WO 8901518-A1 2 23-FEB-1989;	Natural Environment Res. Council",NA,NA
"249",14703001,"1  (bases 1 to 43)","Bishop,D.",NA,"EXPRESSION VECTORS FOR THE SYNTHESIS OF PROTEINS AND PLASMID	REPLICONS AND SEQUENCE CASSETTES FOR USE IN CONSTRUCTING SUCH	VECTORS","Patent: WO 8901518-A1 3 23-FEB-1989;	Natural Environment Res. Council",NA,NA
"250",14704001,"1  (bases 1 to 660)","Bishop,D.",NA,"EXPRESSION VECTORS FOR THE SYNTHESIS OF PROTEINS AND PLASMID	REPLICONS AND SEQUENCE CASSETTES FOR USE IN CONSTRUCTING SUCH	VECTORS","Patent: WO 8901518-A1 4 23-FEB-1989;	Natural Environment Res. Council",NA,NA
"251",14706001,"1  (bases 1 to 2980)","Vaeck,M.",NA,"","Patent: WO 8901515-A2 1 23-FEB-1989;	Plant Genetic Systems",NA,NA
"252",14708001,"1  (bases 1 to 29)","Vaeck,M.",NA,"","Patent: WO 8901515-A2 3 23-FEB-1989;	Plant Genetic Systems",NA,NA
"253",14709001,"1  (bases 1 to 332)","Vaeck,M.",NA,"","Patent: WO 8901515-A2 4 23-FEB-1989;	Plant Genetic Systems",NA,NA
"254",14720001,"1  (bases 1 to 1095)","Bridges,I.G.",NA,"REGULATION OF PLANT GENE EXPRESSION","Patent: WO 9008829-A1 1 09-AUG-1990;	Imperial Chemical Industries PLC",NA,NA
"255",14721001,"1  (bases 1 to 14)","Bridges,I.G.",NA,"REGULATION OF GENE EXPRESSION","Patent: WO 9008827-A1 1 09-AUG-1990;	Imperial Chemical Industries Plc",NA,NA
"256",14722001,"1  (bases 1 to 14)","Bridges,I.G.",NA,"REGULATION OF GENE EXPRESSION","Patent: WO 9008827-A1 2 09-AUG-1990;	Imperial Chemical Industries Plc",NA,NA
"257",14723001,"1  (bases 1 to 24)",".",NA,"METHOD FOR IMMOBILIZING PROTEINS OR ENZYMES","Patent: WO 8404537-A1 1 22-NOV-1984;",NA,NA
"258",14724001,"1  (bases 1 to 24)",".",NA,"METHOD FOR IMMOBILIZING PROTEINS OR ENZYMES","Patent: WO 8404537-A1 2 22-NOV-1984;",NA,NA
"259",14725001,"1  (bases 1 to 200)","Hinnen,A.",NA,"EUKARYGOTIC HYBRID VECTORS AND PREPARATION OF POLYPEPTIDES","Patent: WO 8600089-A1 13 03-JAN-1986;	CIBA-GEIGY",NA,NA
"260",14726001,"1  (bases 1 to 534)","Hinnen,A.",NA,"EUKARYGOTIC HYBRID VECTORS AND PREPARATION OF POLYPEPTIDES","Patent: WO 8600089-A1 10 03-JAN-1986;	CIBA-GEIGY",NA,NA
"261",14727001,"1  (bases 1 to 540)","Hinnen,A.",NA,"EUKARYGOTIC HYBRID VECTORS AND PREPARATION OF POLYPEPTIDES","Patent: WO 8600089-A1 11 03-JAN-1986;	CIBA-GEIGY",NA,NA
"262",14728001,"1  (bases 1 to 1062)","Holmes,I.",NA,"ROTAVIRUS","Patent: WO 8505122-A1 1 21-NOV-1985;	The University of Melbourne",NA,NA
"263",14730001,"1  (bases 1 to 27)","Allet,B.",NA,"A MODIFIED GAMMA INTERFERON, DNA SEQUENCES ENCODING IT AND	PROCESSES FOR PRODUCING IT","Patent: WO 8504186-A2 2 26-SEP-1985;	Biogen N.V",NA,NA
"264",14731001,"1  (bases 1 to 18)","Allet,B.",NA,"A MODIFIED GAMMA INTERFERON, DNA SEQUENCES ENCODING IT AND	PROCESSES FOR PRODUCING IT","Patent: WO 8504186-A2 3 26-SEP-1985;	Biogen N.V",NA,NA
"265",14732001,"1  (bases 1 to 306)","Mach,B.",NA,"DNA SEQUENCES, RECOMBINANT DNA AND PROCESSES FOR PRODUCING ANTIGENS	OF PLASMODIUM FALCIPARUM","Patent: WO 8503725-A1 2 29-AUG-1985;	Biogen N.V",NA,NA
"266",14733001,"1  (bases 1 to 737)","Mach,B.",NA,"DNA SEQUENCES, RECOMBINANT DNA AND PROCESSES FOR PRODUCING ANTIGENS	OF PLASMODIUM FALCIPARUM","Patent: WO 8503725-A1 4 29-AUG-1985;	Biogen N.V",NA,NA
"267",14734001,"1  (bases 1 to 180)","Kok,J.",NA,"","Patent: WO 8503945-A1 1 12-SEP-1985;	Unilever N.V",NA,NA
"268",14735001,"1  (bases 1 to 21)","Kok,J.",NA,"","Patent: WO 8503945-A1 4 12-SEP-1985;	Unilever N.V",NA,NA
"269",14736001,"1  (bases 1 to 143)","Grandi,G., Franchi,E., Maisano,F. and Astrua Testori,S.",NA,"A method for the preparation of human growth hormone","Patent: EP 0306673-A1 3 15-MAR-1989;	ENIRICERCHE S.p.A",NA,NA
"270",14737001,"1  (bases 1 to 43)","Brewer,S.J. and Sassenfeld,H.M.",NA,"Process for the preparation of polypeptides utilizing a charged	amino acid polymer and exopeptidase","Patent: EP 0306610-A1 3 15-MAR-1989;	G.D. Searle & Co",NA,NA
"271",14738001,"1  (bases 1 to 1254)","Certa,U.",NA,"Antimalaria vaccines","Patent: EP 0309746-A1 16 05-APR-1989;	F. HOFFMANN-LA ROCHE AG",NA,NA
"272",14740001,"1  (bases 1 to 51)","Jensen,S.E., Westlake,D.W.S., Leskiw,B.K., Aharonowitz,Y. and	Mevarech,M.",NA,"Cloning and nucleotide sequence determination of the isopenicillin	N synthetase gene from streptomyces clavuligerus","Patent: EP 0303364-A1 1 15-FEB-1989;	The Governors of the University of Alberta",NA,NA
"273",14741001,"1  (bases 1 to 990)","Jensen,S.E., Westlake,D.W.S., Leskiw,B.K., Aharonowitz,Y. and	Mevarech,M.",NA,"Cloning and nucleotide sequence determination of the isopenicillin	N synthetase gene from streptomyces clavuligerus","Patent: EP 0303364-A1 2 15-FEB-1989;	The Governors of the University of Alberta",NA,NA
"274",14743001,"1  (bases 1 to 559)","Hudson,P.J., Tregear,G.W. and Niall,H.D.",NA,"Molecular cloning and characterization of a further gene sequence	coding for human relaxin","Patent: EP 0303033-A2 2 15-FEB-1989;	HOWARD FLOREY INSTITUTE OF EXPERIMENTAL PHYSIOLOGY AND MEDICINE",NA,NA
"275",14744001,"1  (bases 1 to 558)","Hudson,P.J., Tregear,G.W. and Niall,H.D.",NA,"Molecular cloning and characterization of a further gene sequence	coding for human relaxin","Patent: EP 0303033-A2 3 15-FEB-1989;	HOWARD FLOREY INSTITUTE OF EXPERIMENTAL PHYSIOLOGY AND MEDICINE",NA,NA
"276",14746001,"1  (bases 1 to 15)","Kok,J.",NA,"","Patent: WO 8503945-A1 6 12-SEP-1985;	Unilever N.V",NA,NA
"277",14747001,"1  (bases 1 to 45)","Kok,J.",NA,"","Patent: WO 8503945-A1 7 12-SEP-1985;	Unilever N.V",NA,NA
"278",14748001,"1  (bases 1 to 1336)","Williamson,R.",NA,"","Patent: WO 8500381-A1 3 31-JAN-1985;	CellTech Ltd",NA,NA
"279",14750001,"1  (bases 1 to 22)","Heighway,J.",NA,"GENETICALLY ENGINEERED PROCESSING OF MICRO-ORGANISM CULTURES AND	DNA RELATED THERETO","Patent: WO 9010065-A1 1 07-SEP-1990;	Cancer Research Campaign Tech. Ltd",NA,NA
"280",14751001,"1  (bases 1 to 22)","Heighway,J.",NA,"GENETICALLY ENGINEERED PROCESSING OF MICRO-ORGANISM CULTURES AND	DNA RELATED THERETO","Patent: WO 9010065-A1 2 07-SEP-1990;	Cancer Research Campaign Tech. Ltd",NA,NA
"281",14752001,"1  (bases 1 to 46)","Heighway,J.",NA,"GENETICALLY ENGINEERED PROCESSING OF MICRO-ORGANISM CULTURES AND	DNA RELATED THERETO","Patent: WO 9010065-A1 3 07-SEP-1990;	Cancer Research Campaign Tech. Ltd",NA,NA
"282",14753001,"1  (bases 1 to 46)","Heighway,J.",NA,"GENETICALLY ENGINEERED PROCESSING OF MICRO-ORGANISM CULTURES AND	DNA RELATED THERETO","Patent: WO 9010065-A1 4 07-SEP-1990;	Cancer Research Campaign Tech. Ltd",NA,NA
"283",14754001,"1  (bases 1 to 141)","Heighway,J.",NA,"GENETICALLY ENGINEERED PROCESSING OF MICRO-ORGANISM CULTURES AND	DNA RELATED THERETO","Patent: WO 9010065-A1 5 07-SEP-1990;	Cancer Research Campaign Tech. Ltd",NA,NA
"284",14755001,"1  (bases 1 to 141)","Heighway,J.",NA,"GENETICALLY ENGINEERED PROCESSING OF MICRO-ORGANISM CULTURES AND	DNA RELATED THERETO","Patent: WO 9010065-A1 6 07-SEP-1990;	Cancer Research Campaign Tech. Ltd",NA,NA
"285",14756001,"1  (bases 1 to 1062)","Dyall-Smith,M.L.",NA,"MOLECULAR CLONING OF HUMAN ROTAVIRUS SEROTYPE 4 GENE 9 ENCODING	VP7, THE MAJOR OUTER CAPSID NEUTRALISATION SPECIFIC GLYCOPROTEIN	AND EXPRESSION OF VP7 AND FRAGMENTS THEREOF FOR USE IN A VACCINE","Patent: WO 8901514-A1 1 23-FEB-1989;	The University of Melbourne",NA,NA
"286",14758001,"1  (bases 1 to 2133)",".",NA,"RECOMBINANT DNA EXPRESSION VECTORS","Patent: WO 8901036-A1 1 09-FEB-1989;",NA,NA
"287",14759001,"1  (bases 1 to 2129)",".",NA,"RECOMBINANT DNA EXPRESSION VECTORS","Patent: WO 8901036-A1 2 09-FEB-1989;",NA,NA
"288",14760001,"1  (bases 1 to 149)","Huber,M., Gitler,C., Revel,M., Mirelman,D., Garfinkel,L.I. and	Giladi,M.",NA,"","Patent: GB 2223307-A 5 04-APR-1990;	Yeda Res. and Dev. Company Limited",NA,NA
"289",14761001,"1  (bases 1 to 139)","Huber,M., Gitler,C., Revel,M., Mirelman,D., Garfinkel,L.I. and	Giladi,M.",NA,"","Patent: GB 2223307-A 6 04-APR-1990;	Yeda Res. and Dev. Company Limited",NA,NA
"290",22766001,"1  (bases 1 to 641)","Horisberger,M.A., Hochkeppel,H.K. and Content,J.",NA,"Interferon-induced human protein in pure form, monoclonal	antibodies thereto, and test kits containing these antibodies","Patent: EP 0242329-A2 1 21-OCT-1987;	CIBA-GEIGY AG",NA,NA
"291",22768001,"1  (bases 1 to 2382)","Cassani,G., Blasi,F., Robbiati,F.M. and Nolli,M.",NA,"Modified plasminogen activators","Patent: EP 0308716-A2 3 29-MAR-1989;	GRUPPO LEPETIT S.P.A.; GRUPPO LEPETIT S.p.A",NA,NA
"292",38630001,"1  (bases 1 to 1155)","Hastrup,S.",NA,"Gene expression system","Patent: EP 0242220-A2 1 21-OCT-1987;	NOVO NORDISK A/S; Bagsvaerd, ; Denmark",NA,NA
"293",38632001,"1  (bases 1 to 82)","Hastrup,S.",NA,"Gene expression system","Patent: EP 0242220-A2 3 21-OCT-1987;	NOVO NORDISK A/S; Bagsvaerd, ; Denmark",NA,NA
"294",38633001,"1  (bases 1 to 82)","Hastrup,S.",NA,"Gene expression system","Patent: EP 0242220-A2 4 21-OCT-1987;	NOVO NORDISK A/S; Bagsvaerd, ; Denmark",NA,NA
"295",38634001,"1  (bases 1 to 82)","Hastrup,S.",NA,"Gene expression system","Patent: EP 0242220-A2 6 21-OCT-1987;	NOVO NORDISK A/S; Bagsvaerd, ; Denmark",NA,NA
"296",38635001,"1  (bases 1 to 82)","Hastrup,S.",NA,"Gene expression system","Patent: EP 0242220-A2 7 21-OCT-1987;	NOVO NORDISK A/S; Bagsvaerd, ; Denmark",NA,NA
"297",38636001,"1  (bases 1 to 53)","Vega,D.P., Martinez,A.G., Falgueras,M.S., Mellado,R.P. and	Redondo,A.M.",NA,"Streptomyces expression vectors","Patent: EP 0310436-A2 1 05-APR-1989;	Antibioticos, S.A",NA,NA
"298",57971001,"1  (bases 1 to 30)","Auerswald,E.A., Schroeder,W., Schnabel,E., Bruns,W., Reinhardt,G.	and Kotick,M.",NA,"Aprotinin homologues produced by genetic engineering","Patent: EP 0238993-A2 3 30-SEP-1987;	BAYER AG",NA,NA
"299",57972001,"1  (bases 1 to 18)","Auerswald,E.A., Schroeder,W., Schnabel,E., Bruns,W., Reinhardt,G.	and Kotick,M.",NA,"Aprotinin homologues produced by genetic engineering","Patent: EP 0238993-A2 4 30-SEP-1987;	BAYER AG",NA,NA
"300",57973001,"1  (bases 1 to 26)","Auerswald,E.A., Schroeder,W., Schnabel,E., Bruns,W., Reinhardt,G.	and Kotick,M.",NA,"Aprotinin homologues produced by genetic engineering","Patent: EP 0238993-A2 5 30-SEP-1987;	BAYER AG",NA,NA
"301",57974001,"1  (bases 1 to 18)","Auerswald,E.A., Schroeder,W., Schnabel,E., Bruns,W., Reinhardt,G.	and Kotick,M.",NA,"Aprotinin homologues produced by genetic engineering","Patent: EP 0238993-A2 7 30-SEP-1987;	BAYER AG",NA,NA
"302",57975001,"1  (bases 1 to 20)","Auerswald,E.A., Schroeder,W., Schnabel,E., Bruns,W., Reinhardt,G.	and Kotick,M.",NA,"Aprotinin homologues produced by genetic engineering","Patent: EP 0238993-A2 8 30-SEP-1987;	BAYER AG",NA,NA
"303",57976001,"1  (bases 1 to 30)","Auerswald,E.A., Schroeder,W., Schnabel,E., Bruns,W., Reinhardt,G.	and Kotick,M.",NA,"Aprotinin homologues produced by genetic engineering","Patent: EP 0238993-A2 9 30-SEP-1987;	BAYER AG",NA,NA
"304",57977001,"1  (bases 1 to 27)","Auerswald,E.A., Schroeder,W., Schnabel,E., Bruns,W., Reinhardt,G.	and Kotick,M.",NA,"Aprotinin homologues produced by genetic engineering","Patent: EP 0238993-A2 10 30-SEP-1987;	BAYER AG",NA,NA
"305",57978001,"1  (bases 1 to 30)","Auerswald,E.A., Schroeder,W., Schnabel,E., Bruns,W., Reinhardt,G.	and Kotick,M.",NA,"Aprotinin homologues produced by genetic engineering","Patent: EP 0238993-A2 11 30-SEP-1987;	BAYER AG",NA,NA
"306",57979001,"1  (bases 1 to 29)","Auerswald,E.A., Schroeder,W., Schnabel,E., Bruns,W., Reinhardt,G.	and Kotick,M.",NA,"Aprotinin homologues produced by genetic engineering","Patent: EP 0238993-A2 12 30-SEP-1987;	BAYER AG",NA,NA
"307",57980001,"1  (bases 1 to 30)","Auerswald,E.A., Schroeder,W., Schnabel,E., Bruns,W., Reinhardt,G.	and Kotick,M.",NA,"Aprotinin homologues produced by genetic engineering","Patent: EP 0238993-A2 13 30-SEP-1987;	BAYER AG",NA,NA
"308",57981001,"1  (bases 1 to 27)","Auerswald,E.A., Schroeder,W., Schnabel,E., Bruns,W., Reinhardt,G.	and Kotick,M.",NA,"Aprotinin homologues produced by genetic engineering","Patent: EP 0238993-A2 14 30-SEP-1987;	BAYER AG",NA,NA
"309",57982001,"1  (bases 1 to 30)","Auerswald,E.A., Schroeder,W., Schnabel,E., Bruns,W., Reinhardt,G.	and Kotick,M.",NA,"Aprotinin homologues produced by genetic engineering","Patent: EP 0238993-A2 15 30-SEP-1987;	BAYER AG",NA,NA
"310",57983001,"1  (bases 1 to 30)","Auerswald,E.A., Schroeder,W., Schnabel,E., Bruns,W., Reinhardt,G.	and Kotick,M.",NA,"Aprotinin homologues produced by genetic engineering","Patent: EP 0238993-A2 16 30-SEP-1987;	BAYER AG",NA,NA
"311",57984001,"1  (bases 1 to 21)","Auerswald,E.A., Schroeder,W., Schnabel,E., Bruns,W., Reinhardt,G.	and Kotick,M.",NA,"Aprotinin homologues produced by genetic engineering","Patent: EP 0238993-A2 18 30-SEP-1987;	BAYER AG",NA,NA
"312",57985001,"1  (bases 1 to 45)","Auerswald,E.A., Schroeder,W., Schnabel,E., Bruns,W., Reinhardt,G.	and Kotick,M.",NA,"Aprotinin homologues produced by genetic engineering","Patent: EP 0238993-A2 19 30-SEP-1987;	BAYER AG",NA,NA
"313",57986001,"1  (bases 1 to 45)","Auerswald,E.A., Schroeder,W., Schnabel,E., Bruns,W., Reinhardt,G.	and Kotick,M.",NA,"Aprotinin homologues produced by genetic engineering","Patent: EP 0238993-A2 22 30-SEP-1987;	BAYER AG",NA,NA
"314",57987001,"1  (bases 1 to 45)","Auerswald,E.A., Schroeder,W., Schnabel,E., Bruns,W., Reinhardt,G.	and Kotick,M.",NA,"Aprotinin homologues produced by genetic engineering","Patent: EP 0238993-A2 25 30-SEP-1987;	BAYER AG",NA,NA
"315",57988001,"1  (bases 1 to 194)","Auerswald,E.A., Schroeder,W., Schnabel,E., Bruns,W., Reinhardt,G.	and Kotick,M.",NA,"Aprotinin homologues produced by genetic engineering","Patent: EP 0238993-A2 28 30-SEP-1987;	BAYER AG",NA,NA
"316",57989001,"1  (bases 1 to 1179)","Mattes,R.",NA,"Tissue plasminogen activator (tPA) derivative and its production","Patent: EP 0242836-A1 5 28-OCT-1987;	BOEHRINGER MANNHEIM GMBH",NA,NA
"317",57991001,"1  (bases 1 to 1179)","Mattes,R.",NA,"Method for preparing plasminogen activators in procaryotes","Patent: EP 0242835-A1 3 28-OCT-1987;	BOEHRINGER MANNHEIM GMBH",NA,NA
"318",57993001,"1  (bases 1 to 143)","Grandi,G., Franchi,E., Maisano,F. and Astrua Testori,S.",NA,"A method for the preparation of human growth hormone","Patent: EP 0306673-A1 2 15-MAR-1989;	ENIRICERCHE S.p.A",NA,NA
"319",57995001,"1  (bases 1 to 43)","Brewer,S.J. and Sassenfeld,H.M.",NA,"Process for the preparation of polypeptides utilizing a charged	amino acid polymer and exopeptidase","Patent: EP 0306610-A1 2 15-MAR-1989;	G.D. Searle & Co",NA,NA
"320",57997001,"1  (bases 1 to 28)","Meulien,P. and Pavirani,A.",NA,"Factor VIII analog, process for its preparation and composition	containing it","Patent: EP 0303540-A1 1 15-FEB-1989;	MORETTIN, Enrico",NA,NA
"321",58310001,"1  (bases 1 to 20)","Horisberger,M.A., Hochkeppel,H.K. and Content,J.",NA,"Interferon-induced human protein in pure form, monoclonal	antibodies thereto, and test kits containing these antibodies","Patent: EP 0242329-A2 3 21-OCT-1987;	CIBA-GEIGY AG",NA,NA
"322",58311001,"1  (bases 1 to 17)","Horisberger,M.A., Hochkeppel,H.K. and Content,J.",NA,"Interferon-induced human protein in pure form, monoclonal	antibodies thereto, and test kits containing these antibodies","Patent: EP 0242329-A2 4 21-OCT-1987;	CIBA-GEIGY AG",NA,NA
"323",58312001,"1  (bases 1 to 21)","Horisberger,M.A., Hochkeppel,H.K. and Content,J.",NA,"Interferon-induced human protein in pure form, monoclonal	antibodies thereto, and test kits containing these antibodies","Patent: EP 0242329-A2 5 21-OCT-1987;	CIBA-GEIGY AG",NA,NA
"324",58313001,"1  (bases 1 to 1704)","Schroeder,G., Schroeder,J., Hain,R. and Schreier,P.H.",NA,"Stilbene synthase gene","Patent: EP 0309862-A1 1 05-APR-1989;	BAYER AG",NA,NA
"325",58315001,"1  (bases 1 to 21)","Cassani,G., Blasi,F., Robbiati,F.M. and Nolli,M.",NA,"Modified plasminogen activators","Patent: EP 0308716-A2 4 29-MAR-1989;	GRUPPO LEPETIT S.P.A.; GRUPPO LEPETIT S.p.A",NA,NA
"326",58316001,"1  (bases 1 to 27)","Cassani,G., Blasi,F., Robbiati,F.M. and Nolli,M.",NA,"Modified plasminogen activators","Patent: EP 0308716-A2 5 29-MAR-1989;	GRUPPO LEPETIT S.P.A.; GRUPPO LEPETIT S.p.A",NA,NA
"327",58317001,"1  (bases 1 to 33)","Cassani,G., Blasi,F., Robbiati,F.M. and Nolli,M.",NA,"Modified plasminogen activators","Patent: EP 0308716-A2 6 29-MAR-1989;	GRUPPO LEPETIT S.P.A.; GRUPPO LEPETIT S.p.A",NA,NA
"328",58318001,"1  (bases 1 to 27)","Cassani,G., Blasi,F., Robbiati,F.M. and Nolli,M.",NA,"Modified plasminogen activators","Patent: EP 0308716-A2 7 29-MAR-1989;	GRUPPO LEPETIT S.P.A.; GRUPPO LEPETIT S.p.A",NA,NA
"329",58319001,"1  (bases 1 to 33)","Cassani,G., Blasi,F., Robbiati,F.M. and Nolli,M.",NA,"Modified plasminogen activators","Patent: EP 0308716-A2 8 29-MAR-1989;	GRUPPO LEPETIT S.P.A.; GRUPPO LEPETIT S.p.A",NA,NA
"330",58418001,"1  (bases 1 to 335)","Baulcombe,D.C., Mayo,M.A., Harrison,B.D. and Bevan,M.W.",NA,"Modification of plant viruses or their effects","Patent: EP 0242016-A1 1 21-OCT-1987;	AGRICULTURAL GENETICS COMPANY LIMITED",NA,NA
"331",267668001,"1  (bases 1 to 20)","Wu,R.J., Bahl,C.P. and Narang,S.A.",NA,"Oligonucleotides useful as adaptors in DNA cloning, adapted DNA	molecules, and methods of preparing adaptors and adapted molecules","Patent: US 4321365-A 1 23-MAR-1982;	Research Corporation; New York, NY",NA,NA
"332",267669001,"1  (bases 1 to 145)","Baxter,J.D., Roberts,J.L., Seeburg,P.H., Goodman,H.M. and Shine,J.",NA,"Adrenocorticotropin-lipotropin precursor gene","Patent: US 4322499-A 1 30-MAR-1982;	The Regents of the University of California; Berkeley, CA",NA,NA
"333",267677001,"1  (bases 1 to 87)","Reusser,F.",NA,"Hybrid plasmid and process of making same","Patent: US 4332898-A 1 01-JUN-1982;	The Upjohn Company; Kalamazoo, MI",NA,NA
"334",267678001,"1  (bases 1 to 120)","Reusser,F.",NA,"Hybrid plasmid and process of making same","Patent: US 4332898-A 2 01-JUN-1982;	The Upjohn Company; Kalamazoo, MI",NA,NA
"335",267685001,"1  (bases 1 to 251)","Gilbert,W. and Talmadge,K.",NA,"Mature protein synthesis","Patent: US 4338397-A 1 06-JUL-1982;	President and Fellows of Harvard College; Cambridge, MA",NA,NA
"336",267688001,"1  (bases 1 to 86)","Gilbert,W. and Talmadge,K.",NA,"Mature protein synthesis","Patent: US 4338397-A 4 06-JUL-1982;	President and Fellows of Harvard College; Cambridge, MA",NA,NA
"337",267690001,"1  (bases 1 to 75)","Gilbert,W. and Talmadge,K.",NA,"Mature protein synthesis","Patent: US 4338397-A 6 06-JUL-1982;	President and Fellows of Harvard College; Cambridge, MA",NA,NA
"338",267695001,"1  (bases 1 to 83)","Goeddel,D.V. and Heyneker,H.L.",NA,"Method of constructing a replicable cloning vehicle having	quasi-synthetic genes","Patent: US 4342832-A 2 03-AUG-1982;	Genentech, Inc.; South San Francisco, CA",NA,NA
"339",267697001,"1  (bases 1 to 556)","Goeddel,D.V. and Heyneker,H.L.",NA,"Method of constructing a replicable cloning vehicle having	quasi-synthetic genes","Patent: US 4342832-A 4 03-AUG-1982;	Genentech, Inc.; South San Francisco, CA",NA,NA
"340",267705001,"1  (bases 1 to 38)","Carey,N.H., Emtage,J.S., Tacon,W.C.A. and Hallewell,R.A.",NA,"Plasmid vectors, production anduse thereof","Patent: US 4349629-A 1 14-SEP-1982;	G.D. Searle & Co.; Skokie, IL",NA,NA
"341",267706001,"1  (bases 1 to 49)","Carey,N.H., Emtage,J.S., Tacon,W.C.A. and Hallewell,R.A.",NA,"Plasmid vectors, production anduse thereof","Patent: US 4349629-A 2 14-SEP-1982;	G.D. Searle & Co.; Skokie, IL",NA,NA
"342",267707001,"1  (bases 1 to 50)","Carey,N.H., Emtage,J.S., Tacon,W.C.A. and Hallewell,R.A.",NA,"Plasmid vectors, production anduse thereof","Patent: US 4349629-A 3 14-SEP-1982;	G.D. Searle & Co.; Skokie, IL",NA,NA
"343",267708001,"1  (bases 1 to 54)","Baxter,J.D., Fettes,I. and Shine,J.",NA,"Microbiological synthesis of beta endorphin","Patent: US 4350764-A 1 21-SEP-1982;	The Regents of the University of California; Berkeley, CA",NA,NA
"344",267710001,"1  (bases 1 to 91)","Baxter,J.D., Fettes,I. and Shine,J.",NA,"Microbiological synthesis of beta endorphin","Patent: US 4350764-A 3 21-SEP-1982;	The Regents of the University of California; Berkeley, CA",NA,NA
"345",267722001,"1  (bases 1 to 56)","Itakura,K.",NA,"Recombinant DNA cloning vehicle","Patent: US 4356270-A 2 26-OCT-1982;	Genentech, Inc.; San Francisco, CA",NA,NA
"346",267724001,"1  (bases 1 to 124)","Itakura,K.",NA,"Recombinant DNA cloning vehicle","Patent: US 4356270-A 4 26-OCT-1982;	Genentech, Inc.; San Francisco, CA",NA,NA
"347",267726001,"1  (bases 1 to 44)","Itakura,K.",NA,"Recombinant DNA cloning vehicle","Patent: US 4356270-A 6 26-OCT-1982;	Genentech, Inc.; San Francisco, CA",NA,NA
"348",267727001,"1  (bases 1 to 62)","Itakura,K.",NA,"Recombinant DNA cloning vehicle","Patent: US 4356270-A 7 26-OCT-1982;	Genentech, Inc.; San Francisco, CA",NA,NA
"349",267729001,"1  (bases 1 to 104)","Itakura,K.",NA,"Recombinant DNA cloning vehicle","Patent: US 4356270-A 9 26-OCT-1982;	Genentech, Inc.; San Francisco, CA",NA,NA
"350",267731001,"1  (bases 1 to 77)","Itakura,K.",NA,"Recombinant DNA cloning vehicle","Patent: US 4356270-A 11 26-OCT-1982;	Genentech, Inc.; San Francisco, CA",NA,NA
"351",267732001,"1  (bases 1 to 1742)","Emtage,J.S. and Carey,N.H.",NA,"Synthetic gene coding for influenza hemagglutinin","Patent: US 4357421-A 1 02-NOV-1982;	G. D. Searle & Co.; Skokie, IL",NA,NA
"352",267733001,"1  (bases 1 to 99)","Emtage,J.S. and Carey,N.H.",NA,"Synthetic gene coding for influenza hemagglutinin","Patent: US 4357421-A 2 02-NOV-1982;	G. D. Searle & Co.; Skokie, IL",NA,NA
"353",267735001,"1  (bases 1 to 102)","Emtage,J.S. and Carey,N.H.",NA,"Synthetic gene coding for influenza hemagglutinin","Patent: US 4357421-A 4 02-NOV-1982;	G. D. Searle & Co.; Skokie, IL",NA,NA
"354",267739001,"1  (bases 1 to 94)","Reusser,F.",NA,"Hybrid plasmid and process of making same","Patent: US 4362816-A 1 07-DEC-1982;	The Upjohn Company; Kalamazoo, MI",NA,NA
"355",267740001,"1  (bases 1 to 46)","Reusser,F.",NA,"Hybrid plasmid and process of making same","Patent: US 4362817-A 1 07-DEC-1982;	The Upjohn Company; Kalamazoo, MI",NA,NA
"356",267742001,"1  (bases 1 to 555)","Goodman,H.M., Shine,J. and Seeburg,P.H.",NA,"Recombinant DNA transfer vectors","Patent: US 4363877-A 2 14-DEC-1982;	The Regents of the University of California; Berkeley, CA",NA,NA
"357",267744001,"1  (bases 1 to 556)","Goodman,H.M., Shine,J. and Seeburg,P.H.",NA,"Recombinant DNA transfer vectors","Patent: US 4363877-A 4 14-DEC-1982;	The Regents of the University of California; Berkeley, CA",NA,NA
"358",267747001,"1  (bases 1 to 774)","Goodman,H.M., Shine,J. and Seeburg,P.H.",NA,"Recombinant DNA transfer vectors","Patent: US 4363877-A 7 14-DEC-1982;	The Regents of the University of California; Berkeley, CA",NA,NA
"359",267749001,"1  (bases 1 to 56)","Riggs,A.D.",NA,"Method for microbial polypeptide expression","Patent: US 4366246-A 2 28-DEC-1982;	Genentech, Inc.; So. San Francisco, CA",NA,NA
"360",267751001,"1  (bases 1 to 124)","Riggs,A.D.",NA,"Method for microbial polypeptide expression","Patent: US 4366246-A 4 28-DEC-1982;	Genentech, Inc.; So. San Francisco, CA",NA,NA
"361",267753001,"1  (bases 1 to 44)","Riggs,A.D.",NA,"Method for microbial polypeptide expression","Patent: US 4366246-A 6 28-DEC-1982;	Genentech, Inc.; So. San Francisco, CA",NA,NA
"362",267754001,"1  (bases 1 to 62)","Riggs,A.D.",NA,"Method for microbial polypeptide expression","Patent: US 4366246-A 7 28-DEC-1982;	Genentech, Inc.; So. San Francisco, CA",NA,NA
"363",267756001,"1  (bases 1 to 104)","Riggs,A.D.",NA,"Method for microbial polypeptide expression","Patent: US 4366246-A 9 28-DEC-1982;	Genentech, Inc.; So. San Francisco, CA",NA,NA
"364",267758001,"1  (bases 1 to 77)","Riggs,A.D.",NA,"Method for microbial polypeptide expression","Patent: US 4366246-A 11 28-DEC-1982;	Genentech, Inc.; So. San Francisco, CA",NA,NA
"365",267762001,"1  (bases 1 to 29)","Tiollais,P.",NA,"Vectors for the insertion therein of foreign DNA fragments,	according to any translation phase","Patent: US 4371625-A 1 01-FEB-1983;	Institut Pasteur; Paris;	FR;",NA,NA
"366",267797001,"1  (bases 1 to 1650)","Curtis,P.J. and Wunner,W.H.",NA,"DNA Which codes for glycoprotein of era-strain rabies virus","Patent: US 4393201-A 1 12-JUL-1983;	The Wistar Institute; Philadelphia, PA",NA,NA
"367",267800001,"1  (bases 1 to 142)","Weissman,S.M., Pereira,D. and Sood,A.",NA,"Method for cloning genes","Patent: US 4394443-A 2 19-JUL-1983;	Yale University; New Haven, CT",NA,NA
"368",267801001,"1  (bases 1 to 30)","Weissman,S.M., Pereira,D. and Sood,A.",NA,"Method for cloning genes","Patent: US 4394443-A 3 19-JUL-1983;	Yale University; New Haven, CT",NA,NA
"369",267802001,"1  (bases 1 to 30)","Weissman,S.M., Pereira,D. and Sood,A.",NA,"Method for cloning genes","Patent: US 4394443-A 4 19-JUL-1983;	Yale University; New Haven, CT",NA,NA
"370",267817001,"1  (bases 1 to 32)","Hartley,J.L. and Gregori,T.J.",NA,"Genetic reagents for generating plasmids containing multiple copies	of DNA segments","Patent: US 4403036-A 1 06-SEP-1983;	University of Iowa Research Foundation; Iowa City, IA",NA,NA
"371",267823001,"1  (bases 1 to 554)","Goodman,H.M., Shine,J. and Seeburg,P.H.",NA,"Purification of nucleotide sequences suitable for expression in	bacteria","Patent: US 4407948-A 2 04-OCT-1983;	The Regents of the University of California; Berkeley, CA",NA,NA
"372",267825001,"1  (bases 1 to 556)","Goodman,H.M., Shine,J. and Seeburg,P.H.",NA,"Purification of nucleotide sequences suitable for expression in	bacteria","Patent: US 4407948-A 4 04-OCT-1983;	The Regents of the University of California; Berkeley, CA",NA,NA
"373",267827001,"1  (bases 1 to 775)","Goodman,H.M., Shine,J. and Seeburg,P.H.",NA,"Purification of nucleotide sequences suitable for expression in	bacteria","Patent: US 4407948-A 6 04-OCT-1983;	The Regents of the University of California; Berkeley, CA",NA,NA
"374",267839001,"1  (bases 1 to 957)","Goeddel,D.V.",NA,"Hybrid human leukocyte interferons","Patent: US 4414150-A 1 08-NOV-1983;	Genentech, Inc.; South San Francisco, CA",NA,NA
"375",267840001,"1  (bases 1 to 985)","Goeddel,D.V.",NA,"Hybrid human leukocyte interferons","Patent: US 4414150-A 2 08-NOV-1983;	Genentech, Inc.; South San Francisco, CA",NA,NA
"376",267841001,"1  (bases 1 to 876)","Goeddel,D.V.",NA,"Hybrid human leukocyte interferons","Patent: US 4414150-A 3 08-NOV-1983;	Genentech, Inc.; South San Francisco, CA",NA,NA
"377",267871001,"1  (bases 1 to 1262)","Galibert,F., Tiollais,P. and Charnay,P.",NA,"Nucleotidic sequence coding the surface antigen of the hepatitis B	virus, vector containing said nucleotidic sequence, process	allowing the obtention thereof and antigen obtained thereby","Patent: US 4428941-A 1 31-JAN-1984;	Institut Pasteur; Paris;	FR;",NA,NA
"378",267872001,"1  (bases 1 to 681)","Galibert,F., Tiollais,P. and Charnay,P.",NA,"Nucleotidic sequence coding the surface antigen of the hepatitis B	virus, vector containing said nucleotidic sequence, process	allowing the obtention thereof and antigen obtained thereby","Patent: US 4428941-A 2 31-JAN-1984;	Institut Pasteur; Paris;	FR;",NA,NA
"379",267874001,"1  (bases 1 to 772)","Galibert,F., Tiollais,P. and Charnay,P.",NA,"Nucleotidic sequence coding the surface antigen of the hepatitis B	virus, vector containing said nucleotidic sequence, process	allowing the obtention thereof and antigen obtained thereby","Patent: US 4428941-A 4 31-JAN-1984;	Institut Pasteur; Paris;	FR;",NA,NA
"380",267876001,"1  (bases 1 to 159)","Galibert,F., Tiollais,P. and Charnay,P.",NA,"Nucleotidic sequence coding the surface antigen of the hepatitis B	virus, vector containing said nucleotidic sequence, process	allowing the obtention thereof and antigen obtained thereby","Patent: US 4428941-A 6 31-JAN-1984;	Institut Pasteur; Paris;	FR;",NA,NA
"381",267892001,"1  (bases 1 to 56)","Riggs,A.D.",NA,"Transformant bacterial culture capable of expressing heterologous	protein","Patent: US 4431739-A 2 14-FEB-1984;	Genentech, Inc.; South San Francisco, CA",NA,NA
"382",267894001,"1  (bases 1 to 124)","Riggs,A.D.",NA,"Transformant bacterial culture capable of expressing heterologous	protein","Patent: US 4431739-A 4 14-FEB-1984;	Genentech, Inc.; South San Francisco, CA",NA,NA
"383",267895001,"1  (bases 1 to 44)","Riggs,A.D.",NA,"Transformant bacterial culture capable of expressing heterologous	protein","Patent: US 4431739-A 5 14-FEB-1984;	Genentech, Inc.; South San Francisco, CA",NA,NA
"384",267897001,"1  (bases 1 to 104)","Riggs,A.D.",NA,"Transformant bacterial culture capable of expressing heterologous	protein","Patent: US 4431739-A 7 14-FEB-1984;	Genentech, Inc.; South San Francisco, CA",NA,NA
"385",267899001,"1  (bases 1 to 77)","Riggs,A.D.",NA,"Transformant bacterial culture capable of expressing heterologous	protein","Patent: US 4431739-A 9 14-FEB-1984;	Genentech, Inc.; South San Francisco, CA",NA,NA
"386",267901001,"1  (bases 1 to 416)","Bell,G., Pictet,R., Goodman,H.M. and Rutter,W.J.",NA,"DNA Transfer vector and transformed microorganism containing human	proinsulin and pre-proinsulin genes","Patent: US 4431740-A 2 14-FEB-1984;	The Regents of the University of California; Berkeley, CA",NA,NA
"387",267903001,"1  (bases 1 to 98)","Hershberger,C.L. and Rosteck,P.R. Jr.",NA,"Method for stabilizing and selecting recombinant DNA containing	host cells","Patent: US 4436815-A 2 13-MAR-1984;	Eli Lilly and Company; Indianapolis, IN",NA,NA
"388",267907001,"1  (bases 1 to 354)","Rutter,W.J., Goodman,H.M., Ullrich,A., Shine,J., Chirgwin,J. and	Pictet,R.",NA,"Method for producing recombinant bacterial plasmids containing the	coding sequences of higher organisms","Patent: US 4440859-A 1 03-APR-1984;	The Regents of the University of California; Berkeley, CA",NA,NA
"389",267917001,"1  (bases 1 to 1826)","Seeburg,P.H.",NA,"Method for cloning human growth hormone varient genes","Patent: US 4446235-A 1 01-MAY-1984;	Genentech, Inc.; South San Francisco, CA",NA,NA
"390",267918001,"1  (bases 1 to 1841)","Seeburg,P.H.",NA,"Method for cloning human growth hormone varient genes","Patent: US 4446235-A 2 01-MAY-1984;	Genentech, Inc.; South San Francisco, CA",NA,NA
"391",267919001,"1  (bases 1 to 831)","Seeburg,P.H.",NA,"Method for cloning human growth hormone varient genes","Patent: US 4446235-A 3 01-MAY-1984;	Genentech, Inc.; South San Francisco, CA",NA,NA
"392",267920001,"1  (bases 1 to 1125)","Seeburg,P.H.",NA,"Method for cloning human growth hormone varient genes","Patent: US 4446235-A 4 01-MAY-1984;	Genentech, Inc.; South San Francisco, CA",NA,NA
"393",267922001,"1  (bases 1 to 651)","Seeburg,P.H.",NA,"Method for cloning human growth hormone varient genes","Patent: US 4446235-A 6 01-MAY-1984;	Genentech, Inc.; South San Francisco, CA",NA,NA
"394",267930001,"1  (bases 1 to 753)","Goodman,H.M., Shine,J. and Seeburg,P.H.",NA,"Microorganism containing gene for human chorionic somatomammotropin","Patent: US 4447538-A 6 08-MAY-1984;	Regents of the University of California; Berkeley, CA",NA,NA
"395",267951001,"1  (bases 1 to 54)","Baxter,J.D., Fettes,I. and Shine,J.",NA,"Fusion peptides comprising an expressible bacterial gene and	.beta.-endorphin","Patent: US 4469631-A 1 04-SEP-1984;	The Regents of the University of California; Berkeley, CA",NA,NA
"396",267953001,"1  (bases 1 to 91)","Baxter,J.D., Fettes,I. and Shine,J.",NA,"Fusion peptides comprising an expressible bacterial gene and	.beta.-endorphin","Patent: US 4469631-A 3 04-SEP-1984;	The Regents of the University of California; Berkeley, CA",NA,NA
"397",268024001,"1  (bases 1 to 551)","Konrad,M.W. and Mark,D.F.",NA,"Bacterial production of heterologous polypeptides under the control	of a repressible promoter-operator","Patent: US 4499188-A 2 12-FEB-1985;	Cetus Corporation; Emeryville, CA",NA,NA
"398",268025001,"1  (bases 1 to 620)","Konrad,M.W. and Mark,D.F.",NA,"Bacterial production of heterologous polypeptides under the control	of a repressible promoter-operator","Patent: US 4499188-A 3 12-FEB-1985;	Cetus Corporation; Emeryville, CA",NA,NA
"399",268033001,"1  (bases 1 to 98)","Hershberger,C.L., Radue,A.K. and Rosteck,P.R. Jr.",NA,"Stabilizing and selecting recombinant DNA host cells","Patent: US 4506013-A 2 19-MAR-1985;	Eli Lilly and Company; Indianapolis, IN",NA,NA
"400",268039001,"1  (bases 1 to 560)","Cousens,L.S., Bell,G.I. and Valenzuela,P.D.T.",NA,"Adenovirus promoter system","Patent: US 4510245-A 1 09-APR-1985;	Chiron Corporation; Emeryville, CA",NA,NA
"401",268040001,"1  (bases 1 to 578)","Cousens,L.S., Bell,G.I. and Valenzuela,P.D.T.",NA,"Adenovirus promoter system","Patent: US 4510245-A 2 09-APR-1985;	Chiron Corporation; Emeryville, CA",NA,NA
"402",268042001,"1  (bases 1 to 183)","Fogel,S., Welch,J.W. and Karin,M.",NA,"High efficiency eukaryotic metallothionein promoter system","Patent: US 4511652-A 2 16-APR-1985;	The Regents of the University of California; Berkeley, CA",NA,NA
"403",268044001,"1  (bases 1 to 1686)","Kit,M. and Kit,S.",NA,"Modified live pseudorabies viruses","Patent: US 4514497-A 1 30-APR-1985;	Novagene, Ltd.; Houston, TX",NA,NA
"404",268048001,"1  (bases 1 to 1599)","Bock,S.C. and Lawn,R.M.",NA,"Human antithrombin III","Patent: US 4517294-A 1 14-MAY-1985;	Genentech, Inc.; South San Francisco, CA",NA,NA
"405",268050001,"1  (bases 1 to 36)","Bock,S.C. and Lawn,R.M.",NA,"Human antithrombin III","Patent: US 4517294-A 3 14-MAY-1985;	Genentech, Inc.; South San Francisco, CA",NA,NA
"406",268051001,"1  (bases 1 to 37)","Bock,S.C. and Lawn,R.M.",NA,"Human antithrombin III","Patent: US 4517294-A 4 14-MAY-1985;	Genentech, Inc.; South San Francisco, CA",NA,NA
"407",268055001,"1  (bases 1 to 506)","Mark,D.F., Lin,L.S. and Lu,S.-D.Y.",NA,"Human recombinant interleukin-2 muteins","Patent: US 4518584-A 2 21-MAY-1985;	Cetus Corporation; Emeryville, CA",NA,NA
"408",268056001,"1  (bases 1 to 402)","Mark,D.F., Lin,L.S. and Lu,S.-D.Y.",NA,"Human recombinant interleukin-2 muteins","Patent: US 4518584-A 3 21-MAY-1985;	Cetus Corporation; Emeryville, CA",NA,NA
"409",268058001,"1  (bases 1 to 20)","Mark,D.F., Lin,L.S. and Lu,S.-D.Y.",NA,"Human recombinant interleukin-2 muteins","Patent: US 4518584-A 5 21-MAY-1985;	Cetus Corporation; Emeryville, CA",NA,NA
"410",268059001,"1  (bases 1 to 23)","Mark,D.F., Lin,L.S. and Lu,S.-D.Y.",NA,"Human recombinant interleukin-2 muteins","Patent: US 4518584-A 6 21-MAY-1985;	Cetus Corporation; Emeryville, CA",NA,NA
"411",268060001,"1  (bases 1 to 24)","Mark,D.F., Lin,L.S. and Lu,S.-D.Y.",NA,"Human recombinant interleukin-2 muteins","Patent: US 4518584-A 7 21-MAY-1985;	Cetus Corporation; Emeryville, CA",NA,NA
"412",268067001,"1  (bases 1 to 154)","Guntaka,R.V.",NA,"DNA promoter sequence of Avian tumor virus and use thereof for	enhanced gene expression in E. coli","Patent: US 4518690-A 1 21-MAY-1985;	Research Corporation; New York, NY",NA,NA
"413",268073001,"1  (bases 1 to 1287)","Yoshida,M., Sugano,H., Shimizu,F. and Imagawa,K.",NA,"Human leukemia virus-related peptides, antibodies of the peptides	and a process for production of the antibodies","Patent: US 4525300-A 1 25-JUN-1985;	Japanese Foundation for Cancer Research; both of;	JP;",NA,NA
"414",268102001,"1  (bases 1 to 99)","Weissmann,C.",NA,"Recombinant DNA molecules and their use in producing human	interferon-like polypeptides","Patent: US 4530901-A 2 23-JUL-1985;	Biogen N.V.; Curacao;	AN;",NA,NA
"415",268104001,"1  (bases 1 to 85)","Weissmann,C.",NA,"Recombinant DNA molecules and their use in producing human	interferon-like polypeptides","Patent: US 4530901-A 4 23-JUL-1985;	Biogen N.V.; Curacao;	AN;",NA,NA
"416",268106001,"1  (bases 1 to 86)","Weissmann,C.",NA,"Recombinant DNA molecules and their use in producing human	interferon-like polypeptides","Patent: US 4530901-A 6 23-JUL-1985;	Biogen N.V.; Curacao;	AN;",NA,NA
"417",268108001,"1  (bases 1 to 93)","Weissmann,C.",NA,"Recombinant DNA molecules and their use in producing human	interferon-like polypeptides","Patent: US 4530901-A 8 23-JUL-1985;	Biogen N.V.; Curacao;	AN;",NA,NA
"418",268110001,"1  (bases 1 to 98)","Hershberger,C.L. and Rosteck,P.R. Jr.",NA,"Method for conferring bacteriophage resistance to bacteria","Patent: US 4530904-A 2 23-JUL-1985;	Eli Lilly and Company; Indianapolis, IN",NA,NA
"419",268112001,"1  (bases 1 to 342)","Hershberger,C.L. and Rosteck,P.R. Jr.",NA,"Method for conferring bacteriophage resistance to bacteria","Patent: US 4530904-A 4 23-JUL-1985;	Eli Lilly and Company; Indianapolis, IN",NA,NA
"420",268115001,"1  (bases 1 to 330)","Weinberg,R.A., Tabin,C.J. and Bradley,S.M.",NA,"Characterization of oncogenes and assays based thereon","Patent: US 4535058-A 1 13-AUG-1985;	Massachusetts Institute of Technology; Cambridge, MA",NA,NA
"421",268133001,"1  (bases 1 to 848)","Kurjan,J. and Herskowitz,I.",NA,"E. coli/Saccharomyces cerevisiae plasmid cloning vector containing	the alpha-factor gene for secretion and processing of hybrid	proteins","Patent: US 4546082-A 1 08-OCT-1985;	Regents of the Univ. of California; Berkeley, CA",NA,NA
"422",268139001,"1  (bases 1 to 138)","Evans,R.M. and Rosenfeld,M.G.",NA,"Human CGRP","Patent: US 4549986-A 4 29-OCT-1985;	The Salk Institute for Biological Studies; San Diego, CA",NA,NA
"423",268142001,"1  (bases 1 to 1521)","Danos,O., Katinka,M. and Yaniv,M.",NA,"DNA Fragments coding for polypeptides containing at least one	antigenic determinant of the papillomavirus, particularly of the	HPV 1a type and corresponding polypeptides","Patent: US 4551270-A 2 05-NOV-1985;	Institut Pasteur; Paris;	FR;",NA,NA
"424",268144001,"1  (bases 1 to 758)","Danos,O., Katinka,M. and Yaniv,M.",NA,"DNA Fragments coding for polypeptides containing at least one	antigenic determinant of the papillomavirus, particularly of the	HPV 1a type and corresponding polypeptides","Patent: US 4551270-A 4 05-NOV-1985;	Institut Pasteur; Paris;	FR;",NA,NA
"425",268146001,"1  (bases 1 to 181)","Danos,O., Katinka,M. and Yaniv,M.",NA,"DNA Fragments coding for polypeptides containing at least one	antigenic determinant of the papillomavirus, particularly of the	HPV 1a type and corresponding polypeptides","Patent: US 4551270-A 6 05-NOV-1985;	Institut Pasteur; Paris;	FR;",NA,NA
"426",268147001,"1  (bases 1 to 180)","Danos,O., Katinka,M. and Yaniv,M.",NA,"DNA Fragments coding for polypeptides containing at least one	antigenic determinant of the papillomavirus, particularly of the	HPV 1a type and corresponding polypeptides","Patent: US 4551270-A 7 05-NOV-1985;	Institut Pasteur; Paris;	FR;",NA,NA
"427",268150001,"1  (bases 1 to 33)","Danos,O., Katinka,M. and Yaniv,M.",NA,"DNA Fragments coding for polypeptides containing at least one	antigenic determinant of the papillomavirus, particularly of the	HPV 1a type and corresponding polypeptides","Patent: US 4551270-A 10 05-NOV-1985;	Institut Pasteur; Paris;	FR;",NA,NA
"428",268154001,"1  (bases 1 to 51)","Danos,O., Katinka,M. and Yaniv,M.",NA,"DNA Fragments coding for polypeptides containing at least one	antigenic determinant of the papillomavirus, particularly of the	HPV 1a type and corresponding polypeptides","Patent: US 4551270-A 14 05-NOV-1985;	Institut Pasteur; Paris;	FR;",NA,NA
"429",268157001,"1  (bases 1 to 76)","DeBoer,H.A.",NA,"Microbial hybrid promoters","Patent: US 4551433-A 1 05-NOV-1985;	Genentech, Inc.; San Francisco, CA",NA,NA
"430",268158001,"1  (bases 1 to 85)","DeBoer,H.A.",NA,"Microbial hybrid promoters","Patent: US 4551433-A 2 05-NOV-1985;	Genentech, Inc.; San Francisco, CA",NA,NA
"431",268159001,"1  (bases 1 to 86)","DeBoer,H.A.",NA,"Microbial hybrid promoters","Patent: US 4551433-A 3 05-NOV-1985;	Genentech, Inc.; San Francisco, CA",NA,NA
"432",268160001,"1  (bases 1 to 87)","DeBoer,H.A.",NA,"Microbial hybrid promoters","Patent: US 4551433-A 4 05-NOV-1985;	Genentech, Inc.; San Francisco, CA",NA,NA
"433",268161001,"1  (bases 1 to 51)","DeBoer,H.A.",NA,"Microbial hybrid promoters","Patent: US 4551433-A 5 05-NOV-1985;	Genentech, Inc.; San Francisco, CA",NA,NA
"434",268162001,"1  (bases 1 to 51)","DeBoer,H.A.",NA,"Microbial hybrid promoters","Patent: US 4551433-A 6 05-NOV-1985;	Genentech, Inc.; San Francisco, CA",NA,NA
"435",268163001,"1  (bases 1 to 43)","DeBoer,H.A.",NA,"Microbial hybrid promoters","Patent: US 4551433-A 7 05-NOV-1985;	Genentech, Inc.; San Francisco, CA",NA,NA
"436",268164001,"1  (bases 1 to 64)","DeBoer,H.A.",NA,"Microbial hybrid promoters","Patent: US 4551433-A 8 05-NOV-1985;	Genentech, Inc.; San Francisco, CA",NA,NA
"437",268165001,"1  (bases 1 to 49)","DeBoer,H.A.",NA,"Microbial hybrid promoters","Patent: US 4551433-A 9 05-NOV-1985;	Genentech, Inc.; San Francisco, CA",NA,NA
"438",268169001,"1  (bases 1 to 63)","Ingolia,T.D.",NA,"DNA for directing transcription and expression of structural genes","Patent: US 4559302-A 1 17-DEC-1985;	Eli Lilly and Company; Indianapolis, IN",NA,NA
"439",268177001,"1  (bases 1 to 64)","Murray,K. and MacKay,P.",NA,"Products displaying the antigenicity of hepatitis B virus e	antigens and methods of producing those antigens","Patent: US 4563423-A 2 07-JAN-1986;	Biogen N.V.; Curacao;	AN;",NA,NA
"440",268179001,"1  (bases 1 to 56)","Riggs,A.D.",NA,"Method and means for somatostatin protein conjugate expression","Patent: US 4563424-A 2 07-JAN-1986;	Genentech, Inc.; South San Francisco, CA",NA,NA
"441",268181001,"1  (bases 1 to 124)","Riggs,A.D.",NA,"Method and means for somatostatin protein conjugate expression","Patent: US 4563424-A 4 07-JAN-1986;	Genentech, Inc.; South San Francisco, CA",NA,NA
"442",268183001,"1  (bases 1 to 106)","Riggs,A.D.",NA,"Method and means for somatostatin protein conjugate expression","Patent: US 4563424-A 6 07-JAN-1986;	Genentech, Inc.; South San Francisco, CA",NA,NA
"443",268185001,"1  (bases 1 to 104)","Riggs,A.D.",NA,"Method and means for somatostatin protein conjugate expression","Patent: US 4563424-A 8 07-JAN-1986;	Genentech, Inc.; South San Francisco, CA",NA,NA
"444",268187001,"1  (bases 1 to 77)","Riggs,A.D.",NA,"Method and means for somatostatin protein conjugate expression","Patent: US 4563424-A 10 07-JAN-1986;	Genentech, Inc.; South San Francisco, CA",NA,NA
"445",268188001,"1  (bases 1 to 1106)","Gilbert,W., Broome,S.A., Villa-Komaroff,L.J. and Efstratiadis,A.A.",NA,"Recombinant DNA molecule","Patent: US 4565785-A 1 21-JAN-1986;	The President and Fellows of Harvard College; Cambridge, MA",NA,NA
"446",268201001,"1  (bases 1 to 568)","Mark,D.F. and Creasey,A.A.",NA,"Multiclass hybrid interferons","Patent: US 4569908-A 9 11-FEB-1986;	Cetus Corporation; Emeryville, CA",NA,NA
"447",268203001,"1  (bases 1 to 506)","Mark,D.F. and Creasey,A.A.",NA,"Multiclass hybrid interferons","Patent: US 4569908-A 11 11-FEB-1986;	Cetus Corporation; Emeryville, CA",NA,NA
"448",268205001,"1  (bases 1 to 506)","Mark,D.F. and Creasey,A.A.",NA,"Multiclass hybrid interferons","Patent: US 4569908-A 13 11-FEB-1986;	Cetus Corporation; Emeryville, CA",NA,NA
"449",268207001,"1  (bases 1 to 568)","Mark,D.F. and Creasey,A.A.",NA,"Multiclass hybrid interferons","Patent: US 4569908-A 15 11-FEB-1986;	Cetus Corporation; Emeryville, CA",NA,NA
"450",268209001,"1  (bases 1 to 486)","Mark,D.F. and Creasey,A.A.",NA,"Multiclass hybrid interferons","Patent: US 4569908-A 17 11-FEB-1986;	Cetus Corporation; Emeryville, CA",NA,NA
"451",268213001,"1  (bases 1 to 56)","Itakura,K.",NA,"Mammalian gene for microbial expression","Patent: US 4571421-A 2 18-FEB-1986;	Genentech, Inc.; South San Francisco, CA",NA,NA
"452",268215001,"1  (bases 1 to 124)","Itakura,K.",NA,"Mammalian gene for microbial expression","Patent: US 4571421-A 4 18-FEB-1986;	Genentech, Inc.; South San Francisco, CA",NA,NA
"453",268216001,"1  (bases 1 to 104)","Itakura,K.",NA,"Mammalian gene for microbial expression","Patent: US 4571421-A 5 18-FEB-1986;	Genentech, Inc.; South San Francisco, CA",NA,NA
"454",268217001,"1  (bases 1 to 77)","Itakura,K.",NA,"Mammalian gene for microbial expression","Patent: US 4571421-A 6 18-FEB-1986;	Genentech, Inc.; South San Francisco, CA",NA,NA
"455",268218001,"1  (bases 1 to 56)","Itakura,K.",NA,"Mammalian gene for microbial expression","Patent: US 4571421-A 7 18-FEB-1986;	Genentech, Inc.; South San Francisco, CA",NA,NA
"456",268233001,"1  (bases 1 to 1099)","Erlich,H.A.",NA,"HLA typing method and cDNA probes used therein","Patent: US 4582788-A 1 15-APR-1986;	Cetus Corporation; Emeryville, CA",NA,NA
"457",268234001,"1  (bases 1 to 150)","Erlich,H.A.",NA,"HLA typing method and cDNA probes used therein","Patent: US 4582788-A 2 15-APR-1986;	Cetus Corporation; Emeryville, CA",NA,NA
"458",268235001,"1  (bases 1 to 140)","Erlich,H.A.",NA,"HLA typing method and cDNA probes used therein","Patent: US 4582788-A 3 15-APR-1986;	Cetus Corporation; Emeryville, CA",NA,NA
"459",268236001,"1  (bases 1 to 72)","Erlich,H.A.",NA,"HLA typing method and cDNA probes used therein","Patent: US 4582788-A 4 15-APR-1986;	Cetus Corporation; Emeryville, CA",NA,NA
"460",268237001,"1  (bases 1 to 106)","Erlich,H.A.",NA,"HLA typing method and cDNA probes used therein","Patent: US 4582788-A 5 15-APR-1986;	Cetus Corporation; Emeryville, CA",NA,NA
"461",268239001,"1  (bases 1 to 60)","Sheldon,E.L. III, Levenson,C.H., Mullis,K.B. and Rapoport,H.",NA,"Process for labeling nucleic acids using psoralen derivatives","Patent: US 4582789-A 2 15-APR-1986;	Cetus Corporation; Emeryville, CA",NA,NA
"462",268241001,"1  (bases 1 to 75)","Sheldon,E.L. III, Levenson,C.H., Mullis,K.B. and Rapoport,H.",NA,"Process for labeling nucleic acids using psoralen derivatives","Patent: US 4582789-A 4 15-APR-1986;	Cetus Corporation; Emeryville, CA",NA,NA
"463",268242001,"1  (bases 1 to 661)","Sheldon,E.L. III, Levenson,C.H., Mullis,K.B. and Rapoport,H.",NA,"Process for labeling nucleic acids using psoralen derivatives","Patent: US 4582789-A 5 15-APR-1986;	Cetus Corporation; Emeryville, CA",NA,NA
"464",268243001,"1  (bases 1 to 1099)","Sheldon,E.L. III, Levenson,C.H., Mullis,K.B. and Rapoport,H.",NA,"Process for labeling nucleic acids using psoralen derivatives","Patent: US 4582789-A 6 15-APR-1986;	Cetus Corporation; Emeryville, CA",NA,NA
"465",268244001,"1  (bases 1 to 1140)","Sheldon,E.L. III, Levenson,C.H., Mullis,K.B. and Rapoport,H.",NA,"Process for labeling nucleic acids using psoralen derivatives","Patent: US 4582789-A 7 15-APR-1986;	Cetus Corporation; Emeryville, CA",NA,NA
"466",268247001,"1  (bases 1 to 439)","Crowl,R.M.",NA,"Novel vectors and method for controlling interferon expression","Patent: US 4582800-A 3 15-APR-1986;	Hoffmann-La Roche Inc.; Nutley, NJ",NA,NA
"467",268249001,"1  (bases 1 to 21)","Crowl,R.M.",NA,"Novel vectors and method for controlling interferon expression","Patent: US 4582800-A 5 15-APR-1986;	Hoffmann-La Roche Inc.; Nutley, NJ",NA,NA
"468",268258001,"1  (bases 1 to 487)","Lovett,P.S. and Schoner,R.G.",NA,"Plasmid for foreign gene expression in B. subtilis","Patent: US 4585739-A 1 29-APR-1986;	E. I. Du Pont de Nemours and Company; Wilmington, DE",NA,NA
"469",268264001,"1  (bases 1 to 506)","Mark,D.F., Lin,L.S. and Yu Lu,S.-D.",NA,"Human recombinant cysteine depleted interferon-.beta. muteins","Patent: US 4588585-A 2 13-MAY-1986;	Cetus Corporation; Emeryville, CA",NA,NA
"470",268266001,"1  (bases 1 to 402)","Mark,D.F., Lin,L.S. and Yu Lu,S.-D.",NA,"Human recombinant cysteine depleted interferon-.beta. muteins","Patent: US 4588585-A 4 13-MAY-1986;	Cetus Corporation; Emeryville, CA",NA,NA
"471",268268001,"1  (bases 1 to 24)","Mark,D.F., Lin,L.S. and Yu Lu,S.-D.",NA,"Human recombinant cysteine depleted interferon-.beta. muteins","Patent: US 4588585-A 6 13-MAY-1986;	Cetus Corporation; Emeryville, CA",NA,NA
"472",268269001,"1  (bases 1 to 1569)","Brake,A.J.",NA,"a-Factor and its processing signals","Patent: US 4588684-A 1 13-MAY-1986;	Chiron Corporation; Emeryville, CA",NA,NA
"473",268271001,"1  (bases 1 to 154)","Brake,A.J.",NA,"a-Factor and its processing signals","Patent: US 4588684-A 3 13-MAY-1986;	Chiron Corporation; Emeryville, CA",NA,NA
"474",268359001,"1  (bases 1 to 1312)","Kawasaki,G.H.",NA,"Glycolytic promotersfor regulated protein expression: protease	inhibitor","Patent: US 4599311-A 1 08-JUL-1986;	1547 - 16th Ave. East; Seattle, WA",NA,NA
"475",268361001,"1  (bases 1 to 1647)","Kawasaki,G.H.",NA,"Glycolytic promotersfor regulated protein expression: protease	inhibitor","Patent: US 4599311-A 3 08-JUL-1986;	1547 - 16th Ave. East; Seattle, WA",NA,NA
"476",268363001,"1  (bases 1 to 701)","Kawasaki,G.H.",NA,"Glycolytic promotersfor regulated protein expression: protease	inhibitor","Patent: US 4599311-A 5 08-JUL-1986;	1547 - 16th Ave. East; Seattle, WA",NA,NA
"477",268365001,"1  (bases 1 to 83)","Goeddel,D.V. and Heyneker,H.L.",NA,"Microbial expression of a gene for human growth hormone","Patent: US 4601980-A 2 22-JUL-1986;	Genentech Inc.; South San Francisco, CA",NA,NA
"478",268367001,"1  (bases 1 to 556)","Goeddel,D.V. and Heyneker,H.L.",NA,"Microbial expression of a gene for human growth hormone","Patent: US 4601980-A 4 22-JUL-1986;	Genentech Inc.; South San Francisco, CA",NA,NA
"479",268381001,"1  (bases 1 to 455)","Kung,H.-F., Sugino,H. and Honda,S.",NA,"Homogeneous immune interferon fragment","Patent: US 4604284-A 1 05-AUG-1986;	Hoffmann-La Roche Inc.; Nutley, NJ;	JP;",NA,NA
"480",268384001,"1  (bases 1 to 83)","Goeddel,D.V. and Heyneker,H.L.",NA,"Microbial expression of a gene for human growth hormone","Patent: US 4604359-A 2 05-AUG-1986;	Genentech, Inc.; South San Francisco, CA",NA,NA
"481",268386001,"1  (bases 1 to 553)","Goeddel,D.V. and Heyneker,H.L.",NA,"Microbial expression of a gene for human growth hormone","Patent: US 4604359-A 4 05-AUG-1986;	Genentech, Inc.; South San Francisco, CA",NA,NA
"482",268410001,"1  (bases 1 to 1686)","Kit,M. and Kit,S.",NA,"Vaccines for pseudorabies disease and methods for use of same","Patent: US 4609548-A 1 02-SEP-1986;	Novagene, Ltd.; Houston, TX",NA,NA
"483",268442001,"1  (bases 1 to 1845)","Hughes,J.V., Scolnick,E.M. and Tomassini,J.E.",NA,"Hepatitis A--subunit antigen","Patent: US 4614793-A 6 30-SEP-1986;	Merck & Co., Inc.; Rahway, NJ",NA,NA
"484",268444001,"1  (bases 1 to 1135)","Hughes,J.V., Scolnick,E.M. and Tomassini,J.E.",NA,"Hepatitis A--subunit antigen","Patent: US 4614793-A 8 30-SEP-1986;	Merck & Co., Inc.; Rahway, NJ",NA,NA
"485",268446001,"1  (bases 1 to 273)","Kingsman,A.J. and Kingsman,S.M.",NA,"Yeast expression vectors","Patent: US 4615974-A 1 07-OCT-1986;	Celltech Limited; Berkshire;	GB;",NA,NA
"486",268448001,"1  (bases 1 to 247)","Kingsman,A.J. and Kingsman,S.M.",NA,"Yeast expression vectors","Patent: US 4615974-A 3 07-OCT-1986;	Celltech Limited; Berkshire;	GB;",NA,NA
"487",268449001,"1  (bases 1 to 850)","Kingsman,A.J. and Kingsman,S.M.",NA,"Yeast expression vectors","Patent: US 4615974-A 4 07-OCT-1986;	Celltech Limited; Berkshire;	GB;",NA,NA
"488",268451001,"1  (bases 1 to 369)","Kingsman,A.J. and Kingsman,S.M.",NA,"Yeast expression vectors","Patent: US 4615974-A 6 07-OCT-1986;	Celltech Limited; Berkshire;	GB;",NA,NA
"489",268453001,"1  (bases 1 to 941)","Kingsman,A.J. and Kingsman,S.M.",NA,"Yeast expression vectors","Patent: US 4615974-A 8 07-OCT-1986;	Celltech Limited; Berkshire;	GB;",NA,NA
"490",268458001,"1  (bases 1 to 60)","Sheldon,E.L. III, Levenson,C.H., Mullis,K.B., Rapoport,H. and	Watson,R.M.",NA,"Process for labeling nucleic acids and hybridization probes","Patent: US 4617261-A 2 14-OCT-1986;	Cetus Corporation; Emeryville, CA",NA,NA
"491",268460001,"1  (bases 1 to 75)","Sheldon,E.L. III, Levenson,C.H., Mullis,K.B., Rapoport,H. and	Watson,R.M.",NA,"Process for labeling nucleic acids and hybridization probes","Patent: US 4617261-A 4 14-OCT-1986;	Cetus Corporation; Emeryville, CA",NA,NA
"492",268461001,"1  (bases 1 to 1099)","Sheldon,E.L. III, Levenson,C.H., Mullis,K.B., Rapoport,H. and	Watson,R.M.",NA,"Process for labeling nucleic acids and hybridization probes","Patent: US 4617261-A 5 14-OCT-1986;	Cetus Corporation; Emeryville, CA",NA,NA
"493",268462001,"1  (bases 1 to 1201)","Sheldon,E.L. III, Levenson,C.H., Mullis,K.B., Rapoport,H. and	Watson,R.M.",NA,"Process for labeling nucleic acids and hybridization probes","Patent: US 4617261-A 6 14-OCT-1986;	Cetus Corporation; Emeryville, CA",NA,NA
"494",268464001,"1  (bases 1 to 63)","Narang,S.A. and Wu,R.J.",NA,"Adaptor molecules for DNA and their application to synthesis of	gene-derived products","Patent: US 4617384-A 2 14-OCT-1986;	Cornell Research Foundation, Inc.; Ithaca, NY",NA,NA
"495",268465001,"1  (bases 1 to 43)","Narang,S.A. and Wu,R.J.",NA,"Adaptor molecules for DNA and their application to synthesis of	gene-derived products","Patent: US 4617384-A 3 14-OCT-1986;	Cornell Research Foundation, Inc.; Ithaca, NY",NA,NA
"496",268466001,"1  (bases 1 to 36)","Narang,S.A. and Wu,R.J.",NA,"Adaptor molecules for DNA and their application to synthesis of	gene-derived products","Patent: US 4617384-A 4 14-OCT-1986;	Cornell Research Foundation, Inc.; Ithaca, NY",NA,NA
"497",268467001,"1  (bases 1 to 53)","Narang,S.A. and Wu,R.J.",NA,"Adaptor molecules for DNA and their application to synthesis of	gene-derived products","Patent: US 4617384-A 5 14-OCT-1986;	Cornell Research Foundation, Inc.; Ithaca, NY",NA,NA
"498",268468001,"1  (bases 1 to 48)","Narang,S.A. and Wu,R.J.",NA,"Adaptor molecules for DNA and their application to synthesis of	gene-derived products","Patent: US 4617384-A 6 14-OCT-1986;	Cornell Research Foundation, Inc.; Ithaca, NY",NA,NA
"499",268469001,"1  (bases 1 to 83)","Narang,S.A. and Wu,R.J.",NA,"Adaptor molecules for DNA and their application to synthesis of	gene-derived products","Patent: US 4617384-A 7 14-OCT-1986;	Cornell Research Foundation, Inc.; Ithaca, NY",NA,NA
"500",268471001,"1  (bases 1 to 111)","Burke,R.L., Urdea,M.S. and Valenzuela,P.D.T.",NA,"Expression of glycoprotein D of herpes simplex virus","Patent: US 4618578-A 2 21-OCT-1986;	Chiron Corporation; Emeryville, CA",NA,NA
"501",268473001,"1  (bases 1 to 69)","Burke,R.L., Urdea,M.S. and Valenzuela,P.D.T.",NA,"Expression of glycoprotein D of herpes simplex virus","Patent: US 4618578-A 4 21-OCT-1986;	Chiron Corporation; Emeryville, CA",NA,NA
"502",268474001,"1  (bases 1 to 28)","Burke,R.L., Urdea,M.S. and Valenzuela,P.D.T.",NA,"Expression of glycoprotein D of herpes simplex virus","Patent: US 4618578-A 5 21-OCT-1986;	Chiron Corporation; Emeryville, CA",NA,NA
"503",268475001,"1  (bases 1 to 129)","Burke,R.L., Urdea,M.S. and Valenzuela,P.D.T.",NA,"Expression of glycoprotein D of herpes simplex virus","Patent: US 4618578-A 6 21-OCT-1986;	Chiron Corporation; Emeryville, CA",NA,NA
"504",268476001,"1  (bases 1 to 48)","Burke,R.L., Urdea,M.S. and Valenzuela,P.D.T.",NA,"Expression of glycoprotein D of herpes simplex virus","Patent: US 4618578-A 7 21-OCT-1986;	Chiron Corporation; Emeryville, CA",NA,NA
"505",268500001,"1  (bases 1 to 799)","Inouye,M. and Nakamura,K.",NA,"Novel cloning vehicles for polypeptide expression in microbial	hosts","Patent: US 4624926-A 1 25-NOV-1986;	The Research Foundation of State University of New York; Albany, NY",NA,NA
"506",268502001,"1  (bases 1 to 322)","Inouye,M. and Nakamura,K.",NA,"Novel cloning vehicles for polypeptide expression in microbial	hosts","Patent: US 4624926-A 3 25-NOV-1986;	The Research Foundation of State University of New York; Albany, NY",NA,NA
"507",268505001,"1  (bases 1 to 272)","Inouye,M. and Nakamura,K.",NA,"Novel cloning vehicles for polypeptide expression in microbial	hosts","Patent: US 4624926-A 6 25-NOV-1986;	The Research Foundation of State University of New York; Albany, NY",NA,NA
"508",268514001,"1  (bases 1 to 190)","Grandi,G.",NA,"Plasmidic vectors for expressing in bacillus subtilis and a method	of preparing them","Patent: US 4626510-A 1 02-DEC-1986;	Eni-Ente Nazionale Idrocarburi; Roma;	IT;",NA,NA
"509",268543001,"1  (bases 1 to 69)","Cosand,W.L.",NA,"Synthetic antigen for the detection of AIDS-related disease","Patent: US 4629783-A 9 16-DEC-1986;	Genetic Systems Corporation; Seattle, WA",NA,NA
"510",268544001,"1  (bases 1 to 63)","Cosand,W.L.",NA,"Synthetic antigen for the detection of AIDS-related disease","Patent: US 4629783-A 10 16-DEC-1986;	Genetic Systems Corporation; Seattle, WA",NA,NA
"511",268545001,"1  (bases 1 to 75)","Cosand,W.L.",NA,"Synthetic antigen for the detection of AIDS-related disease","Patent: US 4629783-A 11 16-DEC-1986;	Genetic Systems Corporation; Seattle, WA",NA,NA
"512",268546001,"1  (bases 1 to 60)","Cosand,W.L.",NA,"Synthetic antigen for the detection of AIDS-related disease","Patent: US 4629783-A 12 16-DEC-1986;	Genetic Systems Corporation; Seattle, WA",NA,NA
"513",268547001,"1  (bases 1 to 78)","Cosand,W.L.",NA,"Synthetic antigen for the detection of AIDS-related disease","Patent: US 4629783-A 13 16-DEC-1986;	Genetic Systems Corporation; Seattle, WA",NA,NA
"514",268548001,"1  (bases 1 to 66)","Cosand,W.L.",NA,"Synthetic antigen for the detection of AIDS-related disease","Patent: US 4629783-A 14 16-DEC-1986;	Genetic Systems Corporation; Seattle, WA",NA,NA
"515",268549001,"1  (bases 1 to 78)","Cosand,W.L.",NA,"Synthetic antigen for the detection of AIDS-related disease","Patent: US 4629783-A 15 16-DEC-1986;	Genetic Systems Corporation; Seattle, WA",NA,NA
"516",268550001,"1  (bases 1 to 1809)","Dale,B. and Cordell,B.",NA,"Methods and compositions useful in preventing equine influenza","Patent: US 4631191-A 1 23-DEC-1986;	Biotechnology Research Partners, Ltd.; Mountain View, CA",NA,NA
"517",268552001,"1  (bases 1 to 1797)","Dale,B. and Cordell,B.",NA,"Methods and compositions useful in preventing equine influenza","Patent: US 4631191-A 3 23-DEC-1986;	Biotechnology Research Partners, Ltd.; Mountain View, CA",NA,NA
"518",268554001,"1  (bases 1 to 1515)","Dale,B. and Cordell,B.",NA,"Methods and compositions useful in preventing equine influenza","Patent: US 4631191-A 5 23-DEC-1986;	Biotechnology Research Partners, Ltd.; Mountain View, CA",NA,NA
"519",268556001,"1  (bases 1 to 1481)","Dale,B. and Cordell,B.",NA,"Methods and compositions useful in preventing equine influenza","Patent: US 4631191-A 7 23-DEC-1986;	Biotechnology Research Partners, Ltd.; Mountain View, CA",NA,NA
"520",268574001,"1  (bases 1 to 1599)","Bock,S.C. and Lawn,R.M.",NA,"Human antithrombin III","Patent: US 4632981-A 1 30-DEC-1986;	Genentech, Inc.; South San Francisco, CA",NA,NA
"521",268577001,"1  (bases 1 to 83)","Goeddel,D.V. and Heyneker,H.L.",NA,"Plasmid capable of expressing human growth hormone","Patent: US 4634677-A 2 06-JAN-1987;	Genentech, Inc.; South San Francisco, CA",NA,NA
"522",268579001,"1  (bases 1 to 556)","Goeddel,D.V. and Heyneker,H.L.",NA,"Plasmid capable of expressing human growth hormone","Patent: US 4634677-A 4 06-JAN-1987;	Genentech, Inc.; South San Francisco, CA",NA,NA
"523",268580001,"1  (bases 1 to 347)","Salstrom,J.S., Newman,D., Harbrecht,D.F. and Hu,S.-L.",NA,"Plasmid cloning and expression vectors for use in microorganisms","Patent: US 4634678-A 1 06-JAN-1987;	Molecular Genetics Research and Development Limited Partnership;	Minnetonka, MN",NA,NA
"524",268581001,"1  (bases 1 to 226)","Salstrom,J.S., Newman,D., Harbrecht,D.F. and Hu,S.-L.",NA,"Plasmid cloning and expression vectors for use in microorganisms","Patent: US 4634678-A 2 06-JAN-1987;	Molecular Genetics Research and Development Limited Partnership;	Minnetonka, MN",NA,NA
"525",268582001,"1  (bases 1 to 353)","Salstrom,J.S., Newman,D., Harbrecht,D.F. and Hu,S.-L.",NA,"Plasmid cloning and expression vectors for use in microorganisms","Patent: US 4634678-A 3 06-JAN-1987;	Molecular Genetics Research and Development Limited Partnership;	Minnetonka, MN",NA,NA
"526",268583001,"1  (bases 1 to 354)","Salstrom,J.S., Newman,D., Harbrecht,D.F. and Hu,S.-L.",NA,"Plasmid cloning and expression vectors for use in microorganisms","Patent: US 4634678-A 4 06-JAN-1987;	Molecular Genetics Research and Development Limited Partnership;	Minnetonka, MN",NA,NA
"527",268584001,"1  (bases 1 to 452)","Salstrom,J.S., Newman,D., Harbrecht,D.F. and Hu,S.-L.",NA,"Plasmid cloning and expression vectors for use in microorganisms","Patent: US 4634678-A 5 06-JAN-1987;	Molecular Genetics Research and Development Limited Partnership;	Minnetonka, MN",NA,NA
"528",268585001,"1  (bases 1 to 64)","Salstrom,J.S., Newman,D., Harbrecht,D.F. and Hu,S.-L.",NA,"Plasmid cloning and expression vectors for use in microorganisms","Patent: US 4634678-A 6 06-JAN-1987;	Molecular Genetics Research and Development Limited Partnership;	Minnetonka, MN",NA,NA
"529",268586001,"1  (bases 1 to 74)","Salstrom,J.S., Newman,D., Harbrecht,D.F. and Hu,S.-L.",NA,"Plasmid cloning and expression vectors for use in microorganisms","Patent: US 4634678-A 7 06-JAN-1987;	Molecular Genetics Research and Development Limited Partnership;	Minnetonka, MN",NA,NA
"530",268587001,"1  (bases 1 to 89)","Salstrom,J.S., Newman,D., Harbrecht,D.F. and Hu,S.-L.",NA,"Plasmid cloning and expression vectors for use in microorganisms","Patent: US 4634678-A 8 06-JAN-1987;	Molecular Genetics Research and Development Limited Partnership;	Minnetonka, MN",NA,NA
"531",268588001,"1  (bases 1 to 65)","Salstrom,J.S., Newman,D., Harbrecht,D.F. and Hu,S.-L.",NA,"Plasmid cloning and expression vectors for use in microorganisms","Patent: US 4634678-A 9 06-JAN-1987;	Molecular Genetics Research and Development Limited Partnership;	Minnetonka, MN",NA,NA
"532",268589001,"1  (bases 1 to 28)","Salstrom,J.S., Newman,D., Harbrecht,D.F. and Hu,S.-L.",NA,"Plasmid cloning and expression vectors for use in microorganisms","Patent: US 4634678-A 10 06-JAN-1987;	Molecular Genetics Research and Development Limited Partnership;	Minnetonka, MN",NA,NA
"533",268609001,"1  (bases 1 to 1817)","Person,S.",NA,"Immunologically reactive non-glycosylated amino acid chains of	glycoprotein B of herpes virus types 1 and 2","Patent: US 4642333-A 1 10-FEB-1987;	600 Locust La.; State College, PA",NA,NA
"534",268610001,"1  (bases 1 to 2048)","Person,S.",NA,"Immunologically reactive non-glycosylated amino acid chains of	glycoprotein B of herpes virus types 1 and 2","Patent: US 4642333-A 2 10-FEB-1987;	600 Locust La.; State College, PA",NA,NA
"535",268611001,"1  (bases 1 to 1914)","Person,S.",NA,"Immunologically reactive non-glycosylated amino acid chains of	glycoprotein B of herpes virus types 1 and 2","Patent: US 4642333-A 3 10-FEB-1987;	600 Locust La.; State College, PA",NA,NA
"536",268613001,"1  (bases 1 to 798)","Person,S.",NA,"Immunologically reactive non-glycosylated amino acid chains of	glycoprotein B of herpes virus types 1 and 2","Patent: US 4642333-A 5 10-FEB-1987;	600 Locust La.; State College, PA",NA,NA
"537",268616001,"1  (bases 1 to 78)","Moore,K.W. and Zaffaroni,A.",NA,"Hybrid DNA prepared binding composition","Patent: US 4642334-A 2 10-FEB-1987;	DNAX Research Institute of Molecular and Cellular Biology, Inc.;	Palo Alto, CA",NA,NA
"538",268618001,"1  (bases 1 to 324)","Moore,K.W. and Zaffaroni,A.",NA,"Hybrid DNA prepared binding composition","Patent: US 4642334-A 4 10-FEB-1987;	DNAX Research Institute of Molecular and Cellular Biology, Inc.;	Palo Alto, CA",NA,NA
"539",268620001,"1  (bases 1 to 48)","Moore,K.W. and Zaffaroni,A.",NA,"Hybrid DNA prepared binding composition","Patent: US 4642334-A 6 10-FEB-1987;	DNAX Research Institute of Molecular and Cellular Biology, Inc.;	Palo Alto, CA",NA,NA
"540",268622001,"1  (bases 1 to 57)","Moore,K.W. and Zaffaroni,A.",NA,"Hybrid DNA prepared binding composition","Patent: US 4642334-A 8 10-FEB-1987;	DNAX Research Institute of Molecular and Cellular Biology, Inc.;	Palo Alto, CA",NA,NA
"541",268624001,"1  (bases 1 to 369)","Moore,K.W. and Zaffaroni,A.",NA,"Hybrid DNA prepared binding composition","Patent: US 4642334-A 10 10-FEB-1987;	DNAX Research Institute of Molecular and Cellular Biology, Inc.;	Palo Alto, CA",NA,NA
"542",268626001,"1  (bases 1 to 27)","Moore,K.W. and Zaffaroni,A.",NA,"Hybrid DNA prepared binding composition","Patent: US 4642334-A 12 10-FEB-1987;	DNAX Research Institute of Molecular and Cellular Biology, Inc.;	Palo Alto, CA",NA,NA
"543",268632001,"1  (bases 1 to 1324)","Aggarwal,B.B. and Lee,S.He.",NA,"Synergistic cytotoxic composition","Patent: US 4650674-A 2 17-MAR-1987;	Genentech, Inc.; So. San Francisco, CA",NA,NA
"544",268633001,"1  (bases 1 to 42)","Aggarwal,B.B. and Lee,S.He.",NA,"Synergistic cytotoxic composition","Patent: US 4650674-A 3 17-MAR-1987;	Genentech, Inc.; So. San Francisco, CA",NA,NA
"545",268634001,"1  (bases 1 to 415)","Aggarwal,B.B. and Lee,S.He.",NA,"Synergistic cytotoxic composition","Patent: US 4650674-A 4 17-MAR-1987;	Genentech, Inc.; So. San Francisco, CA",NA,NA
"546",268638001,"1  (bases 1 to 98)","Hershberger,C.L. and Rosteck,P.R. Jr.",NA,"Method for stabilizing and selecting recombinant DNA containing	host cell","Patent: US 4650761-A 2 17-MAR-1987;	Eli Lilly and Company; Indianapolis, IN",NA,NA
"547",268640001,"1  (bases 1 to 342)","Hershberger,C.L. and Rosteck,P.R. Jr.",NA,"Method for stabilizing and selecting recombinant DNA containing	host cell","Patent: US 4650761-A 4 17-MAR-1987;	Eli Lilly and Company; Indianapolis, IN",NA,NA
"548",268654001,"1  (bases 1 to 354)","Rutter,W.J., Pictet,R., Chirgwin,J., Goodman,H.M., Ullrich,A. and	Shine,J.",NA,"Recombinant bacterial plasmids containing the coding sequences of	insulin genes","Patent: US 4652525-A 3 24-MAR-1987;	The Regents of the University of California; Berkeley, CA",NA,NA
"549",268658001,"1  (bases 1 to 1993)","Walfield,A.M. and Pollock,T.J.",NA,"Methods and compositions for expression of BTI endotoxin","Patent: US 4652628-A 1 24-MAR-1987;	Syntro Corporation; San Diego, CA",NA,NA
"550",268660001,"1  (bases 1 to 1738)","Walfield,A.M. and Pollock,T.J.",NA,"Methods and compositions for expression of BTI endotoxin","Patent: US 4652628-A 3 24-MAR-1987;	Syntro Corporation; San Diego, CA",NA,NA
"551",268674001,"1  (bases 1 to 128)","Stabinsky,Y.",NA,"Manufacture and expression of structural genes","Patent: US 4652639-A 4 24-MAR-1987;	Amgen; Thousand Oaks, CA",NA,NA
"552",268675001,"1  (bases 1 to 24)","Stabinsky,Y.",NA,"Manufacture and expression of structural genes","Patent: US 4652639-A 5 24-MAR-1987;	Amgen; Thousand Oaks, CA",NA,NA
"553",268694001,"1  (bases 1 to 600)","Edens,L., Ledeboer,A., Verrips,C. and Van den Berg,J.A.",NA,"Yeast of the genus kluyveromyces modified for the expression of	preprothaumatin or its various allelic and modified forms or their	maturation forms, and the proteins obtained by that expression","Patent: US 4657857-A 1 14-APR-1987;	Internationale Octrooi Maatschappij 'Octropa' B.V.; Rotterdam;	NL;",NA,NA
"554",268695001,"1  (bases 1 to 1578)","Edens,L., Ledeboer,A., Verrips,C. and Van den Berg,J.A.",NA,"Yeast of the genus kluyveromyces modified for the expression of	preprothaumatin or its various allelic and modified forms or their	maturation forms, and the proteins obtained by that expression","Patent: US 4657857-A 2 14-APR-1987;	Internationale Octrooi Maatschappij 'Octropa' B.V.; Rotterdam;	NL;",NA,NA
"555",268696001,"1  (bases 1 to 48)","Edens,L., Ledeboer,A., Verrips,C. and Van den Berg,J.A.",NA,"Yeast of the genus kluyveromyces modified for the expression of	preprothaumatin or its various allelic and modified forms or their	maturation forms, and the proteins obtained by that expression","Patent: US 4657857-A 3 14-APR-1987;	Internationale Octrooi Maatschappij 'Octropa' B.V.; Rotterdam;	NL;",NA,NA
"556",268697001,"1  (bases 1 to 41)","Edens,L., Ledeboer,A., Verrips,C. and Van den Berg,J.A.",NA,"Yeast of the genus kluyveromyces modified for the expression of	preprothaumatin or its various allelic and modified forms or their	maturation forms, and the proteins obtained by that expression","Patent: US 4657857-A 4 14-APR-1987;	Internationale Octrooi Maatschappij 'Octropa' B.V.; Rotterdam;	NL;",NA,NA
"557",268706001,"1  (bases 1 to 83)","Goeddel,D.V. and Heyneker,H.L.",NA,"Methionyl human growth hormone","Patent: US 4658021-A 2 14-APR-1987;	Genentech, Inc.; So. San Francisco, CA",NA,NA
"558",268708001,"1  (bases 1 to 556)","Goeddel,D.V. and Heyneker,H.L.",NA,"Methionyl human growth hormone","Patent: US 4658021-A 4 14-APR-1987;	Genentech, Inc.; So. San Francisco, CA",NA,NA
"559",268710001,"1  (bases 1 to 1775)","Kleid,D.G., Nayak,D.P. and Davis,A.R.",NA,"Microbial expression of human influenza hemagglutinin proteins","Patent: US 4659669-A 1 21-APR-1987;	Regents of the Univ. of California; Berkeley, CA",NA,NA
"560",268716001,"1  (bases 1 to 1585)","Mark,D.F., Wang,A.M., Ladner,M.B., Creasey,A.A., Lin,L.S. and Van	Arsdell,J.",NA,"Human tumor necrosis factor","Patent: US 4677063-A 1 30-JUN-1987;	Cetus Corporation; Emeryville, CA",NA,NA
"561",268719001,"1  (bases 1 to 1585)","Mark,D.F., Wang,A.M., Ladner,M.B., Creasey,A.A., Van Arsdell,J.N.	and Lin,L.S.",NA,"Human tumor necrosis factor","Patent: US 4677064-A 1 30-JUN-1987;	Cetus Corporation; Emeryville, CA",NA,NA
"562",268725001,"1  (bases 1 to 1465)","Lin,L.S. and Yamamoto,R.",NA,"Purification method for tumor necrosis factor","Patent: US 4677197-A 2 30-JUN-1987;	Cetus Corporation; Emeryville, CA",NA,NA
"563",268726001,"1  (bases 1 to 958)","Goeddel,D.V.",NA,"Hybrid human leukocyte interferons","Patent: US 4678751-A 1 07-JUL-1987;	Genentech, Inc.; San Francisco, CA",NA,NA
"564",268727001,"1  (bases 1 to 985)","Goeddel,D.V.",NA,"Hybrid human leukocyte interferons","Patent: US 4678751-A 2 07-JUL-1987;	Genentech, Inc.; San Francisco, CA",NA,NA
"565",268728001,"1  (bases 1 to 985)","Goeddel,D.V.",NA,"Hybrid human leukocyte interferons","Patent: US 4678751-A 3 07-JUL-1987;	Genentech, Inc.; San Francisco, CA",NA,NA
"566",268733001,"1  (bases 1 to 1107)","Goeddel,D.V.",NA,"Hybrid human leukocyte interferons","Patent: US 4678751-A 8 07-JUL-1987;	Genentech, Inc.; San Francisco, CA",NA,NA
"567",268734001,"1  (bases 1 to 1069)","Goeddel,D.V.",NA,"Hybrid human leukocyte interferons","Patent: US 4678751-A 9 07-JUL-1987;	Genentech, Inc.; San Francisco, CA",NA,NA
"568",268735001,"1  (bases 1 to 1109)","Goeddel,D.V.",NA,"Hybrid human leukocyte interferons","Patent: US 4678751-A 10 07-JUL-1987;	Genentech, Inc.; San Francisco, CA",NA,NA
"569",268742001,"1  (bases 1 to 117)","Masakazu,K. and Kazuo,N.",NA,"Promoter plasmid containing the promoter and use thereof in	transforming Bacillus","Patent: US 4705750-A 1 10-NOV-1987;	Takeda Chemical Industries, Ltd.; Osaka;	JP;",NA,NA
"570",268743001,"1  (bases 1 to 604)","Masakazu,K. and Kazuo,N.",NA,"Promoter plasmid containing the promoter and use thereof in	transforming Bacillus","Patent: US 4705750-A 2 10-NOV-1987;	Takeda Chemical Industries, Ltd.; Osaka;	JP;",NA,NA
"571",268744001,"1  (bases 1 to 34)","Masakazu,K. and Kazuo,N.",NA,"Promoter plasmid containing the promoter and use thereof in	transforming Bacillus","Patent: US 4705750-A 3 10-NOV-1987;	Takeda Chemical Industries, Ltd.; Osaka;	JP;",NA,NA
"572",268751001,"1  (bases 1 to 2013)","Dame,J.B., Williams,J.L., McCutchan,T.F. and Schneider,I.",NA,"Immunologically active peptides capable of inducing immunization	against malaria and genes encoding therefor","Patent: US 4707357-A 1 17-NOV-1987;	The United States of America as represented by the Secretary of the	Army; Washington, DC",NA,NA
"573",268752001,"1  (bases 1 to 324)","Dame,J.B., Williams,J.L., McCutchan,T.F. and Schneider,I.",NA,"Immunologically active peptides capable of inducing immunization	against malaria and genes encoding therefor","Patent: US 4707357-A 2 17-NOV-1987;	The United States of America as represented by the Secretary of the	Army; Washington, DC",NA,NA
"574",268755001,"1  (bases 1 to 1680)","Kieff,E., Tanner,J., Hummel,M. and Beisel,C.",NA,"Vaccine against Epstein-Barr Virus","Patent: US 4707358-A 1 17-NOV-1987;	The University of Chicago; Chicago, IL",NA,NA
"575",268757001,"1  (bases 1 to 1041)","Kieff,E., Tanner,J., Hummel,M. and Beisel,C.",NA,"Vaccine against Epstein-Barr Virus","Patent: US 4707358-A 3 17-NOV-1987;	The University of Chicago; Chicago, IL",NA,NA
"576",268759001,"1  (bases 1 to 12)","McCutchan,T.F. and Dame,J.B.",NA,"Intact gene and method of excising and cloning same","Patent: US 4707445-A 1 17-NOV-1987;	The United States of America as represented by the Secretary of	the; Washington, DC",NA,NA
"577",268760001,"1  (bases 1 to 12)","McCutchan,T.F. and Dame,J.B.",NA,"Intact gene and method of excising and cloning same","Patent: US 4707445-A 2 17-NOV-1987;	The United States of America as represented by the Secretary of	the; Washington, DC",NA,NA
"578",268761001,"1  (bases 1 to 24)","McCutchan,T.F. and Dame,J.B.",NA,"Intact gene and method of excising and cloning same","Patent: US 4707445-A 3 17-NOV-1987;	The United States of America as represented by the Secretary of	the; Washington, DC",NA,NA
"579",268762001,"1  (bases 1 to 24)","McCutchan,T.F. and Dame,J.B.",NA,"Intact gene and method of excising and cloning same","Patent: US 4707445-A 4 17-NOV-1987;	The United States of America as represented by the Secretary of	the; Washington, DC",NA,NA
"580",268763001,"1  (bases 1 to 24)","McCutchan,T.F. and Dame,J.B.",NA,"Intact gene and method of excising and cloning same","Patent: US 4707445-A 5 17-NOV-1987;	The United States of America as represented by the Secretary of	the; Washington, DC",NA,NA
"581",268764001,"1  (bases 1 to 24)","McCutchan,T.F. and Dame,J.B.",NA,"Intact gene and method of excising and cloning same","Patent: US 4707445-A 6 17-NOV-1987;	The United States of America as represented by the Secretary of	the; Washington, DC",NA,NA
"582",268773001,"1  (bases 1 to 65)","Belagaje,R., Kuhstoss,S.A. and Rao,R.Nagaraja.",NA,"Transcription terminators","Patent: US 4710464-A 1 01-DEC-1987;	Eli Lilly and Company; Indianapolis, IN",NA,NA
"583",268774001,"1  (bases 1 to 65)","Belagaje,R., Kuhstoss,S.A. and Rao,R.Nagaraja.",NA,"Transcription terminators","Patent: US 4710464-A 2 01-DEC-1987;	Eli Lilly and Company; Indianapolis, IN",NA,NA
"584",268775001,"1  (bases 1 to 1524)","Insley,M.Y. and Kawasaki,G.",NA,"Site specific mutagenesis in alpha-1-antitrypsin","Patent: US 4711848-A 1 08-DEC-1987;	ZymoGenetics, Inc.; Seattle, WA",NA,NA
"585",268777001,"1  (bases 1 to 75)","Insley,M.Y. and Kawasaki,G.",NA,"Site specific mutagenesis in alpha-1-antitrypsin","Patent: US 4711848-A 3 08-DEC-1987;	ZymoGenetics, Inc.; Seattle, WA",NA,NA
"586",268780001,"1  (bases 1 to 1151)","Mak,T.W.",NA,"T cell specific CDNA clone","Patent: US 4713332-A 2 15-DEC-1987;	The Ontario Cancer Institute; Toronto;	CA;",NA,NA
"587",268791001,"1  (bases 1 to 728)","Beck,A.K.",NA,"Porcine beta FSH","Patent: US 4717670-A 1 05-JAN-1988;	Integrated Genetics, Inc.; Framingham, MA",NA,NA
"588",268793001,"1  (bases 1 to 742)","Baltimore,D. and Racaniello,V.R.",NA,"Production of complementary DNA representing RNA viral sequences by	recombinant DNA methods and uses therefor","Patent: US 4719177-A 1 12-JAN-1988;	Massachusetts Institute of Technology; Cambridge, MA",NA,NA
"589",268795001,"1  (bases 1 to 1800)","Baltimore,D. and Racaniello,V.R.",NA,"Production of complementary DNA representing RNA viral sequences by	recombinant DNA methods and uses therefor","Patent: US 4719177-A 3 12-JAN-1988;	Massachusetts Institute of Technology; Cambridge, MA",NA,NA
"590",268797001,"1  (bases 1 to 1800)","Baltimore,D. and Racaniello,V.R.",NA,"Production of complementary DNA representing RNA viral sequences by	recombinant DNA methods and uses therefor","Patent: US 4719177-A 5 12-JAN-1988;	Massachusetts Institute of Technology; Cambridge, MA",NA,NA
"591",268799001,"1  (bases 1 to 1800)","Baltimore,D. and Racaniello,V.R.",NA,"Production of complementary DNA representing RNA viral sequences by	recombinant DNA methods and uses therefor","Patent: US 4719177-A 7 12-JAN-1988;	Massachusetts Institute of Technology; Cambridge, MA",NA,NA
"592",268801001,"1  (bases 1 to 1298)","Baltimore,D. and Racaniello,V.R.",NA,"Production of complementary DNA representing RNA viral sequences by	recombinant DNA methods and uses therefor","Patent: US 4719177-A 9 12-JAN-1988;	Massachusetts Institute of Technology; Cambridge, MA",NA,NA
"593",268803001,"1  (bases 1 to 210)","Eaton,M.A.W., Doel,M.T., Carey,N.H., Smith,J.C., Lilley,D.M.J. and	Bell,L.D.",NA,"Synthetic urogastrone gene, corresponding plasmid recombinants,	transformed cells, production thereof and urgastrone expression","Patent: US 4719180-A 2 12-JAN-1988;	G. D. Searle & Co.; Skokie, IL",NA,NA
"594",268806001,"1  (bases 1 to 487)","White,P.C., Dupont,B. and New,M.I.",NA,"Genetic probe used in the detection of adrenal hyperplasia","Patent: US 4720454-A 2 19-JAN-1988;	3001 Henry Hudson Pkwy.; Bronx, NY",NA,NA
"595",268807001,"1  (bases 1 to 487)","White,P.C., Dupont,B. and New,M.I.",NA,"Genetic probe used in the detection of adrenal hyperplasia","Patent: US 4720454-A 3 19-JAN-1988;	3001 Henry Hudson Pkwy.; Bronx, NY",NA,NA
"596",268812001,"1  (bases 1 to 111)","Jansz,H.S., Lips,C.J.M., Steenbergh,P.H., Rink,H. and Sieber,P.",NA,"Oligopeptides and intermediates and processes for their manufacture","Patent: US 4720483-A 2 19-JAN-1988;	Ciba-Geigy Corporation; Ardsley, NY",NA,NA
"597",268813001,"1  (bases 1 to 131)","Jansz,H.S., Lips,C.J.M., Steenbergh,P.H., Rink,H. and Sieber,P.",NA,"Oligopeptides and intermediates and processes for their manufacture","Patent: US 4720483-A 3 19-JAN-1988;	Ciba-Geigy Corporation; Ardsley, NY",NA,NA
"598",268814001,"1  (bases 1 to 1011)","Anilionis,A. and Palmer,J.L.",NA,"Efficient prokaryotic expression system using portions of the E.	coli .beta","Patent: US 4721671-A 1 26-JAN-1988;	Repligen Corporation; Cambridge, MA",NA,NA
"599",268818001,"1  (bases 1 to 26)","Vallee,B.L. and Kurachi,K.",NA,"CDNA and gene for human angiogenin (angiogenesis factor) and	methods of expression","Patent: US 4721672-A 3 26-JAN-1988;	President and Fellows of Harvard College; Cambridge, MA",NA,NA
"600",268830001,"1  (bases 1 to 28)","Valenzuela,P.D.T., Kuo,G. and Barr,P.J.",NA,"Hybrid particle immunogens","Patent: US 4722840-A 1 02-FEB-1988;	Chiron Corporation; Emeryville, CA",NA,NA
"601",268832001,"1  (bases 1 to 36)","Valenzuela,P.D.T., Kuo,G. and Barr,P.J.",NA,"Hybrid particle immunogens","Patent: US 4722840-A 3 02-FEB-1988;	Chiron Corporation; Emeryville, CA",NA,NA
"602",268834001,"1  (bases 1 to 27)","Valenzuela,P.D.T., Kuo,G. and Barr,P.J.",NA,"Hybrid particle immunogens","Patent: US 4722840-A 5 02-FEB-1988;	Chiron Corporation; Emeryville, CA",NA,NA
"603",268836001,"1  (bases 1 to 30)","Valenzuela,P.D.T., Kuo,G. and Barr,P.J.",NA,"Hybrid particle immunogens","Patent: US 4722840-A 7 02-FEB-1988;	Chiron Corporation; Emeryville, CA",NA,NA
"604",268841001,"1  (bases 1 to 511)","Soeda,E. and Yoshimura,H.",NA,"Viral enhancer DNA segments","Patent: US 4722897-A 1 02-FEB-1988;	Taisho Pharmaceutical Co., Ltd.; Tokyo;	JP;",NA,NA
"605",268842001,"1  (bases 1 to 451)","Soeda,E. and Yoshimura,H.",NA,"Viral enhancer DNA segments","Patent: US 4722897-A 2 02-FEB-1988;	Taisho Pharmaceutical Co., Ltd.; Tokyo;	JP;",NA,NA
"606",268843001,"1  (bases 1 to 508)","Soeda,E. and Yoshimura,H.",NA,"Viral enhancer DNA segments","Patent: US 4722897-A 3 02-FEB-1988;	Taisho Pharmaceutical Co., Ltd.; Tokyo;	JP;",NA,NA
"607",268858001,"1  (bases 1 to 73)","Goeddel,D.V. and Gray,P.",NA,"Human immune interferon","Patent: US 4727138-A 4 23-FEB-1988;	Genentech, Inc.; South San Francisco, CA",NA,NA
"608",268860001,"1  (bases 1 to 145)","Bhatt,R.S., Collier,K.J., Crowl,R.M. and Poonian,M.S.",NA,"Recombinant growth hormone releasing factor","Patent: US 4728609-A 1 01-MAR-1988;	Hoffmann-La-Roche Inc.; Nutley, NJ",NA,NA
"609",268861001,"1  (bases 1 to 149)","Bhatt,R.S., Collier,K.J., Crowl,R.M. and Poonian,M.S.",NA,"Recombinant growth hormone releasing factor","Patent: US 4728609-A 2 01-MAR-1988;	Hoffmann-La-Roche Inc.; Nutley, NJ",NA,NA
"610",268872001,"1  (bases 1 to 98)","Hershberger,C.L. and Rosteck,P.R. Jr.",NA,"Method for conferring bacteriophage resistance to bacteria","Patent: US 4732859-A 2 22-MAR-1988;	Eli Lilly and Company; Indianapolis, IN",NA,NA
"611",268874001,"1  (bases 1 to 342)","Hershberger,C.L. and Rosteck,P.R. Jr.",NA,"Method for conferring bacteriophage resistance to bacteria","Patent: US 4732859-A 4 22-MAR-1988;	Eli Lilly and Company; Indianapolis, IN",NA,NA
"612",268888001,"1  (bases 1 to 1317)","Barr,P.J., Hallewell,R.A. and Rosenberg,S.",NA,"Active site modified protease .alpha.-1-antitrypsin inhibitors","Patent: US 4732973-A 2 22-MAR-1988;	Chiron Corporation; Emeryville, CA",NA,NA
"613",268889001,"1  (bases 1 to 30)","Barr,P.J., Hallewell,R.A. and Rosenberg,S.",NA,"Active site modified protease .alpha.-1-antitrypsin inhibitors","Patent: US 4732973-A 3 22-MAR-1988;	Chiron Corporation; Emeryville, CA",NA,NA
"614",268890001,"1  (bases 1 to 21)","Barr,P.J., Hallewell,R.A. and Rosenberg,S.",NA,"Active site modified protease .alpha.-1-antitrypsin inhibitors","Patent: US 4732973-A 4 22-MAR-1988;	Chiron Corporation; Emeryville, CA",NA,NA
"615",268891001,"1  (bases 1 to 44)","Barr,P.J., Hallewell,R.A. and Rosenberg,S.",NA,"Active site modified protease .alpha.-1-antitrypsin inhibitors","Patent: US 4732973-A 5 22-MAR-1988;	Chiron Corporation; Emeryville, CA",NA,NA
"616",268894001,"1  (bases 1 to 598)","Caruthers,M.H.",NA,"DNA sequences encoding hybrid lymphoblastoid-leukocyte human	interferons","Patent: US 4734491-A 1 29-MAR-1988;	University Patents, Inc.; Westport, CT",NA,NA
"617",268901001,"1  (bases 1 to 1280)","Collett,M.S. and Purchio,A.F.",NA,"Vaccines against rift valley fever virus","Patent: US 4735800-A 1 05-APR-1988;	Molecular Genetics, Inc.; Minnetonka, MN",NA,NA
"618",268903001,"1  (bases 1 to 1320)","Collett,M.S. and Purchio,A.F.",NA,"Vaccines against rift valley fever virus","Patent: US 4735800-A 3 05-APR-1988;	Molecular Genetics, Inc.; Minnetonka, MN",NA,NA
"619",268905001,"1  (bases 1 to 1284)","Collett,M.S. and Purchio,A.F.",NA,"Vaccines against rift valley fever virus","Patent: US 4735800-A 5 05-APR-1988;	Molecular Genetics, Inc.; Minnetonka, MN",NA,NA
"620",268919001,"1  (bases 1 to 138)","Evans,R.M. and Rosenfeld,M.G.",NA,"DNA encoding human CGRP","Patent: US 4736023-A 4 05-APR-1988;	The Salk Institute for Biological Studies; San Diego, CA",NA,NA
"621",268920001,"1  (bases 1 to 111)","Evans,R.M. and Rosenfeld,M.G.",NA,"DNA encoding human CGRP","Patent: US 4736023-A 5 05-APR-1988;	The Salk Institute for Biological Studies; San Diego, CA",NA,NA
"622",268921001,"1  (bases 1 to 506)","Mark,D.F., Lin,L.S. and Yu Lu,S.-D.",NA,"Structural genes, plasmids and transformed cells for producing	cysteine depleted muteins of interferon-.beta","Patent: US 4737462-A 1 12-APR-1988;	Cetus Corporation; Emeryville, CA",NA,NA
"623",268923001,"1  (bases 1 to 1338)","Evans,R.M., Rosenfeld,M.G., Cerelli,G., Mayo,K.E., Spiess,J.,	Rivier,J.E.F. and Vale,W.W. Jr.",NA,"Human inhibin","Patent: US 4737578-A 1 12-APR-1988;	The Salk Institute for Biological Studies; San Diego, CA",NA,NA
"624",268930001,"1  (bases 1 to 223)","Twardzik,D.R. and Todaro,G.J.",NA,"Platelet related growth regulator","Patent: US 4737580-A 4 12-APR-1988;	Oncogen; Seattle, WA",NA,NA
"625",268933001,"1  (bases 1 to 223)","Twardzik,D.R. and Todaro,G.J.",NA,"Platelet related growth regulator","Patent: US 4737580-A 7 12-APR-1988;	Oncogen; Seattle, WA",NA,NA
"626",268934001,"1  (bases 1 to 81)","Bell,L.D., Smith,J.C., Boseley,P.G. and Houghton,M.",NA,"Modified (1-28) beta interferons","Patent: US 4738844-A 1 19-APR-1988;	G. D. Searle & Co.; Chicago, IL",NA,NA
"627",268941001,"1  (bases 1 to 137)","Bell,L.D., Smith,J.C., Boseley,P.G. and Houghton,M.",NA,"Modified (1-28) beta interferons","Patent: US 4738844-A 8 19-APR-1988;	G. D. Searle & Co.; Chicago, IL",NA,NA
"628",268942001,"1  (bases 1 to 82)","Bell,L.D., Smith,J.C., Boseley,P.G. and Houghton,M.",NA,"Modified (115-145) beta interferons","Patent: US 4738845-A 1 19-APR-1988;	G. D. Searle & Co.; Chicago, IL",NA,NA
"629",268943001,"1  (bases 1 to 99)","Bell,L.D., Smith,J.C., Boseley,P.G. and Houghton,M.",NA,"Modified (115-145) beta interferons","Patent: US 4738845-A 2 19-APR-1988;	G. D. Searle & Co.; Chicago, IL",NA,NA
"630",268947001,"1  (bases 1 to 137)","Bell,L.D., Smith,J.C., Boseley,P.G. and Houghton,M.",NA,"Modified (115-145) beta interferons","Patent: US 4738845-A 6 19-APR-1988;	G. D. Searle & Co.; Chicago, IL",NA,NA
"631",268949001,"1  (bases 1 to 501)","Bell,L.D., Smith,J.C., Boseley,P.G. and Houghton,M.",NA,"Modified (115-145) beta interferons","Patent: US 4738845-A 8 19-APR-1988;	G. D. Searle & Co.; Chicago, IL",NA,NA
"632",268951001,"1  (bases 1 to 501)","Bell,L.D., Smith,J.C., Boseley,P.G. and Houghton,M.",NA,"Modified (115-145) beta interferons","Patent: US 4738845-A 10 19-APR-1988;	G. D. Searle & Co.; Chicago, IL",NA,NA
"633",268953001,"1  (bases 1 to 516)","Bell,L.D., Smith,J.C., Boseley,P.G. and Houghton,M.",NA,"Modified (115-145) beta interferons","Patent: US 4738845-A 12 19-APR-1988;	G. D. Searle & Co.; Chicago, IL",NA,NA
"634",268962001,"1  (bases 1 to 30)","Weissman,S.M., Pereira,D. and Sood,A.",NA,"Method for cloning genes","Patent: US 4738928-A 2 19-APR-1988;	Yale University; New Haven, CT",NA,NA
"635",268964001,"1  (bases 1 to 142)","Weissman,S.M., Pereira,D. and Sood,A.",NA,"Method for cloning genes","Patent: US 4738928-A 4 19-APR-1988;	Yale University; New Haven, CT",NA,NA
"636",268982001,"1  (bases 1 to 180)","Derynck,R.M.A. and Goeddel,D.V.",NA,"Human transforming growth factor","Patent: US 4742003-A 2 03-MAY-1988;	Genentech, Inc.; South San Francisco, CA",NA,NA
"637",269001001,"1  (bases 1 to 204)","Delwiche,F., Flament-Grivegnee,J., Gangji,D., Monsieur,R.,	Stryckmans,P., Velu,T. and Wybran,J.",NA,"Method for treatment of essential (hemorrhagic) thrombocythemia","Patent: US 4743445-A 2 10-MAY-1988;	Boehringer Ingelheim International GmbH;;	DE;",NA,NA
"638",269005001,"1  (bases 1 to 202)","Boothroyd,J.C., Cross,G.A.M., Highfield,M.D., Winther,M.D.,	Rowlands,D.J., Brown,F. and Harris,T.J.R.",NA,"Recombinant DNA expression vector encoding for foot and mouth	disease virus proteins","Patent: US 4743554-A 1 10-MAY-1988;	7 Westgate Road; Beckenham, Kent;	GB;",NA,NA
"639",269007001,"1  (bases 1 to 315)","Boothroyd,J.C., Cross,G.A.M., Highfield,M.D., Winther,M.D.,	Rowlands,D.J., Brown,F. and Harris,T.J.R.",NA,"Recombinant DNA expression vector encoding for foot and mouth	disease virus proteins","Patent: US 4743554-A 3 10-MAY-1988;	7 Westgate Road; Beckenham, Kent;	GB;",NA,NA
"640",269009001,"1  (bases 1 to 235)","Boothroyd,J.C., Cross,G.A.M., Highfield,M.D., Winther,M.D.,	Rowlands,D.J., Brown,F. and Harris,T.J.R.",NA,"Recombinant DNA expression vector encoding for foot and mouth	disease virus proteins","Patent: US 4743554-A 5 10-MAY-1988;	7 Westgate Road; Beckenham, Kent;	GB;",NA,NA
"641",269012001,"1  (bases 1 to 203)","Boothroyd,J.C., Cross,G.A.M., Highfield,M.D., Winther,M.D.,	Rowlands,D.J., Brown,F. and Harris,T.J.R.",NA,"Recombinant DNA expression vector encoding for foot and mouth	disease virus proteins","Patent: US 4743554-A 8 10-MAY-1988;	7 Westgate Road; Beckenham, Kent;	GB;",NA,NA
"642",269020001,"1  (bases 1 to 273)","Boothroyd,J.C., Cross,G.A.M., Highfield,M.D., Winther,M.D.,	Rowlands,D.J., Brown,F. and Harris,T.J.R.",NA,"Recombinant DNA expression vector encoding for foot and mouth	disease virus proteins","Patent: US 4743554-A 16 10-MAY-1988;	7 Westgate Road; Beckenham, Kent;	GB;",NA,NA
"643",269022001,"1  (bases 1 to 165)","Boothroyd,J.C., Cross,G.A.M., Highfield,M.D., Winther,M.D.,	Rowlands,D.J., Brown,F. and Harris,T.J.R.",NA,"Recombinant DNA expression vector encoding for foot and mouth	disease virus proteins","Patent: US 4743554-A 18 10-MAY-1988;	7 Westgate Road; Beckenham, Kent;	GB;",NA,NA
"644",269057001,"1  (bases 1 to 968)","Boothroyd,J.C., Cross,G.A.M., Highfield,M.D., Winther,M.D.,	Rowlands,D.J., Brown,F. and Harris,T.J.R.",NA,"Recombinant DNA expression vector encoding for foot and mouth	disease virus proteins","Patent: US 4743554-A 53 10-MAY-1988;	7 Westgate Road; Beckenham, Kent;	GB;",NA,NA
"645",269059001,"1  (bases 1 to 195)","Boothroyd,J.C., Cross,G.A.M., Highfield,M.D., Winther,M.D.,	Rowlands,D.J., Brown,F. and Harris,T.J.R.",NA,"Recombinant DNA expression vector encoding for foot and mouth	disease virus proteins","Patent: US 4743554-A 55 10-MAY-1988;	7 Westgate Road; Beckenham, Kent;	GB;",NA,NA
"646",269062001,"1  (bases 1 to 497)","Smith,G.E. and Summers,M.D.",NA,"Method for producing a recombinant baculovirus expression vector","Patent: US 4745051-A 1 17-MAY-1988;	The Texas A&M University System; College Station, TX",NA,NA
"647",269065001,"1  (bases 1 to 54)","Schenk,D.B. and Spratt,S.K.",NA,"Fused protein for enzyme immunoassay system","Patent: US 4745055-A 2 17-MAY-1988;	California Biotechnology Inc.; Mountain View, CA",NA,NA
"648",269067001,"1  (bases 1 to 55)","Schenk,D.B. and Spratt,S.K.",NA,"Fused protein for enzyme immunoassay system","Patent: US 4745055-A 4 17-MAY-1988;	California Biotechnology Inc.; Mountain View, CA",NA,NA
"649",269070001,"1  (bases 1 to 42)","Guterman,S., Pero,J. and Robbins,P.",NA,"Streptomyces secretion vector","Patent: US 4745056-A 1 17-MAY-1988;	Biotechnica International, Inc.; Cambridge, MA",NA,NA
"650",269072001,"1  (bases 1 to 42)","Guterman,S., Pero,J. and Robbins,P.",NA,"Streptomyces secretion vector","Patent: US 4745056-A 3 17-MAY-1988;	Biotechnica International, Inc.; Cambridge, MA",NA,NA
"651",269074001,"1  (bases 1 to 42)","Guterman,S., Pero,J. and Robbins,P.",NA,"Streptomyces secretion vector","Patent: US 4745056-A 5 17-MAY-1988;	Biotechnica International, Inc.; Cambridge, MA",NA,NA
"652",269077001,"1  (bases 1 to 90)","Guterman,S., Pero,J. and Robbins,P.",NA,"Streptomyces secretion vector","Patent: US 4745056-A 8 17-MAY-1988;	Biotechnica International, Inc.; Cambridge, MA",NA,NA
"653",269079001,"1  (bases 1 to 126)","Guterman,S., Pero,J. and Robbins,P.",NA,"Streptomyces secretion vector","Patent: US 4745056-A 10 17-MAY-1988;	Biotechnica International, Inc.; Cambridge, MA",NA,NA
"654",269080001,"1  (bases 1 to 161)","Beckage,C.A. and Ingolia,T.D.",NA,"Method, vectors and transformants for high expression of	heterologous polypeptides in yeast","Patent: US 4745057-A 1 17-MAY-1988;	Eli Lilly and Company; Indianapolis, IN",NA,NA
"655",269081001,"1  (bases 1 to 90)","Mayne,N.G., Burnett,J.Paul., Belegaje,R. and Hsiung,H.M.",NA,"Cloning vectors for expression of exogenous protein","Patent: US 4745069-A 1 17-MAY-1988;	Eli Lilly and Company; Indianapolis, IN",NA,NA
"656",269082001,"1  (bases 1 to 63)","Mayne,N.G., Burnett,J.Paul., Belegaje,R. and Hsiung,H.M.",NA,"Cloning vectors for expression of exogenous protein","Patent: US 4745069-A 2 17-MAY-1988;	Eli Lilly and Company; Indianapolis, IN",NA,NA
"657",269086001,"1  (bases 1 to 210)","Ueda,I., Niwa,M., Saito,Y., Sato,S., Ono,H. and Kitaguchi,T.",NA,".sup.59 Valine insulin-like growth factor I and process for	production thereof","Patent: US 4745179-A 2 17-MAY-1988;	Fujisawa Pharmaceutical Co., Ltd.; Osaka;	JP;",NA,NA
"658",269087001,"1  (bases 1 to 107)","Ueda,I., Niwa,M., Saito,Y., Sato,S., Ono,H. and Kitaguchi,T.",NA,".sup.59 Valine insulin-like growth factor I and process for	production thereof","Patent: US 4745179-A 3 17-MAY-1988;	Fujisawa Pharmaceutical Co., Ltd.; Osaka;	JP;",NA,NA
"659",269088001,"1  (bases 1 to 163)","Ueda,I., Niwa,M., Saito,Y., Sato,S., Ono,H. and Kitaguchi,T.",NA,".sup.59 Valine insulin-like growth factor I and process for	production thereof","Patent: US 4745179-A 4 17-MAY-1988;	Fujisawa Pharmaceutical Co., Ltd.; Osaka;	JP;",NA,NA
"660",269090001,"1  (bases 1 to 278)","Ueda,I., Niwa,M., Saito,Y., Sato,S., Ono,H. and Kitaguchi,T.",NA,".sup.59 Valine insulin-like growth factor I and process for	production thereof","Patent: US 4745179-A 6 17-MAY-1988;	Fujisawa Pharmaceutical Co., Ltd.; Osaka;	JP;",NA,NA
"661",269092001,"1  (bases 1 to 422)","Ueda,I., Niwa,M., Saito,Y., Sato,S., Ono,H. and Kitaguchi,T.",NA,".sup.59 Valine insulin-like growth factor I and process for	production thereof","Patent: US 4745179-A 8 17-MAY-1988;	Fujisawa Pharmaceutical Co., Ltd.; Osaka;	JP;",NA,NA
"662",269094001,"1  (bases 1 to 1950)","Ueda,I., Niwa,M., Saito,Y., Sato,S., Ono,H. and Kitaguchi,T.",NA,".sup.59 Valine insulin-like growth factor I and process for	production thereof","Patent: US 4745179-A 10 17-MAY-1988;	Fujisawa Pharmaceutical Co., Ltd.; Osaka;	JP;",NA,NA
"663",269096001,"1  (bases 1 to 1284)","Ueda,I., Niwa,M., Saito,Y., Sato,S., Ono,H. and Kitaguchi,T.",NA,".sup.59 Valine insulin-like growth factor I and process for	production thereof","Patent: US 4745179-A 12 17-MAY-1988;	Fujisawa Pharmaceutical Co., Ltd.; Osaka;	JP;",NA,NA
"664",269102001,"1  (bases 1 to 849)","Rich,A. and Nordheim,A.E.",NA,"Process for altering and regulating gene expression","Patent: US 4748119-A 1 31-MAY-1988;	2 Walnut Ave.; Cambridge, MA",NA,NA
"665",269105001,"1  (bases 1 to 1032)","Sloma,A.",NA,"Alpha-interferon Gx-1","Patent: US 4748233-A 1 31-MAY-1988;	Bristol-Myers Company; Syracuse, NY",NA,NA
"666",269112001,"1  (bases 1 to 1440)","Stabinsky,Y.",NA,"Methods and kits for performing nucleic acid hybridization assays","Patent: US 4751177-A 1 14-JUN-1988;	Amgen; Thousand Oaks, CA",NA,NA
"667",269115001,"1  (bases 1 to 33)","Cousens,L.S., Tekamp-Olson,P.A., Shuster,J.R. and Merryweather,J.P.",NA,"Expression using fused genes providing for protein product","Patent: US 4751180-A 2 14-JUN-1988;	Chiron Corporation; Emeryville, CA",NA,NA
"668",269116001,"1  (bases 1 to 39)","Cousens,L.S., Tekamp-Olson,P.A., Shuster,J.R. and Merryweather,J.P.",NA,"Expression using fused genes providing for protein product","Patent: US 4751180-A 3 14-JUN-1988;	Chiron Corporation; Emeryville, CA",NA,NA
"669",269117001,"1  (bases 1 to 49)","Cousens,L.S., Tekamp-Olson,P.A., Shuster,J.R. and Merryweather,J.P.",NA,"Expression using fused genes providing for protein product","Patent: US 4751180-A 4 14-JUN-1988;	Chiron Corporation; Emeryville, CA",NA,NA
"670",269118001,"1  (bases 1 to 168)","Keene,J.D.",NA,"Methods and compositions useful in the diagnosis and treatment of	autoimmune diseases","Patent: US 4751181-A 1 14-JUN-1988;	Duke University; Durham, NC",NA,NA
"671",269123001,"1  (bases 1 to 498)","Berzin,V.M., Tsimanis,A.J., Vishnevsky,J.I., Apsalon,U.R.,	Dishler,A.V., Gren,E.Y., Sverdlov,E.D., Monastyrskaya,G.S.,	Tsarev,S.A., Smorodintsev,A.A., Iovlev,V.I., Feldmane,G.Y. and	Duk,A.E.",NA,"Human leukocyte interferon N and a method of producing same in	bacterial cells","Patent: US 4751287-A 2 14-JUN-1988;	Institut Organicheskogo Sinteza Akademii Nauk Latviiskoi SSR; Riga;	SU;",NA,NA
"672",269126001,"1  (bases 1 to 44)","Brake,A.J., Hallewell,R.A. and Rosenberg,S.",NA,"Expression of .alpha.-1 antitrypsin in yeast","Patent: US 4752576-A 3 21-JUN-1988;	Chiron Corporation; Emeryville, CA",NA,NA
"673",269127001,"1  (bases 1 to 59)","Belagaje,R., Fayerman,J.T. and Richardson,M.A.",NA,"Method for using a novel transcriptional- and	translational-activating sequence in streptomyces","Patent: US 4752577-A 1 21-JUN-1988;	Eli Lilly and Company; Indianapolis, IN",NA,NA
"674",269128001,"1  (bases 1 to 66)","Belagaje,R., Fayerman,J.T. and Richardson,M.A.",NA,"Method for using a novel transcriptional- and	translational-activating sequence in streptomyces","Patent: US 4752577-A 2 21-JUN-1988;	Eli Lilly and Company; Indianapolis, IN",NA,NA
"675",269129001,"1  (bases 1 to 65)","Belagaje,R., Fayerman,J.T. and Richardson,M.A.",NA,"Method for using a novel transcriptional- and	translational-activating sequence in streptomyces","Patent: US 4752577-A 3 21-JUN-1988;	Eli Lilly and Company; Indianapolis, IN",NA,NA
"676",269145001,"1  (bases 1 to 137)","Bell,L.D., Smith,J.C., Boseley,P.G. and Houghton,M.",NA,"Modified (80-113) beta interferons","Patent: US 4753795-A 1 28-JUN-1988;	G. D. Searle & Co.; Chicago, IL",NA,NA
"677",269146001,"1  (bases 1 to 137)","Bell,L.D., Smith,J.C., Boseley,P.G. and Houghton,M.",NA,"Modified (80-113) beta interferons","Patent: US 4753795-A 2 28-JUN-1988;	G. D. Searle & Co.; Chicago, IL",NA,NA
"678",269149001,"1  (bases 1 to 137)","Bell,L.D., Smith,J.C., Boseley,P.G. and Houghton,M.",NA,"Modified (80-113) beta interferons","Patent: US 4753795-A 5 28-JUN-1988;	G. D. Searle & Co.; Chicago, IL",NA,NA
"679",269152001,"1  (bases 1 to 566)","Beltz,G.A., Thorn,R.M., Marciani,D.J., Hung,C.-H. and	Haseltine,W.A.",NA,"Peptides for the diagnosis of HTLV-III antibodies, their	preparation and use","Patent: US 4753873-A 1 28-JUN-1988;	Cambridge Bioscience Corporation; Hopkinton, MA",NA,NA
"680",269153001,"1  (bases 1 to 1312)","Beltz,G.A., Thorn,R.M., Marciani,D.J., Hung,C.-H. and	Haseltine,W.A.",NA,"Peptides for the diagnosis of HTLV-III antibodies, their	preparation and use","Patent: US 4753873-A 2 28-JUN-1988;	Cambridge Bioscience Corporation; Hopkinton, MA",NA,NA
"681",269154001,"1  (bases 1 to 1469)","Beltz,G.A., Thorn,R.M., Marciani,D.J., Hung,C.-H. and	Haseltine,W.A.",NA,"Peptides for the diagnosis of HTLV-III antibodies, their	preparation and use","Patent: US 4753873-A 3 28-JUN-1988;	Cambridge Bioscience Corporation; Hopkinton, MA",NA,NA
"682",269155001,"1  (bases 1 to 580)","Beltz,G.A., Thorn,R.M., Marciani,D.J., Hung,C.-H. and	Haseltine,W.A.",NA,"Peptides for the diagnosis of HTLV-III antibodies, their	preparation and use","Patent: US 4753873-A 4 28-JUN-1988;	Cambridge Bioscience Corporation; Hopkinton, MA",NA,NA
"683",269156001,"1  (bases 1 to 854)","Beltz,G.A., Thorn,R.M., Marciani,D.J., Hung,C.-H. and	Haseltine,W.A.",NA,"Peptides for the diagnosis of HTLV-III antibodies, their	preparation and use","Patent: US 4753873-A 5 28-JUN-1988;	Cambridge Bioscience Corporation; Hopkinton, MA",NA,NA
"684",269157001,"1  (bases 1 to 960)","Beltz,G.A., Thorn,R.M., Marciani,D.J., Hung,C.-H. and	Haseltine,W.A.",NA,"Peptides for the diagnosis of HTLV-III antibodies, their	preparation and use","Patent: US 4753873-A 6 28-JUN-1988;	Cambridge Bioscience Corporation; Hopkinton, MA",NA,NA
"685",269159001,"1  (bases 1 to 30)","Hemming,B.C. and Drahos,D.J.",NA,"Marker genes in pseudomonad bacteria","Patent: US 4753876-A 1 28-JUN-1988;	Monsanto Company; St. Louis, MO",NA,NA
"686",269160001,"1  (bases 1 to 31)","Hemming,B.C. and Drahos,D.J.",NA,"Marker genes in pseudomonad bacteria","Patent: US 4753876-A 2 28-JUN-1988;	Monsanto Company; St. Louis, MO",NA,NA
"687",269161001,"1  (bases 1 to 31)","Hemming,B.C. and Drahos,D.J.",NA,"Marker genes in pseudomonad bacteria","Patent: US 4753876-A 3 28-JUN-1988;	Monsanto Company; St. Louis, MO",NA,NA
"688",269162001,"1  (bases 1 to 30)","Hemming,B.C. and Drahos,D.J.",NA,"Marker genes in pseudomonad bacteria","Patent: US 4753876-A 4 28-JUN-1988;	Monsanto Company; St. Louis, MO",NA,NA
"689",269185001,"1  (bases 1 to 80)","Gray,G.L. and Heyneker,H.L.",NA,"Secretion of correctly processed human growth hormone in E. coli	and Pseudomonas","Patent: US 4755465-A 2 05-JUL-1988;	Genentech, Inc.; South San Francisco, CA",NA,NA
"690",269191001,"1  (bases 1 to 45)","Toole,J.J. Jr. and Fritsch,E.",NA,"Human factor VIII:C gene and recombinant methods for production","Patent: US 4757006-A 6 12-JUL-1988;	Genetics Institute, Inc.; Cambridge, MA",NA,NA
"691",269192001,"1  (bases 1 to 691)","Toole,J.J. Jr. and Fritsch,E.",NA,"Human factor VIII:C gene and recombinant methods for production","Patent: US 4757006-A 7 12-JUL-1988;	Genetics Institute, Inc.; Cambridge, MA",NA,NA
"692",269193001,"1  (bases 1 to 366)","Toole,J.J. Jr. and Fritsch,E.",NA,"Human factor VIII:C gene and recombinant methods for production","Patent: US 4757006-A 8 12-JUL-1988;	Genetics Institute, Inc.; Cambridge, MA",NA,NA
"693",269195001,"1  (bases 1 to 84)","Toole,J.J. Jr. and Fritsch,E.",NA,"Human factor VIII:C gene and recombinant methods for production","Patent: US 4757006-A 10 12-JUL-1988;	Genetics Institute, Inc.; Cambridge, MA",NA,NA
"694",269196001,"1  (bases 1 to 51)","Toole,J.J. Jr. and Fritsch,E.",NA,"Human factor VIII:C gene and recombinant methods for production","Patent: US 4757006-A 11 12-JUL-1988;	Genetics Institute, Inc.; Cambridge, MA",NA,NA
"695",269197001,"1  (bases 1 to 93)","Toole,J.J. Jr. and Fritsch,E.",NA,"Human factor VIII:C gene and recombinant methods for production","Patent: US 4757006-A 12 12-JUL-1988;	Genetics Institute, Inc.; Cambridge, MA",NA,NA
"696",269198001,"1  (bases 1 to 84)","Toole,J.J. Jr. and Fritsch,E.",NA,"Human factor VIII:C gene and recombinant methods for production","Patent: US 4757006-A 13 12-JUL-1988;	Genetics Institute, Inc.; Cambridge, MA",NA,NA
"697",269199001,"1  (bases 1 to 1853)","Estell,D.A., Lazarus,R.A., Light,D.R., Miller,J.V. and	Rastetter,W.H.",NA,"Ascorbic acid intermediates and process enzymes","Patent: US 4757012-A 1 12-JUL-1988;	Genentech, Inc.; South San Francisco, CA",NA,NA
"698",269201001,"1  (bases 1 to 43)","Estell,D.A., Lazarus,R.A., Light,D.R., Miller,J.V. and	Rastetter,W.H.",NA,"Ascorbic acid intermediates and process enzymes","Patent: US 4757012-A 3 12-JUL-1988;	Genentech, Inc.; South San Francisco, CA",NA,NA
"699",269202001,"1  (bases 1 to 43)","Estell,D.A., Lazarus,R.A., Light,D.R., Miller,J.V. and	Rastetter,W.H.",NA,"Ascorbic acid intermediates and process enzymes","Patent: US 4757012-A 4 12-JUL-1988;	Genentech, Inc.; South San Francisco, CA",NA,NA
"700",269203001,"1  (bases 1 to 31)","Estell,D.A., Lazarus,R.A., Light,D.R., Miller,J.V. and	Rastetter,W.H.",NA,"Ascorbic acid intermediates and process enzymes","Patent: US 4757012-A 5 12-JUL-1988;	Genentech, Inc.; South San Francisco, CA",NA,NA
"701",269206001,"1  (bases 1 to 322)","Inouye,M. and Masui,Y.",NA,"Cloning vehicles for polypeptide expression in microbial hosts","Patent: US 4757013-A 2 12-JUL-1988;	The Research Foundation of State University of New York; Albany, NY",NA,NA
"702",269208001,"1  (bases 1 to 594)","Inouye,M. and Masui,Y.",NA,"Cloning vehicles for polypeptide expression in microbial hosts","Patent: US 4757013-A 4 12-JUL-1988;	The Research Foundation of State University of New York; Albany, NY",NA,NA
"703",269211001,"1  (bases 1 to 41)","Inouye,M. and Masui,Y.",NA,"Cloning vehicles for polypeptide expression in microbial hosts","Patent: US 4757013-A 7 12-JUL-1988;	The Research Foundation of State University of New York; Albany, NY",NA,NA
"704",269212001,"1  (bases 1 to 24)","Beppu,T., Uozumi,T., Nishimori,K., Shimizu,N., Kawaguchi,Y. and	Yanagida,N.",NA,"Novel expression plasmids containing the full cDNA sequence of calf	prochymosin","Patent: US 4757020-A 1 12-JUL-1988;	Beppu; Teruhiko; Tokyo;	JP;",NA,NA
"705",269220001,"1  (bases 1 to 568)","Mark,D.F. and Creasey,A.A.",NA,"Multiclass hybrid interferons","Patent: US 4758428-A 3 19-JUL-1988;	Cetus Corporation; Emeryville, CA",NA,NA
"706",269222001,"1  (bases 1 to 506)","Mark,D.F. and Creasey,A.A.",NA,"Multiclass hybrid interferons","Patent: US 4758428-A 5 19-JUL-1988;	Cetus Corporation; Emeryville, CA",NA,NA
"707",269224001,"1  (bases 1 to 506)","Mark,D.F. and Creasey,A.A.",NA,"Multiclass hybrid interferons","Patent: US 4758428-A 7 19-JUL-1988;	Cetus Corporation; Emeryville, CA",NA,NA
"708",269226001,"1  (bases 1 to 568)","Mark,D.F. and Creasey,A.A.",NA,"Multiclass hybrid interferons","Patent: US 4758428-A 9 19-JUL-1988;	Cetus Corporation; Emeryville, CA",NA,NA
"709",269228001,"1  (bases 1 to 668)","Mark,D.F. and Creasey,A.A.",NA,"Multiclass hybrid interferons","Patent: US 4758428-A 11 19-JUL-1988;	Cetus Corporation; Emeryville, CA",NA,NA
"710",269230001,"1  (bases 1 to 486)","Mark,D.F. and Creasey,A.A.",NA,"Multiclass hybrid interferons","Patent: US 4758428-A 13 19-JUL-1988;	Cetus Corporation; Emeryville, CA",NA,NA
"711",269232001,"1  (bases 1 to 64)","Murray,K. and MacKay,P.",NA,"Products displaying the antigenicity of hepatitis B virus e	antigens and methods of producing those antigens","Patent: US 4758507-A 1 19-JUL-1988;	Biogen N.P.; Curacao;	AN;",NA,NA
"712",269234001,"1  (bases 1 to 1880)","Martens,C.L., Moore,K.W., Ishizaka,K. and Huff,T.F.",NA,"CDNA clones coding for polypeptides exhibiting IGE binding factor	activity","Patent: US 4758511-A 1 19-JUL-1988;	DNAX Research Institute of Molecular and Cellular Biology, Inc.;	Palo Alto, CA",NA,NA
"713",269236001,"1  (bases 1 to 1492)","Martens,C.L., Moore,K.W., Ishizaka,K. and Huff,T.F.",NA,"CDNA clones coding for polypeptides exhibiting IGE binding factor	activity","Patent: US 4758511-A 3 19-JUL-1988;	DNAX Research Institute of Molecular and Cellular Biology, Inc.;	Palo Alto, CA",NA,NA
"714",269237001,"1  (bases 1 to 1668)","Martens,C.L., Moore,K.W., Ishizaka,K. and Huff,T.F.",NA,"CDNA clones coding for polypeptides exhibiting IGE binding factor	activity","Patent: US 4758511-A 4 19-JUL-1988;	DNAX Research Institute of Molecular and Cellular Biology, Inc.;	Palo Alto, CA",NA,NA
"715",269238001,"1  (bases 1 to 1872)","Martens,C.L., Moore,K.W., Ishizaka,K. and Huff,T.F.",NA,"CDNA clones coding for polypeptides exhibiting IGE binding factor	activity","Patent: US 4758511-A 5 19-JUL-1988;	DNAX Research Institute of Molecular and Cellular Biology, Inc.;	Palo Alto, CA",NA,NA
"716",269239001,"1  (bases 1 to 450)","Martens,C.L., Moore,K.W., Ishizaka,K. and Huff,T.F.",NA,"CDNA clones coding for polypeptides exhibiting IGE binding factor	activity","Patent: US 4758511-A 6 19-JUL-1988;	DNAX Research Institute of Molecular and Cellular Biology, Inc.;	Palo Alto, CA",NA,NA
"717",269243001,"1  (bases 1 to 43)","Light,D.R. and Rastetter,W.H.",NA,"Ascorbic acid intermediates and process enzymes","Patent: US 4758514-A 4 19-JUL-1988;	Genentech, Inc.; South San Francisco, CA",NA,NA
"718",269244001,"1  (bases 1 to 43)","Light,D.R. and Rastetter,W.H.",NA,"Ascorbic acid intermediates and process enzymes","Patent: US 4758514-A 5 19-JUL-1988;	Genentech, Inc.; South San Francisco, CA",NA,NA
"719",269245001,"1  (bases 1 to 31)","Light,D.R. and Rastetter,W.H.",NA,"Ascorbic acid intermediates and process enzymes","Patent: US 4758514-A 6 19-JUL-1988;	Genentech, Inc.; South San Francisco, CA",NA,NA
"720",269247001,"1  (bases 1 to 558)","Hudson,P.J., Niall,H.D. and Tregear,G.W.",NA,"Molecular cloning and characterization of a further gene sequence	coding for human relaxin","Patent: US 4758516-A 2 19-JUL-1988;	Howard Florey Institute of Experimental Physiology and Medicine;;	AU;",NA,NA
"721",269248001,"1  (bases 1 to 558)","Hudson,P.J., Niall,H.D. and Tregear,G.W.",NA,"Molecular cloning and characterization of a further gene sequence	coding for human relaxin","Patent: US 4758516-A 3 19-JUL-1988;	Howard Florey Institute of Experimental Physiology and Medicine;;	AU;",NA,NA
"722",269254001,"1  (bases 1 to 558)","Hudson,P.J., Niall,H.D. and Tregear,G.W.",NA,"Molecular cloning and characterization of a further gene sequence	coding for human relaxin","Patent: US 4758516-A 9 19-JUL-1988;	Howard Florey Institute of Experimental Physiology and Medicine;;	AU;",NA,NA
"723",269255001,"1  (bases 1 to 72)","Hudson,P.J., Niall,H.D. and Tregear,G.W.",NA,"Molecular cloning and characterization of a further gene sequence	coding for human relaxin","Patent: US 4758516-A 10 19-JUL-1988;	Howard Florey Institute of Experimental Physiology and Medicine;;	AU;",NA,NA
"724",269256001,"1  (bases 1 to 72)","Hudson,P.J., Niall,H.D. and Tregear,G.W.",NA,"Molecular cloning and characterization of a further gene sequence	coding for human relaxin","Patent: US 4758516-A 11 19-JUL-1988;	Howard Florey Institute of Experimental Physiology and Medicine;;	AU;",NA,NA
"725",269257001,"1  (bases 1 to 99)","Hudson,P.J., Niall,H.D. and Tregear,G.W.",NA,"Molecular cloning and characterization of a further gene sequence	coding for human relaxin","Patent: US 4758516-A 12 19-JUL-1988;	Howard Florey Institute of Experimental Physiology and Medicine;;	AU;",NA,NA
"726",269258001,"1  (bases 1 to 312)","Hudson,P.J., Niall,H.D. and Tregear,G.W.",NA,"Molecular cloning and characterization of a further gene sequence	coding for human relaxin","Patent: US 4758516-A 13 19-JUL-1988;	Howard Florey Institute of Experimental Physiology and Medicine;;	AU;",NA,NA
"727",269276001,"1  (bases 1 to 994)","Itoh,S., Sekine,S., Saito,A. and Sato,M.",NA,"Novel human interferon-gamma polypeptide derivative","Patent: US 4758656-A 1 19-JUL-1988;	Kyowa Hakko Kogyo Co., Ltd.; Tokyo;	JP;",NA,NA
"728",269279001,"1  (bases 1 to 159)","Miyoshi,K., Sumi,S., Hasegawa,A. and Suzuki,M.",NA,"21-leucine human urogastrone, corresponding gene, corresponding	recombinant plasmid, transformed cell and process for production	thereof","Patent: US 4760023-A 2 26-JUL-1988;	Wakunaga Seiyaku Kabushiki Kaisha; Osaka;	JP;",NA,NA
"729",269285001,"1  (bases 1 to 1800)","Bell,J.R., Ramachandran,J. and Ullrich,A.",NA,"Insulin receptor","Patent: US 4761371-A 2 02-AUG-1988;	Genentech, Inc.; South San Francisco, CA",NA,NA
"730",269286001,"1  (bases 1 to 1800)","Bell,J.R., Ramachandran,J. and Ullrich,A.",NA,"Insulin receptor","Patent: US 4761371-A 3 02-AUG-1988;	Genentech, Inc.; South San Francisco, CA",NA,NA
"731",269289001,"1  (bases 1 to 600)","Bell,J.R., Ramachandran,J. and Ullrich,A.",NA,"Insulin receptor","Patent: US 4761371-A 6 02-AUG-1988;	Genentech, Inc.; South San Francisco, CA",NA,NA
"732",269298001,"1  (bases 1 to 63)","Bell,J.R., Ramachandran,J. and Ullrich,A.",NA,"Insulin receptor","Patent: US 4761371-A 15 02-AUG-1988;	Genentech, Inc.; South San Francisco, CA",NA,NA
"733",269300001,"1  (bases 1 to 54)","Bell,J.R., Ramachandran,J. and Ullrich,A.",NA,"Insulin receptor","Patent: US 4761371-A 17 02-AUG-1988;	Genentech, Inc.; South San Francisco, CA",NA,NA
"734",269302001,"1  (bases 1 to 782)","Clark,S.C.",NA,"Human interleukin-2 cDNA sequence","Patent: US 4761375-A 2 02-AUG-1988;	Genetics Institute, Inc.; Cambridge, MA",NA,NA
"735",269304001,"1  (bases 1 to 787)","de Bold,A.J.",NA,"Isolation, purification and sequence determination of cardionatrins","Patent: US 4761469-A 2 02-AUG-1988;	Queen's University at Kingston; Kingston;	CA;",NA,NA
"736",269313001,"1  (bases 1 to 1608)","Snitman,D.L.",NA,"Compositions and methods for functionalizing nucleic acids","Patent: US 4762779-A 1 09-AUG-1988;	Amgen Inc.; Thousand Oaks, CA",NA,NA
"737",269314001,"1  (bases 1 to 1014)","Chapman,J.L. Jr., Ingolia,T.D., Kaster,K.R., Queener,S.W. and	Skatrud,P.L.",NA,"Vectors and conditions which allow genetic transformation of	cephalosporium","Patent: US 4762786-A 1 09-AUG-1988;	Eli Lilly and Company; Indianapolis, IN",NA,NA
"738",269316001,"1  (bases 1 to 1170)","Chapman,J.L. Jr., Ingolia,T.D., Kaster,K.R., Queener,S.W. and	Skatrud,P.L.",NA,"Vectors and conditions which allow genetic transformation of	cephalosporium","Patent: US 4762786-A 3 09-AUG-1988;	Eli Lilly and Company; Indianapolis, IN",NA,NA
"739",269318001,"1  (bases 1 to 1211)","Goeddel,D.V. and Gray,P.W.",NA,"Human immune interferon","Patent: US 4762791-A 2 09-AUG-1988;	Genentech, Inc.; South San Francisco, CA",NA,NA
"740",269319001,"1  (bases 1 to 73)","Goeddel,D.V. and Gray,P.W.",NA,"Human immune interferon","Patent: US 4762791-A 3 09-AUG-1988;	Genentech, Inc.; South San Francisco, CA",NA,NA
"741",269359001,"1  (bases 1 to 171)","Banks,A.R. and Hare,D.L.",NA,"Manufacture and expression of genes for urogastrone and polypeptide	analogs thereof","Patent: US 4764593-A 1 16-AUG-1988;	Amgen Inc.; Thousand Oaks, CA",NA,NA
"742",269362001,"1  (bases 1 to 21)","Diamond,S.E., Brewen,J.G., Williams,J.I., Ellwood,M.S., Collins,M.	and Fritsch,E.F.",NA,"Displacement polynucleotide assay method and polynucleotide complex	reagent therefor","Patent: US 4766062-A 1 23-AUG-1988;	Allied Corporation; Morristown, NJ",NA,NA
"743",269363001,"1  (bases 1 to 32)","Diamond,S.E., Brewen,J.G., Williams,J.I., Ellwood,M.S., Collins,M.	and Fritsch,E.F.",NA,"Displacement polynucleotide assay method and polynucleotide complex	reagent therefor","Patent: US 4766062-A 2 23-AUG-1988;	Allied Corporation; Morristown, NJ",NA,NA
"744",269364001,"1  (bases 1 to 1800)","Oeda,K., Sakaki,T., Ohkawa,H., Yabusaki,Y., Murakami,H.,	Nakamura,K. and Shimizu,M.",NA,"Cytochrome P-450MC gene, expression plasmid carrying the said gene,	yeasts transformed with the said plasmid and a process for	producing cytochrome P-450MC by culturing the said transformant	yeasts","Patent: US 4766068-A 1 23-AUG-1988;	Agency of Industrial Science and Technology; Tokyo;	JP;",NA,NA
"745",269366001,"1  (bases 1 to 896)","Oeda,K., Sakaki,T., Ohkawa,H., Yabusaki,Y., Murakami,H.,	Nakamura,K. and Shimizu,M.",NA,"Cytochrome P-450MC gene, expression plasmid carrying the said gene,	yeasts transformed with the said plasmid and a process for	producing cytochrome P-450MC by culturing the said transformant	yeasts","Patent: US 4766068-A 3 23-AUG-1988;	Agency of Industrial Science and Technology; Tokyo;	JP;",NA,NA
"746",269368001,"1  (bases 1 to 1514)","Auron,P.E., Dinarello,C.A., Webb,A.C., Rich,A. and Wolff,S.M.",NA,"Recombinant DNA which codes for interleukin-1 B","Patent: US 4766069-A 2 23-AUG-1988;	New England Medical Center; Boston, MA",NA,NA
"747",269369001,"1  (bases 1 to 606)","Auron,P.E., Dinarello,C.A., Webb,A.C., Rich,A. and Wolff,S.M.",NA,"Recombinant DNA which codes for interleukin-1 B","Patent: US 4766069-A 3 23-AUG-1988;	New England Medical Center; Boston, MA",NA,NA
"748",269371001,"1  (bases 1 to 100)","Jendrisak,J.J., Lewis,M.K. and Fiandt,M.J.",NA,"Vectors for in vitro production of RNA copies of either strand of a	cloned DNA sequence","Patent: US 4766072-A 1 23-AUG-1988;	Promega Corporation; Madison, WI",NA,NA
"749",269372001,"1  (bases 1 to 104)","Jendrisak,J.J., Lewis,M.K. and Fiandt,M.J.",NA,"Vectors for in vitro production of RNA copies of either strand of a	cloned DNA sequence","Patent: US 4766072-A 2 23-AUG-1988;	Promega Corporation; Madison, WI",NA,NA
"750",269373001,"1  (bases 1 to 134)","Jendrisak,J.J., Lewis,M.K. and Fiandt,M.J.",NA,"Vectors for in vitro production of RNA copies of either strand of a	cloned DNA sequence","Patent: US 4766072-A 3 23-AUG-1988;	Promega Corporation; Madison, WI",NA,NA
"751",269374001,"1  (bases 1 to 1031)","Murray,M.J. and Kelly,J.D.",NA,"Expression of biologically active PDGF analogs in eucaryotic cells","Patent: US 4766073-A 1 23-AUG-1988;	ZymoGenetics Inc.; Seattle, WA",NA,NA
"752",269378001,"1  (bases 1 to 46)","Murray,M.J. and Kelly,J.D.",NA,"Expression of biologically active PDGF analogs in eucaryotic cells","Patent: US 4766073-A 5 23-AUG-1988;	ZymoGenetics Inc.; Seattle, WA",NA,NA
"753",269379001,"1  (bases 1 to 1834)","Goeddel,D.V., Kohr,W.J., Pennica,D. and Vehar,G.A.",NA,"Human tissue plasminogen activator","Patent: US 4766075-A 1 23-AUG-1988;	Genentech, Inc.; South San Francisco, CA",NA,NA
"754",269381001,"1  (bases 1 to 710)","Goeddel,D.V., Kohr,W.J., Pennica,D. and Vehar,G.A.",NA,"Human tissue plasminogen activator","Patent: US 4766075-A 3 23-AUG-1988;	Genentech, Inc.; South San Francisco, CA",NA,NA
"755",269384001,"1  (bases 1 to 791)","Nathans,D. and Linzer,D.I.H.",NA,"Growth-related hormones","Patent: US 4767709-A 2 30-AUG-1988;	The Johns Hopkins University; Baltimore, MD",NA,NA
"756",269411001,"1  (bases 1 to 46)","Comai,L.",NA,"Inhibition resistant 5-enolpyruvyl-3-phosphoshikimate synthase,	production and use","Patent: US 4769061-A 1 06-SEP-1988;	Calgene Inc.; Davis, CA",NA,NA
"757",269412001,"1  (bases 1 to 1332)","Comai,L.",NA,"Inhibition resistant 5-enolpyruvyl-3-phosphoshikimate synthase,	production and use","Patent: US 4769061-A 2 06-SEP-1988;	Calgene Inc.; Davis, CA",NA,NA
"758",269414001,"1  (bases 1 to 231)","Bell,L.D., Boseley,P.G. and Porter,A.G.",NA,"Structure and properties of modified interferons","Patent: US 4769233-A 1 06-SEP-1988;	G. D. Searle & Co.; Chicago, IL",NA,NA
"759",269415001,"1  (bases 1 to 231)","Bell,L.D., Boseley,P.G. and Porter,A.G.",NA,"Structure and properties of modified interferons","Patent: US 4769233-A 2 06-SEP-1988;	G. D. Searle & Co.; Chicago, IL",NA,NA
"760",269416001,"1  (bases 1 to 231)","Bell,L.D., Boseley,P.G. and Porter,A.G.",NA,"Structure and properties of modified interferons","Patent: US 4769233-A 3 06-SEP-1988;	G. D. Searle & Co.; Chicago, IL",NA,NA
"761",269417001,"1  (bases 1 to 137)","Bell,L.D., Boseley,P.G. and Porter,A.G.",NA,"Structure and properties of modified interferons","Patent: US 4769233-A 4 06-SEP-1988;	G. D. Searle & Co.; Chicago, IL",NA,NA
"762",269449001,"1  (bases 1 to 21)","Rutter,W.J.",NA,"Expression linkers","Patent: US 4769326-A 1 06-SEP-1988;	The Regents of the University of California;",NA,NA
"763",269450001,"1  (bases 1 to 30)","Rutter,W.J.",NA,"Expression linkers","Patent: US 4769326-A 2 06-SEP-1988;	The Regents of the University of California;",NA,NA
"764",269451001,"1  (bases 1 to 47)","Rutter,W.J.",NA,"Expression linkers","Patent: US 4769326-A 3 06-SEP-1988;	The Regents of the University of California;",NA,NA
"765",269452001,"1  (bases 1 to 57)","Rutter,W.J.",NA,"Expression linkers","Patent: US 4769326-A 4 06-SEP-1988;	The Regents of the University of California;",NA,NA
"766",269456001,"1  (bases 1 to 123)","Stephens,M.A., Rudolph,C.F., Hannett,N.M., Stassi,D.L. and	Pero,J.G.",NA,"Secretion vector","Patent: US 4769327-A 4 06-SEP-1988;	Biotechnica International, Inc.; Cambridge, MA",NA,NA
"767",269458001,"1  (bases 1 to 93)","Stephens,M.A., Rudolph,C.F., Hannett,N.M., Stassi,D.L. and	Pero,J.G.",NA,"Secretion vector","Patent: US 4769327-A 6 06-SEP-1988;	Biotechnica International, Inc.; Cambridge, MA",NA,NA
"768",269460001,"1  (bases 1 to 42)","Stephens,M.A., Rudolph,C.F., Hannett,N.M., Stassi,D.L. and	Pero,J.G.",NA,"Secretion vector","Patent: US 4769327-A 8 06-SEP-1988;	Biotechnica International, Inc.; Cambridge, MA",NA,NA
"769",269462001,"1  (bases 1 to 454)","Stephens,M.A., Rudolph,C.F., Hannett,N.M., Stassi,D.L. and	Pero,J.G.",NA,"Secretion vector","Patent: US 4769327-A 10 06-SEP-1988;	Biotechnica International, Inc.; Cambridge, MA",NA,NA
"770",269463001,"1  (bases 1 to 1031)","Murray,M.J. and Kelly,J.D.",NA,"Expression of biologically active PDGF analogs in yeast","Patent: US 4769328-A 1 06-SEP-1988;	ZymoGenetics Inc.; Seattle, WA",NA,NA
"771",269467001,"1  (bases 1 to 222)","Burleigh,B.D. and Murphy,D.S.",NA,"Method for purifying and isolating two ionic forms of somatomedin C","Patent: US 4769361-A 1 06-SEP-1988;	International Minerals & Chemical Corp.; Terre Haute, IN",NA,NA
"772",269469001,"1  (bases 1 to 1445)","Kaufman,R.J., Shoemaker,C.B. and Wasley,L.C.",NA,"High yield production of active Factor IX","Patent: US 4770999-A 1 13-SEP-1988;	Genetics Institute, Inc.; Cambridge, MA",NA,NA
"773",269470001,"1  (bases 1 to 1361)","Kaufman,R.J., Shoemaker,C.B. and Wasley,L.C.",NA,"High yield production of active Factor IX","Patent: US 4770999-A 2 13-SEP-1988;	Genetics Institute, Inc.; Cambridge, MA",NA,NA
"774",269472001,"1  (bases 1 to 961)","Verrips,C.T., Maat,J., Edens,L. and Ledeboer,A.M.",NA,"Structural genes encoding the various allelic and maturation forms	of preprothaumatin, recombinant cloning vehicles comprising said	structural genes and expression thereof in transformed microbial	host cells","Patent: US 4771000-A 2 13-SEP-1988;	Internationale Octrooi Maatschappij Octropa B.V.; Rotterdam;	NL;",NA,NA
"775",269474001,"1  (bases 1 to 705)","Verrips,C.T., Maat,J., Edens,L. and Ledeboer,A.M.",NA,"Structural genes encoding the various allelic and maturation forms	of preprothaumatin, recombinant cloning vehicles comprising said	structural genes and expression thereof in transformed microbial	host cells","Patent: US 4771000-A 4 13-SEP-1988;	Internationale Octrooi Maatschappij Octropa B.V.; Rotterdam;	NL;",NA,NA
"776",269476001,"1  (bases 1 to 639)","Verrips,C.T., Maat,J., Edens,L. and Ledeboer,A.M.",NA,"Structural genes encoding the various allelic and maturation forms	of preprothaumatin, recombinant cloning vehicles comprising said	structural genes and expression thereof in transformed microbial	host cells","Patent: US 4771000-A 6 13-SEP-1988;	Internationale Octrooi Maatschappij Octropa B.V.; Rotterdam;	NL;",NA,NA
"777",269478001,"1  (bases 1 to 687)","Verrips,C.T., Maat,J., Edens,L. and Ledeboer,A.M.",NA,"Structural genes encoding the various allelic and maturation forms	of preprothaumatin, recombinant cloning vehicles comprising said	structural genes and expression thereof in transformed microbial	host cells","Patent: US 4771000-A 8 13-SEP-1988;	Internationale Octrooi Maatschappij Octropa B.V.; Rotterdam;	NL;",NA,NA
"778",269479001,"1  (bases 1 to 705)","Verrips,C.T., Maat,J., Edens,L. and Ledeboer,A.M.",NA,"Structural genes encoding the various allelic and maturation forms	of preprothaumatin, recombinant cloning vehicles comprising said	structural genes and expression thereof in transformed microbial	host cells","Patent: US 4771000-A 9 13-SEP-1988;	Internationale Octrooi Maatschappij Octropa B.V.; Rotterdam;	NL;",NA,NA
"779",269488001,"1  (bases 1 to 50)","De Boer,H.A.",NA,"Dedicated ribosomes and their use","Patent: US 4772555-A 1 20-SEP-1988;	Genentech, Inc.; South San Francisco, CA",NA,NA
"780",269489001,"1  (bases 1 to 27)","De Boer,H.A.",NA,"Dedicated ribosomes and their use","Patent: US 4772555-A 2 20-SEP-1988;	Genentech, Inc.; South San Francisco, CA",NA,NA
"781",269490001,"1  (bases 1 to 27)","De Boer,H.A.",NA,"Dedicated ribosomes and their use","Patent: US 4772555-A 3 20-SEP-1988;	Genentech, Inc.; South San Francisco, CA",NA,NA
"782",269491001,"1  (bases 1 to 41)","De Boer,H.A.",NA,"Dedicated ribosomes and their use","Patent: US 4772555-A 4 20-SEP-1988;	Genentech, Inc.; South San Francisco, CA",NA,NA
"783",269492001,"1  (bases 1 to 41)","De Boer,H.A.",NA,"Dedicated ribosomes and their use","Patent: US 4772555-A 5 20-SEP-1988;	Genentech, Inc.; South San Francisco, CA",NA,NA
"784",269493001,"1  (bases 1 to 31)","De Boer,H.A.",NA,"Dedicated ribosomes and their use","Patent: US 4772555-A 6 20-SEP-1988;	Genentech, Inc.; South San Francisco, CA",NA,NA
"785",269494001,"1  (bases 1 to 29)","De Boer,H.A.",NA,"Dedicated ribosomes and their use","Patent: US 4772555-A 7 20-SEP-1988;	Genentech, Inc.; South San Francisco, CA",NA,NA
"786",269495001,"1  (bases 1 to 32)","De Boer,H.A.",NA,"Dedicated ribosomes and their use","Patent: US 4772555-A 8 20-SEP-1988;	Genentech, Inc.; South San Francisco, CA",NA,NA
"787",269515001,"1  (bases 1 to 249)","Chang,T.W., Kato,I., Chanda,P. and Chang,N.T.",NA,"Immunochemical methods for the detection of antibody against	HTLV-III","Patent: US 4774175-A 1 27-SEP-1988;	Centocor, Inc.; Malvern, PA",NA,NA
"788",269517001,"1  (bases 1 to 169)","Gottlieb,A.Arthur.",NA,"Sensitive tests for malignancies based on DNA detection","Patent: US 4774176-A 1 27-SEP-1988;	5915 Pitt St.; New Orleans, LA",NA,NA
"789",269518001,"1  (bases 1 to 67)","Gottlieb,A.Arthur.",NA,"Sensitive tests for malignancies based on DNA detection","Patent: US 4774176-A 2 27-SEP-1988;	5915 Pitt St.; New Orleans, LA",NA,NA
"790",269519001,"1  (bases 1 to 49)","Gottlieb,A.Arthur.",NA,"Sensitive tests for malignancies based on DNA detection","Patent: US 4774176-A 3 27-SEP-1988;	5915 Pitt St.; New Orleans, LA",NA,NA
"791",269528001,"1  (bases 1 to 60)","Urdea,M.S.",NA,"Polynucleotide determination with selectable cleavage sites","Patent: US 4775619-A 1 04-OCT-1988;	Chiron Corporation; Emeryville, CA",NA,NA
"792",269529001,"1  (bases 1 to 60)","Urdea,M.S.",NA,"Polynucleotide determination with selectable cleavage sites","Patent: US 4775619-A 2 04-OCT-1988;	Chiron Corporation; Emeryville, CA",NA,NA
"793",269530001,"1  (bases 1 to 20)","Urdea,M.S.",NA,"Polynucleotide determination with selectable cleavage sites","Patent: US 4775619-A 3 04-OCT-1988;	Chiron Corporation; Emeryville, CA",NA,NA
"794",269531001,"1  (bases 1 to 60)","Urdea,M.S.",NA,"Polynucleotide determination with selectable cleavage sites","Patent: US 4775619-A 4 04-OCT-1988;	Chiron Corporation; Emeryville, CA",NA,NA
"795",269532001,"1  (bases 1 to 32)","Urdea,M.S.",NA,"Polynucleotide determination with selectable cleavage sites","Patent: US 4775619-A 5 04-OCT-1988;	Chiron Corporation; Emeryville, CA",NA,NA
"796",269533001,"1  (bases 1 to 57)","Urdea,M.S.",NA,"Polynucleotide determination with selectable cleavage sites","Patent: US 4775619-A 6 04-OCT-1988;	Chiron Corporation; Emeryville, CA",NA,NA
"797",269534001,"1  (bases 1 to 72)","Urdea,M.S.",NA,"Polynucleotide determination with selectable cleavage sites","Patent: US 4775619-A 7 04-OCT-1988;	Chiron Corporation; Emeryville, CA",NA,NA
"798",269535001,"1  (bases 1 to 60)","Urdea,M.S.",NA,"Polynucleotide determination with selectable cleavage sites","Patent: US 4775619-A 8 04-OCT-1988;	Chiron Corporation; Emeryville, CA",NA,NA
"799",269544001,"1  (bases 1 to 73)","Hitzeman,R.A. and Leung,D.W.",NA,"Expression, processing and secretion of heterologous protein by	yeast","Patent: US 4775622-A 9 04-OCT-1988;	Genentech, Inc.; South San Francisco, CA",NA,NA
"800",269545001,"1  (bases 1 to 1260)","Bang,N.U., Beckmann,R.J., Jaskunas,S.Richard., Lai,M.-H.T.,	Little,S.P., Long,G.L. and Santerre,R.F.",NA,"Vectors and compounds for expression of human protein C","Patent: US 4775624-A 1 04-OCT-1988;	Eli Lilly and Company; Indianapolis, IN",NA,NA
"801",269546001,"1  (bases 1 to 30)","Bang,N.U., Beckmann,R.J., Jaskunas,S.Richard., Lai,M.-H.T.,	Little,S.P., Long,G.L. and Santerre,R.F.",NA,"Vectors and compounds for expression of human protein C","Patent: US 4775624-A 2 04-OCT-1988;	Eli Lilly and Company; Indianapolis, IN",NA,NA
"802",269547001,"1  (bases 1 to 96)","Bang,N.U., Beckmann,R.J., Jaskunas,S.Richard., Lai,M.-H.T.,	Little,S.P., Long,G.L. and Santerre,R.F.",NA,"Vectors and compounds for expression of human protein C","Patent: US 4775624-A 3 04-OCT-1988;	Eli Lilly and Company; Indianapolis, IN",NA,NA
"803",269549001,"1  (bases 1 to 96)","Bang,N.U., Beckmann,R.J., Jaskunas,S.Richard., Lai,M.-H.T.,	Little,S.P., Long,G.L. and Santerre,R.F.",NA,"Vectors and compounds for expression of human protein C","Patent: US 4775624-A 5 04-OCT-1988;	Eli Lilly and Company; Indianapolis, IN",NA,NA
"804",269550001,"1  (bases 1 to 103)","Bang,N.U., Beckmann,R.J., Jaskunas,S.Richard., Lai,M.-H.T.,	Little,S.P., Long,G.L. and Santerre,R.F.",NA,"Vectors and compounds for expression of human protein C","Patent: US 4775624-A 6 04-OCT-1988;	Eli Lilly and Company; Indianapolis, IN",NA,NA
"805",269551001,"1  (bases 1 to 731)","Tibbetts,C., Larsen,P.L., Jones,S.N. and McGrane,M.M.",NA,"Transcriptional control element adapted for regulation of gene	expression in animal cells","Patent: US 4775630-A 1 04-OCT-1988;	Vanderbilt University; Nashville, TN",NA,NA
"806",269583001,"1  (bases 1 to 501)","Teraoka,H., Sato,K. and Tanaka,K.",NA,"Novel interferon alphas","Patent: US 4780530-A 1 25-OCT-1988;	Shionogi & Co., Ltd.; Osaka;	JP;",NA,NA
"807",269585001,"1  (bases 1 to 501)","Teraoka,H., Sato,K. and Tanaka,K.",NA,"Novel interferon alphas","Patent: US 4780530-A 3 25-OCT-1988;	Shionogi & Co., Ltd.; Osaka;	JP;",NA,NA
"808",269587001,"1  (bases 1 to 486)","Teraoka,H., Sato,K. and Tanaka,K.",NA,"Novel interferon alphas","Patent: US 4780530-A 5 25-OCT-1988;	Shionogi & Co., Ltd.; Osaka;	JP;",NA,NA
"809",269589001,"1  (bases 1 to 1300)","Puhler,A., Reilaender,H. and Weber,G.",NA,"Nitrogen fixation regulator genes","Patent: US 4782022-A 1 01-NOV-1988;	Lubrizol Genetics, Inc.; Wickliffe, OH",NA,NA
"810",269591001,"1  (bases 1 to 827)","Puhler,A., Reilaender,H. and Weber,G.",NA,"Nitrogen fixation regulator genes","Patent: US 4782022-A 3 01-NOV-1988;	Lubrizol Genetics, Inc.; Wickliffe, OH",NA,NA
"811",269592001,"1  (bases 1 to 1300)","Puhler,A., Reilaender,H. and Weber,G.",NA,"Nitrogen fixation regulator genes","Patent: US 4782022-A 4 01-NOV-1988;	Lubrizol Genetics, Inc.; Wickliffe, OH",NA,NA
"812",269593001,"1  (bases 1 to 1584)","Puhler,A., Reilaender,H. and Weber,G.",NA,"Nitrogen fixation regulator genes","Patent: US 4782022-A 5 01-NOV-1988;	Lubrizol Genetics, Inc.; Wickliffe, OH",NA,NA
"813",269601001,"1  (bases 1 to 138)","Hopp,T.P., Bektesh,S.L., Conlon,P.J. III and March,C.J.",NA,"Synthesis of protein with an identification peptide, and hybrid	polypeptide incorporating same","Patent: US 4782137-A 1 01-NOV-1988;	Immunex Corporation; Seattle, WA",NA,NA
"814",269602001,"1  (bases 1 to 34)","Hopp,T.P., Bektesh,S.L., Conlon,P.J. III and March,C.J.",NA,"Synthesis of protein with an identification peptide, and hybrid	polypeptide incorporating same","Patent: US 4782137-A 2 01-NOV-1988;	Immunex Corporation; Seattle, WA",NA,NA
"815",269604001,"1  (bases 1 to 93)","Kovacevic,S., Miller,J.R. and Hsiung,H.M.",NA,"Recombinant DNA expression vectors useful in bacillus and other	host cells","Patent: US 4783405-A 1 08-NOV-1988;	Eli Lilly and Company; Indianapolis, IN",NA,NA
"816",269605001,"1  (bases 1 to 233)","Hoshiko,S., Makabe,O., Fukatsu,S. and Nagaoka,K.",NA,"Gene coding for signal peptides and utilization thereof","Patent: US 4783415-A 1 08-NOV-1988;	Meiji Seika Kabushiki Kaisha; Kyobashi;	JP;",NA,NA
"817",269611001,"1  (bases 1 to 477)","Larsen,B.R., Siegel,N.R., Kotts,C.E., McGrath,M.F., Ogden,S.D.,	Krivi,G.G. and Minnerly,J.C.",NA,"Growth factors","Patent: US 4783524-A 5 08-NOV-1988;	Monsanto Company; St. Louis, MO",NA,NA
"818",269616001,"1  (bases 1 to 70)","Watanabe,S.M., Cosand,W.L., McArdle,S. and Travis,B.M.",NA,"Expression and diagnostic use of pENV-3 encoded peptides which are	immunologically reactive with antibodies to LAV","Patent: US 4784941-A 1 15-NOV-1988;	Genetic Systems Corporation; Seattle, WA",NA,NA
"819",269619001,"1  (bases 1 to 912)","Watanabe,S.M., Cosand,W.L., McArdle,S. and Travis,B.M.",NA,"Expression and diagnostic use of pENV-3 encoded peptides which are	immunologically reactive with antibodies to LAV","Patent: US 4784941-A 4 15-NOV-1988;	Genetic Systems Corporation; Seattle, WA",NA,NA
"820",269621001,"1  (bases 1 to 960)","Watanabe,S.M., Cosand,W.L., McArdle,S. and Travis,B.M.",NA,"Expression and diagnostic use of pENV-3 encoded peptides which are	immunologically reactive with antibodies to LAV","Patent: US 4784941-A 6 15-NOV-1988;	Genetic Systems Corporation; Seattle, WA",NA,NA
"821",269623001,"1  (bases 1 to 735)","Watanabe,S.M., Cosand,W.L., McArdle,S. and Travis,B.M.",NA,"Expression and diagnostic use of pENV-3 encoded peptides which are	immunologically reactive with antibodies to LAV","Patent: US 4784941-A 8 15-NOV-1988;	Genetic Systems Corporation; Seattle, WA",NA,NA
"822",269624001,"1  (bases 1 to 301)","Scott,J.R. and Fischetti,V.A.",NA,"Production of streptococcal m protein immunogens and molecular	probes","Patent: US 4784948-A 1 15-NOV-1988;	The Rockefeller University; New York, NY",NA,NA
"823",269627001,"1  (bases 1 to 46)","Gelfand,D.H., Lawyer,F.C. and Stoffel,S.",NA,"Universal dominant selectable marker cassette","Patent: US 4784949-A 2 15-NOV-1988;	Cetus Corporation; Emeryville, CA",NA,NA
"824",269628001,"1  (bases 1 to 31)","Gelfand,D.H., Lawyer,F.C. and Stoffel,S.",NA,"Universal dominant selectable marker cassette","Patent: US 4784949-A 3 15-NOV-1988;	Cetus Corporation; Emeryville, CA",NA,NA
"825",269629001,"1  (bases 1 to 30)","Gelfand,D.H., Lawyer,F.C. and Stoffel,S.",NA,"Universal dominant selectable marker cassette","Patent: US 4784949-A 4 15-NOV-1988;	Cetus Corporation; Emeryville, CA",NA,NA
"826",269631001,"1  (bases 1 to 30)","Gelfand,D.H., Lawyer,F.C. and Stoffel,S.",NA,"Universal dominant selectable marker cassette","Patent: US 4784949-A 6 15-NOV-1988;	Cetus Corporation; Emeryville, CA",NA,NA
"827",269633001,"1  (bases 1 to 33)","Gelfand,D.H., Lawyer,F.C. and Stoffel,S.",NA,"Universal dominant selectable marker cassette","Patent: US 4784949-A 8 15-NOV-1988;	Cetus Corporation; Emeryville, CA",NA,NA
"828",269635001,"1  (bases 1 to 44)","Gelfand,D.H., Lawyer,F.C. and Stoffel,S.",NA,"Universal dominant selectable marker cassette","Patent: US 4784949-A 10 15-NOV-1988;	Cetus Corporation; Emeryville, CA",NA,NA
"829",269638001,"1  (bases 1 to 48)","Gelfand,D.H., Lawyer,F.C. and Stoffel,S.",NA,"Universal dominant selectable marker cassette","Patent: US 4784949-A 13 15-NOV-1988;	Cetus Corporation; Emeryville, CA",NA,NA
"830",269640001,"1  (bases 1 to 221)","Kramer,F.R., Miele,E.A. and Mills,D.R.",NA,"Autocatalytic replication of recombinant RNA","Patent: US 4786600-A 1 22-NOV-1988;	The Trustees of Columbia University in the City of New York; New	York, NY",NA,NA
"831",269641001,"1  (bases 1 to 40)","Kramer,F.R., Miele,E.A. and Mills,D.R.",NA,"Autocatalytic replication of recombinant RNA","Patent: US 4786600-A 2 22-NOV-1988;	The Trustees of Columbia University in the City of New York; New	York, NY",NA,NA
"832",269642001,"1  (bases 1 to 45)","Kramer,F.R., Miele,E.A. and Mills,D.R.",NA,"Autocatalytic replication of recombinant RNA","Patent: US 4786600-A 3 22-NOV-1988;	The Trustees of Columbia University in the City of New York; New	York, NY",NA,NA
"833",269643001,"1  (bases 1 to 330)","Weinberg,R.A., Tabin,C.J. and Bradley,S.M.",NA,"Method of preparing antibodies to characterize oncogenes","Patent: US 4786718-A 1 22-NOV-1988;	Massachusetts Institute of Technology; Boston, MA",NA,NA
"834",269645001,"1  (bases 1 to 357)","Kudo,A., Nishimura,Y., Ichikawa,Y. and Watanabe,T.",NA,"DNA sequence","Patent: US 4786719-A 1 22-NOV-1988;	Teijin, Limited; Osaka;	JP;",NA,NA
"835",269647001,"1  (bases 1 to 324)","Kudo,A., Nishimura,Y., Ichikawa,Y. and Watanabe,T.",NA,"DNA sequence","Patent: US 4786719-A 3 22-NOV-1988;	Teijin, Limited; Osaka;	JP;",NA,NA
"836",269649001,"1  (bases 1 to 1998)","Nunberg,J.H.",NA,"Feline leukemia virus vaccine","Patent: US 4789702-A 1 06-DEC-1988;	Cetus Corporation; Emeryville, CA",NA,NA
"837",269651001,"1  (bases 1 to 27)","Nunberg,J.H.",NA,"Feline leukemia virus vaccine","Patent: US 4789702-A 3 06-DEC-1988;	Cetus Corporation; Emeryville, CA",NA,NA
"838",269653001,"1  (bases 1 to 853)","Nunberg,J.H.",NA,"Feline leukemia virus vaccine","Patent: US 4789702-A 5 06-DEC-1988;	Cetus Corporation; Emeryville, CA",NA,NA
"839",269655001,"1  (bases 1 to 69)","Nunberg,J.H.",NA,"Feline leukemia virus vaccine","Patent: US 4789702-A 7 06-DEC-1988;	Cetus Corporation; Emeryville, CA",NA,NA
"840",269669001,"1  (bases 1 to 715)","Stambrook,P.J. and Tischfield,J.A.",NA,"Methods and kits for identifying mutagenic agents and molecular	mutations in DNA in mammalian cells","Patent: US 4792520-A 2 20-DEC-1988;	University of Cincinnati; Cincinnati, OH",NA,NA
"841",269676001,"1  (bases 1 to 390)","Wong,H.C. and Chang,S.",NA,"3'Expression enhancing fragments and method","Patent: US 4792523-A 1 20-DEC-1988;	Cetus Corporation; Emeryville, CA",NA,NA
"842",269677001,"1  (bases 1 to 59)","Wong,H.C. and Chang,S.",NA,"3'Expression enhancing fragments and method","Patent: US 4792523-A 2 20-DEC-1988;	Cetus Corporation; Emeryville, CA",NA,NA
"843",269689001,"1  (bases 1 to 273)","Narang,S.A. and Wu,R.J.",NA,"Adaptors, and synthesis and cloning of proinsulin genes","Patent: US 4792602-A 2 20-DEC-1988;	Cornell Research Foundation, Inc.; Ithaca, NY",NA,NA
"844",269691001,"1  (bases 1 to 501)","Bell,L.D., Smith,J.C. and Boseley,P.G.",NA,"Modified (1-56) beta interferons","Patent: US 4793995-A 2 27-DEC-1988;	G. D. Searle & Co.; Chicago, IL",NA,NA
"845",269693001,"1  (bases 1 to 501)","Bell,L.D., Smith,J.C. and Boseley,P.G.",NA,"Modified (1-56) beta interferons","Patent: US 4793995-A 4 27-DEC-1988;	G. D. Searle & Co.; Chicago, IL",NA,NA
"846",269695001,"1  (bases 1 to 501)","Bell,L.D., Smith,J.C. and Boseley,P.G.",NA,"Modified (1-56) beta interferons","Patent: US 4793995-A 6 27-DEC-1988;	G. D. Searle & Co.; Chicago, IL",NA,NA
"847",269697001,"1  (bases 1 to 498)","Bell,L.D., Smith,J.C. and Boseley,P.G.",NA,"Modified (1-56) beta interferons","Patent: US 4793995-A 8 27-DEC-1988;	G. D. Searle & Co.; Chicago, IL",NA,NA
"848",269699001,"1  (bases 1 to 501)","Bell,L.D., Smith,J.C. and Boseley,P.G.",NA,"Modified (1-56) beta interferons","Patent: US 4793995-A 10 27-DEC-1988;	G. D. Searle & Co.; Chicago, IL",NA,NA
"849",269701001,"1  (bases 1 to 501)","Bell,L.D., Smith,J.C. and Boseley,P.G.",NA,"Modified (1-56) beta interferons","Patent: US 4793995-A 12 27-DEC-1988;	G. D. Searle & Co.; Chicago, IL",NA,NA
"850",269703001,"1  (bases 1 to 501)","Bell,L.D., Smith,J.C. and Boseley,P.G.",NA,"Modified (1-56) beta interferons","Patent: US 4793995-A 14 27-DEC-1988;	G. D. Searle & Co.; Chicago, IL",NA,NA
"851",269705001,"1  (bases 1 to 501)","Bell,L.D., Smith,J.C. and Boseley,P.G.",NA,"Modified (1-56) beta interferons","Patent: US 4793995-A 16 27-DEC-1988;	G. D. Searle & Co.; Chicago, IL",NA,NA
"852",269707001,"1  (bases 1 to 501)","Bell,L.D., Smith,J.C. and Boseley,P.G.",NA,"Modified (1-56) beta interferons","Patent: US 4793995-A 18 27-DEC-1988;	G. D. Searle & Co.; Chicago, IL",NA,NA
"853",269709001,"1  (bases 1 to 516)","Bell,L.D., Smith,J.C. and Boseley,P.G.",NA,"Modified (1-56) beta interferons","Patent: US 4793995-A 20 27-DEC-1988;	G. D. Searle & Co.; Chicago, IL",NA,NA
"854",269711001,"1  (bases 1 to 498)","Bell,L.D., Smith,J.C. and Boseley,P.G.",NA,"Modified (1-56) beta interferons","Patent: US 4793995-A 22 27-DEC-1988;	G. D. Searle & Co.; Chicago, IL",NA,NA
"855",269713001,"1  (bases 1 to 495)","Bell,L.D., Smith,J.C. and Boseley,P.G.",NA,"Modified (1-56) beta interferons","Patent: US 4793995-A 24 27-DEC-1988;	G. D. Searle & Co.; Chicago, IL",NA,NA
"856",269714001,"1  (bases 1 to 137)","Bell,L.D., Smith,J.C. and Boseley,P.G.",NA,"Modified (1-56) beta interferons","Patent: US 4793995-A 25 27-DEC-1988;	G. D. Searle & Co.; Chicago, IL",NA,NA
"857",269732001,"1  (bases 1 to 1900)","Tabor,S. and Richardson,C.C.",NA,"T7 DNA polymerase","Patent: US 4795699-A 1 03-JAN-1989;	President and Fellows of Harvard College; Cambridge, MA",NA,NA
"858",269733001,"1  (bases 1 to 1652)","Tabor,S. and Richardson,C.C.",NA,"T7 DNA polymerase","Patent: US 4795699-A 2 03-JAN-1989;	President and Fellows of Harvard College; Cambridge, MA",NA,NA
"859",269734001,"1  (bases 1 to 1950)","Tabor,S. and Richardson,C.C.",NA,"T7 DNA polymerase","Patent: US 4795699-A 3 03-JAN-1989;	President and Fellows of Harvard College; Cambridge, MA",NA,NA
"860",269735001,"1  (bases 1 to 1131)","Tabor,S. and Richardson,C.C.",NA,"T7 DNA polymerase","Patent: US 4795699-A 4 03-JAN-1989;	President and Fellows of Harvard College; Cambridge, MA",NA,NA
"861",269736001,"1  (bases 1 to 1950)","Tabor,S. and Richardson,C.C.",NA,"T7 DNA polymerase","Patent: US 4795699-A 5 03-JAN-1989;	President and Fellows of Harvard College; Cambridge, MA",NA,NA
"862",269737001,"1  (bases 1 to 2000)","Tabor,S. and Richardson,C.C.",NA,"T7 DNA polymerase","Patent: US 4795699-A 6 03-JAN-1989;	President and Fellows of Harvard College; Cambridge, MA",NA,NA
"863",269738001,"1  (bases 1 to 2000)","Tabor,S. and Richardson,C.C.",NA,"T7 DNA polymerase","Patent: US 4795699-A 7 03-JAN-1989;	President and Fellows of Harvard College; Cambridge, MA",NA,NA
"864",269739001,"1  (bases 1 to 2000)","Tabor,S. and Richardson,C.C.",NA,"T7 DNA polymerase","Patent: US 4795699-A 8 03-JAN-1989;	President and Fellows of Harvard College; Cambridge, MA",NA,NA
"865",269740001,"1  (bases 1 to 2005)","Tabor,S. and Richardson,C.C.",NA,"T7 DNA polymerase","Patent: US 4795699-A 9 03-JAN-1989;	President and Fellows of Harvard College; Cambridge, MA",NA,NA
"866",269741001,"1  (bases 1 to 58)","Dervan,P.B. and Dreyer,G.B.",NA,"Nucleic acid probes and methods of using same","Patent: US 4795700-A 1 03-JAN-1989;	California Institute of Technology; Pasadena, CA",NA,NA
"867",269742001,"1  (bases 1 to 75)","Hsiung,H.M. and Smith,D.P.",NA,"Novel expression control sequences","Patent: US 4795706-A 1 03-JAN-1989;	Eli Lilly and Company; Indianapolis, IN",NA,NA
"868",269743001,"1  (bases 1 to 55)","Hsiung,H.M. and Smith,D.P.",NA,"Novel expression control sequences","Patent: US 4795706-A 2 03-JAN-1989;	Eli Lilly and Company; Indianapolis, IN",NA,NA
"869",269744001,"1  (bases 1 to 63)","Hsiung,H.M. and Smith,D.P.",NA,"Novel expression control sequences","Patent: US 4795706-A 3 03-JAN-1989;	Eli Lilly and Company; Indianapolis, IN",NA,NA
"870",269745001,"1  (bases 1 to 90)","Hsiung,H.M. and Smith,D.P.",NA,"Novel expression control sequences","Patent: US 4795706-A 4 03-JAN-1989;	Eli Lilly and Company; Indianapolis, IN",NA,NA
"871",269746001,"1  (bases 1 to 63)","Hsiung,H.M. and Smith,D.P.",NA,"Novel expression control sequences","Patent: US 4795706-A 5 03-JAN-1989;	Eli Lilly and Company; Indianapolis, IN",NA,NA
"872",269752001,"1  (bases 1 to 520)","Lindberg,F.C., Lund,B.O., Baga,B.M., Norgren,M.E., Goransson,M.,	Uhlin,B.E., Normark,J.S. and Lark,D.L.",NA,"Adhesin antigens, antibodies and DNA fragment encoding the antigen,	methods and means for diagnosis and immunization etc","Patent: US 4795803-A 4 03-JAN-1989;	Syn-Tek AB; Umea;	SE;",NA,NA
"873",269753001,"1  (bases 1 to 501)","Lindberg,F.C., Lund,B.O., Baga,B.M., Norgren,M.E., Goransson,M.,	Uhlin,B.E., Normark,J.S. and Lark,D.L.",NA,"Adhesin antigens, antibodies and DNA fragment encoding the antigen,	methods and means for diagnosis and immunization etc","Patent: US 4795803-A 5 03-JAN-1989;	Syn-Tek AB; Umea;	SE;",NA,NA
"874",269754001,"1  (bases 1 to 1003)","Lindberg,F.C., Lund,B.O., Baga,B.M., Norgren,M.E., Goransson,M.,	Uhlin,B.E., Normark,J.S. and Lark,D.L.",NA,"Adhesin antigens, antibodies and DNA fragment encoding the antigen,	methods and means for diagnosis and immunization etc","Patent: US 4795803-A 6 03-JAN-1989;	Syn-Tek AB; Umea;	SE;",NA,NA
"875",269756001,"1  (bases 1 to 33)","Itoh,S., Sekine,S., Taniguchi,T., Yoshida,M. and Sugano,H.",NA,"Derivative of adult T cell leukemia virus antigen peptide","Patent: US 4795805-A 1 03-JAN-1989;	Kyowa Hakko Kogyo Co., Ltd.; Tokyo;	JP;",NA,NA
"876",269757001,"1  (bases 1 to 51)","Stabinsky,Y.",NA,"Methods for attaching polynucleotides to supports","Patent: US 4797355-A 1 10-JAN-1989;	Amgen Inc.; Thousand Oaks, CA",NA,NA
"877",269758001,"1  (bases 1 to 24)","Finkelstein,D.B.",NA,"Heat shock regulated production of selected and fused proteins in	yeast","Patent: US 4797359-A 1 10-JAN-1989;	Board of Regents, The University of Texas System; Austin, TX",NA,NA
"878",269761001,"1  (bases 1 to 825)","Lee,F.D., Yokota,T. and Arai,K.-i.",NA,"cDNA clones coding for polypeptides exhibiting murine interleukin-2	activity","Patent: US 4798789-A 1 17-JAN-1989;	DNAX Research Institute of Molecular and Cellular Biology, Inc.;	Palo Alto, CA",NA,NA
"879",269765001,"1  (bases 1 to 107)","Anderson,D.M. and McGuire,J.C.",NA,"Vector for high level gene expression","Patent: US 4798791-A 1 17-JAN-1989;	Genex Corporation; Gaithersburg, MD",NA,NA
"880",269767001,"1  (bases 1 to 1343)","Mason,A.J. and Seeburg,P.H.",NA,"Compositions of hormonally active human and porcine inhibin	containing an .alpha. chain and 62 chain","Patent: US 4798885-A 2 17-JAN-1989;	Genentech, Inc.; South San Francisco, CA",NA,NA
"881",269769001,"1  (bases 1 to 1959)","Mason,A.J. and Seeburg,P.H.",NA,"Compositions of hormonally active human and porcine inhibin	containing an .alpha. chain and 62 chain","Patent: US 4798885-A 4 17-JAN-1989;	Genentech, Inc.; South San Francisco, CA",NA,NA
"882",269770001,"1  (bases 1 to 1629)","Mason,A.J. and Seeburg,P.H.",NA,"Compositions of hormonally active human and porcine inhibin	containing an .alpha. chain and 62 chain","Patent: US 4798885-A 5 17-JAN-1989;	Genentech, Inc.; South San Francisco, CA",NA,NA
"883",269775001,"1  (bases 1 to 1237)","Mason,A.J. and Seeburg,P.H.",NA,"Compositions of hormonally active human and porcine inhibin	containing an .alpha. chain and 62 chain","Patent: US 4798885-A 10 17-JAN-1989;	Genentech, Inc.; South San Francisco, CA",NA,NA
"884",269776001,"1  (bases 1 to 1633)","Mason,A.J. and Seeburg,P.H.",NA,"Compositions of hormonally active human and porcine inhibin	containing an .alpha. chain and 62 chain","Patent: US 4798885-A 11 17-JAN-1989;	Genentech, Inc.; South San Francisco, CA",NA,NA
"885",269781001,"1  (bases 1 to 94)","Mullis,K.B., Erlich,H.A., Arnheim,N., Horn,G.T., Saiki,R.K. and	Scharf,S.J.",NA,"Process for amplifying, detecting, and/or cloning nucleic acid	sequences","Patent: US 4800159-A 1 24-JAN-1989;	Cetus Corporation; Emeryville, CA",NA,NA
"886",269782001,"1  (bases 1 to 60)","Mullis,K.B., Erlich,H.A., Arnheim,N., Horn,G.T., Saiki,R.K. and	Scharf,S.J.",NA,"Process for amplifying, detecting, and/or cloning nucleic acid	sequences","Patent: US 4800159-A 2 24-JAN-1989;	Cetus Corporation; Emeryville, CA",NA,NA
"887",269785001,"1  (bases 1 to 195)","Nogueira,N. and Lizardi,P.",NA,"Nucleotide hybridization assay for protozoan parasites","Patent: US 4801530-A 1 31-JAN-1989;	Rockefeller University; New York, NY",NA,NA
"888",269786001,"1  (bases 1 to 208)","Nogueira,N. and Lizardi,P.",NA,"Nucleotide hybridization assay for protozoan parasites","Patent: US 4801530-A 2 31-JAN-1989;	Rockefeller University; New York, NY",NA,NA
"889",269787001,"1  (bases 1 to 129)","Nogueira,N. and Lizardi,P.",NA,"Nucleotide hybridization assay for protozoan parasites","Patent: US 4801530-A 3 31-JAN-1989;	Rockefeller University; New York, NY",NA,NA
"890",269788001,"1  (bases 1 to 210)","Frossard,P.M.",NA,"Apo AI/CIII genomic polymorphisms predictive of atherosclerosis","Patent: US 4801531-A 1 31-JAN-1989;	Biotechnology Research Partners, Ltd.; Mountain View, CA",NA,NA
"891",269789001,"1  (bases 1 to 139)","Frossard,P.M.",NA,"Apo AI/CIII genomic polymorphisms predictive of atherosclerosis","Patent: US 4801531-A 2 31-JAN-1989;	Biotechnology Research Partners, Ltd.; Mountain View, CA",NA,NA
"892",269790001,"1  (bases 1 to 70)","Frossard,P.M.",NA,"Apo AI/CIII genomic polymorphisms predictive of atherosclerosis","Patent: US 4801531-A 3 31-JAN-1989;	Biotechnology Research Partners, Ltd.; Mountain View, CA",NA,NA
"893",269791001,"1  (bases 1 to 70)","Frossard,P.M.",NA,"Apo AI/CIII genomic polymorphisms predictive of atherosclerosis","Patent: US 4801531-A 4 31-JAN-1989;	Biotechnology Research Partners, Ltd.; Mountain View, CA",NA,NA
"894",269792001,"1  (bases 1 to 1473)","Stahl,M.L. and LaVallie,E.R.",NA,"Method for producing heterologous proteins","Patent: US 4801536-A 1 31-JAN-1989;	Genetics Institute, Inc.; Cambridge, MA",NA,NA
"895",269794001,"1  (bases 1 to 1949)","Stahl,M.L. and LaVallie,E.R.",NA,"Method for producing heterologous proteins","Patent: US 4801536-A 3 31-JAN-1989;	Genetics Institute, Inc.; Cambridge, MA",NA,NA
"896",269795001,"1  (bases 1 to 159)","Stahl,M.L. and LaVallie,E.R.",NA,"Method for producing heterologous proteins","Patent: US 4801536-A 4 31-JAN-1989;	Genetics Institute, Inc.; Cambridge, MA",NA,NA
"897",269797001,"1  (bases 1 to 252)","Stahl,M.L. and LaVallie,E.R.",NA,"Method for producing heterologous proteins","Patent: US 4801536-A 6 31-JAN-1989;	Genetics Institute, Inc.; Cambridge, MA",NA,NA
"898",269798001,"1  (bases 1 to 1085)","Nagarajan,V., Rhodes,C.S. and Banner,C.D.B.",NA,"Vector for expression of polypeptides in bacilli","Patent: US 4801537-A 1 31-JAN-1989;	Genex Corporation; Gaithersburg, MD",NA,NA
"899",269800001,"1  (bases 1 to 1908)","Nagarajan,V., Rhodes,C.S. and Banner,C.D.B.",NA,"Vector for expression of polypeptides in bacilli","Patent: US 4801537-A 3 31-JAN-1989;	Genex Corporation; Gaithersburg, MD",NA,NA
"900",269802001,"1  (bases 1 to 1624)","Hiatt,W.R., Sheehy,R.E., Shewmaker,C.K., Kridl,J.C. and Knauf,V.",NA,"PG gene and its use in plants","Patent: US 4801540-A 1 31-JAN-1989;	Calgene, Inc.; Davis, CA",NA,NA
"901",269803001,"1  (bases 1 to 1031)","Murray,M.J. and Kelly,J.D.",NA,"Expression of biologically active PDGF analogs in eucaryotic cells","Patent: US 4801542-A 1 31-JAN-1989;	ZymoGenetics, Inc.; Seattle, WA",NA,NA
"902",269810001,"1  (bases 1 to 958)","Goeddel,D.V. and Pestka,S.",NA,"Microbial production of mature human leukocyte interferon K and L","Patent: US 4801685-A 1 31-JAN-1989;	Hoffmann-La Roche Inc.; Nutley, NJ",NA,NA
"903",269811001,"1  (bases 1 to 863)","Goeddel,D.V. and Pestka,S.",NA,"Microbial production of mature human leukocyte interferon K and L","Patent: US 4801685-A 2 31-JAN-1989;	Hoffmann-La Roche Inc.; Nutley, NJ",NA,NA
"904",269812001,"1  (bases 1 to 985)","Goeddel,D.V. and Pestka,S.",NA,"Microbial production of mature human leukocyte interferon K and L","Patent: US 4801685-A 3 31-JAN-1989;	Hoffmann-La Roche Inc.; Nutley, NJ",NA,NA
"905",269825001,"1  (bases 1 to 939)","Goeddel,D.V. and Pestka,S.",NA,"Microbial production of mature human leukocyte interferon K and L","Patent: US 4801685-A 16 31-JAN-1989;	Hoffmann-La Roche Inc.; Nutley, NJ",NA,NA
"906",269828001,"1  (bases 1 to 690)","Goeddel,D.V. and Pestka,S.",NA,"Microbial production of mature human leukocyte interferon K and L","Patent: US 4801685-A 19 31-JAN-1989;	Hoffmann-La Roche Inc.; Nutley, NJ",NA,NA
"907",269829001,"1  (bases 1 to 33)","Kronheim,S.R.",NA,"Purification of recombinant interleukin-1","Patent: US 4801686-A 1 31-JAN-1989;	Immunex Corporation; Seattle, WA",NA,NA
"908",269830001,"1  (bases 1 to 49)","Kronheim,S.R.",NA,"Purification of recombinant interleukin-1","Patent: US 4801686-A 2 31-JAN-1989;	Immunex Corporation; Seattle, WA",NA,NA
"909",269844001,"1  (bases 1 to 73)","Hitzeman,R.A., Levinson,A.D. and Yansura,D.G.",NA,"Preparation of hepatitis b surface antigen in yeast","Patent: US 4803164-A 1 07-FEB-1989;	Genentech, Inc.; South San Francisco, CA",NA,NA
"910",269845001,"1  (bases 1 to 1980)","Appelbaum,E.R.",NA,"Nif promoter of fast-growing rhizobium japonicum","Patent: US 4803165-A 1 07-FEB-1989;	Lubrizol Genetics, Inc.; Wickliffe, OH",NA,NA
"911",269846001,"1  (bases 1 to 1800)","Appelbaum,E.R.",NA,"Nif promoter of fast-growing rhizobium japonicum","Patent: US 4803165-A 2 07-FEB-1989;	Lubrizol Genetics, Inc.; Wickliffe, OH",NA,NA
"912",269847001,"1  (bases 1 to 436)","Appelbaum,E.R.",NA,"Nif promoter of fast-growing rhizobium japonicum","Patent: US 4803165-A 3 07-FEB-1989;	Lubrizol Genetics, Inc.; Wickliffe, OH",NA,NA
"913",269848001,"1  (bases 1 to 36)","Appelbaum,E.R.",NA,"Nif promoter of fast-growing rhizobium japonicum","Patent: US 4803165-A 4 07-FEB-1989;	Lubrizol Genetics, Inc.; Wickliffe, OH",NA,NA
"914",269849001,"1  (bases 1 to 36)","Appelbaum,E.R.",NA,"Nif promoter of fast-growing rhizobium japonicum","Patent: US 4803165-A 5 07-FEB-1989;	Lubrizol Genetics, Inc.; Wickliffe, OH",NA,NA
"915",269850001,"1  (bases 1 to 36)","Appelbaum,E.R.",NA,"Nif promoter of fast-growing rhizobium japonicum","Patent: US 4803165-A 6 07-FEB-1989;	Lubrizol Genetics, Inc.; Wickliffe, OH",NA,NA
"916",269851001,"1  (bases 1 to 36)","Appelbaum,E.R.",NA,"Nif promoter of fast-growing rhizobium japonicum","Patent: US 4803165-A 7 07-FEB-1989;	Lubrizol Genetics, Inc.; Wickliffe, OH",NA,NA
"917",269852001,"1  (bases 1 to 36)","Appelbaum,E.R.",NA,"Nif promoter of fast-growing rhizobium japonicum","Patent: US 4803165-A 8 07-FEB-1989;	Lubrizol Genetics, Inc.; Wickliffe, OH",NA,NA
"918",269859001,"1  (bases 1 to 1287)","Yoshida,M., Sugano,H., Shimizu,F. and Imagawa,K.",NA,"Antibodies to human leukemia virus-related peptides and a process	for production of the antibodies","Patent: US 4804746-A 1 14-FEB-1989;	Japanese Foundation for Cancer Research; both of;	JP;",NA,NA
"919",269862001,"1  (bases 1 to 276)","Shoyab,M., Marquardt,H. and Todaro,G.J.",NA,"Polypeptide tumor inhibitors and antibodies thereto","Patent: US 4806492-A 1 21-FEB-1989;	Oncogen, Inc.; Seattle, WA",NA,NA
"920",269867001,"1  (bases 1 to 185)","Revel,M. and Rubinstein,M.",NA,"Constitutive production of human IFN-.beta.1 by mammalian cells	transformed by the IFN-.beta.1 gene fused to an SV40 early promoter","Patent: US 4808523-A 1 28-FEB-1989;	Yeda Research and Development Co., Ltd.; Rehovot;	IL;",NA,NA
"921",269868001,"1  (bases 1 to 197)","Revel,M. and Rubinstein,M.",NA,"Constitutive production of human IFN-.beta.1 by mammalian cells	transformed by the IFN-.beta.1 gene fused to an SV40 early promoter","Patent: US 4808523-A 2 28-FEB-1989;	Yeda Research and Development Co., Ltd.; Rehovot;	IL;",NA,NA
"922",269869001,"1  (bases 1 to 197)","Revel,M. and Rubinstein,M.",NA,"Constitutive production of human IFN-.beta.1 by mammalian cells	transformed by the IFN-.beta.1 gene fused to an SV40 early promoter","Patent: US 4808523-A 3 28-FEB-1989;	Yeda Research and Development Co., Ltd.; Rehovot;	IL;",NA,NA
"923",269870001,"1  (bases 1 to 197)","Revel,M. and Rubinstein,M.",NA,"Constitutive production of human IFN-.beta.1 by mammalian cells	transformed by the IFN-.beta.1 gene fused to an SV40 early promoter","Patent: US 4808523-A 4 28-FEB-1989;	Yeda Research and Development Co., Ltd.; Rehovot;	IL;",NA,NA
"924",269871001,"1  (bases 1 to 199)","Revel,M. and Rubinstein,M.",NA,"Constitutive production of human IFN-.beta.1 by mammalian cells	transformed by the IFN-.beta.1 gene fused to an SV40 early promoter","Patent: US 4808523-A 5 28-FEB-1989;	Yeda Research and Development Co., Ltd.; Rehovot;	IL;",NA,NA
"925",269872001,"1  (bases 1 to 211)","Revel,M. and Rubinstein,M.",NA,"Constitutive production of human IFN-.beta.1 by mammalian cells	transformed by the IFN-.beta.1 gene fused to an SV40 early promoter","Patent: US 4808523-A 6 28-FEB-1989;	Yeda Research and Development Co., Ltd.; Rehovot;	IL;",NA,NA
"926",269873001,"1  (bases 1 to 684)","Chang,N.T. and Ghrayeb,J.",NA,"Immunochemical method for detection of antibody against HTLV-III	core protein based upon recombinant HTLV-III gag gene encoded	protein","Patent: US 4808536-A 1 28-FEB-1989;	Centocor, Inc.; Malvern, PA",NA,NA
"927",269876001,"1  (bases 1 to 57)","Stroman,D.W., Brust,P.F., Ellis,S.B., Gingeras,T.R., Harpold,M.M.	and Tschopp,J.F.",NA,"Methanol inducible genes obtained from pichia and methods of use","Patent: US 4808537-A 2 28-FEB-1989;	Phillips Petroleum Company; Bartlesville, OK",NA,NA
"928",269877001,"1  (bases 1 to 249)","Stroman,D.W., Brust,P.F., Ellis,S.B., Gingeras,T.R., Harpold,M.M.	and Tschopp,J.F.",NA,"Methanol inducible genes obtained from pichia and methods of use","Patent: US 4808537-A 3 28-FEB-1989;	Phillips Petroleum Company; Bartlesville, OK",NA,NA
"929",269878001,"1  (bases 1 to 549)","Stroman,D.W., Brust,P.F., Ellis,S.B., Gingeras,T.R., Harpold,M.M.	and Tschopp,J.F.",NA,"Methanol inducible genes obtained from pichia and methods of use","Patent: US 4808537-A 4 28-FEB-1989;	Phillips Petroleum Company; Bartlesville, OK",NA,NA
"930",269879001,"1  (bases 1 to 49)","Cosman,D.J.",NA,"Use of interleukin-1 to induce development of multipotent	hemopoietic cell populations","Patent: US 4808611-A 1 28-FEB-1989;	Immunex Corporation; Seattle, WA",NA,NA
"931",269880001,"1  (bases 1 to 33)","Cosman,D.J.",NA,"Use of interleukin-1 to induce development of multipotent	hemopoietic cell populations","Patent: US 4808611-A 2 28-FEB-1989;	Immunex Corporation; Seattle, WA",NA,NA
"932",269882001,"1  (bases 1 to 1500)","Fujita,H., Yoshida,I., Takagi,M., Manabe,S. and Fukai,K.",NA,"Flavivirus antigen","Patent: US 4810492-A 1 07-MAR-1989;	The Research Foundation for Microbial Diseases of Osaka University;	Osaka;	JP;",NA,NA
"933",269884001,"1  (bases 1 to 1415)","Souza,L.M.",NA,"Production of pluripotent granulocyte colony-stimulating factor","Patent: US 4810643-A 1 07-MAR-1989;	Kirin- Amgen Inc.; Thousand Oaks, CA",NA,NA
"934",269885001,"1  (bases 1 to 1900)","Souza,L.M.",NA,"Production of pluripotent granulocyte colony-stimulating factor","Patent: US 4810643-A 2 07-MAR-1989;	Kirin- Amgen Inc.; Thousand Oaks, CA",NA,NA
"935",269887001,"1  (bases 1 to 1170)","Souza,L.M.",NA,"Production of pluripotent granulocyte colony-stimulating factor","Patent: US 4810643-A 4 07-MAR-1989;	Kirin- Amgen Inc.; Thousand Oaks, CA",NA,NA
"936",269888001,"1  (bases 1 to 195)","Souza,L.M.",NA,"Production of pluripotent granulocyte colony-stimulating factor","Patent: US 4810643-A 5 07-MAR-1989;	Kirin- Amgen Inc.; Thousand Oaks, CA",NA,NA
"937",269889001,"1  (bases 1 to 212)","Souza,L.M.",NA,"Production of pluripotent granulocyte colony-stimulating factor","Patent: US 4810643-A 6 07-MAR-1989;	Kirin- Amgen Inc.; Thousand Oaks, CA",NA,NA
"938",269890001,"1  (bases 1 to 169)","Souza,L.M.",NA,"Production of pluripotent granulocyte colony-stimulating factor","Patent: US 4810643-A 7 07-MAR-1989;	Kirin- Amgen Inc.; Thousand Oaks, CA",NA,NA
"939",269891001,"1  (bases 1 to 102)","Souza,L.M.",NA,"Production of pluripotent granulocyte colony-stimulating factor","Patent: US 4810643-A 8 07-MAR-1989;	Kirin- Amgen Inc.; Thousand Oaks, CA",NA,NA
"940",269892001,"1  (bases 1 to 1107)","Goeddel,D.V. and Pestka,S.",NA,"Microbial production of mature human leukocyte interferon K and L","Patent: US 4810645-A 1 07-MAR-1989;	Hoffmann-La Roche Inc.; Nutley, NJ",NA,NA
"941",269893001,"1  (bases 1 to 1069)","Goeddel,D.V. and Pestka,S.",NA,"Microbial production of mature human leukocyte interferon K and L","Patent: US 4810645-A 2 07-MAR-1989;	Hoffmann-La Roche Inc.; Nutley, NJ",NA,NA
"942",269894001,"1  (bases 1 to 1109)","Goeddel,D.V. and Pestka,S.",NA,"Microbial production of mature human leukocyte interferon K and L","Patent: US 4810645-A 3 07-MAR-1989;	Hoffmann-La Roche Inc.; Nutley, NJ",NA,NA
"943",269900001,"1  (bases 1 to 939)","Goeddel,D.V. and Pestka,S.",NA,"Microbial production of mature human leukocyte interferon K and L","Patent: US 4810645-A 9 07-MAR-1989;	Hoffmann-La Roche Inc.; Nutley, NJ",NA,NA
"944",269903001,"1  (bases 1 to 690)","Goeddel,D.V. and Pestka,S.",NA,"Microbial production of mature human leukocyte interferon K and L","Patent: US 4810645-A 12 07-MAR-1989;	Hoffmann-La Roche Inc.; Nutley, NJ",NA,NA
"945",269904001,"1  (bases 1 to 1213)","Stalker,D.M.",NA,"Haloarylnitrile degrading gene, its use, and cells containing the	gene","Patent: US 4810648-A 1 07-MAR-1989;	Rhone Poulenc Agrochimie; Lyon;	FR;",NA,NA
"946",269912001,"1  (bases 1 to 56)","Riggs,A.D.",NA,"Somatostatin peptide conjugate","Patent: US 4812554-A 2 14-MAR-1989;	Genentech, Inc.; South San Francisco, CA",NA,NA
"947",269914001,"1  (bases 1 to 124)","Riggs,A.D.",NA,"Somatostatin peptide conjugate","Patent: US 4812554-A 4 14-MAR-1989;	Genentech, Inc.; South San Francisco, CA",NA,NA
"948",269916001,"1  (bases 1 to 104)","Riggs,A.D.",NA,"Somatostatin peptide conjugate","Patent: US 4812554-A 6 14-MAR-1989;	Genentech, Inc.; South San Francisco, CA",NA,NA
"949",269918001,"1  (bases 1 to 77)","Riggs,A.D.",NA,"Somatostatin peptide conjugate","Patent: US 4812554-A 8 14-MAR-1989;	Genentech, Inc.; South San Francisco, CA",NA,NA
"950",269921001,"1  (bases 1 to 1698)","Ellis,R.W., Keller,P.M., Lowe,R.S. and Davison,A.J.",NA,"Vaccine against varicella-zoster virus","Patent: US 4812559-A 1 14-MAR-1989;	Merck & Co., Inc.; Rahway, NJ",NA,NA
"951",269922001,"1  (bases 1 to 909)","Ellis,R.W., Keller,P.M., Lowe,R.S. and Davison,A.J.",NA,"Vaccine against varicella-zoster virus","Patent: US 4812559-A 2 14-MAR-1989;	Merck & Co., Inc.; Rahway, NJ",NA,NA
"952",269928001,"1  (bases 1 to 501)","Chang,S.",NA,"Method and vector organism for controlled accumulation of	heterologous gene products in bacillus subtilis","Patent: US 4816396-A 2 28-MAR-1989;	Cetus Corporation; Emeryville, CA",NA,NA
"953",269929001,"1  (bases 1 to 257)","Chang,S.",NA,"Method and vector organism for controlled accumulation of	heterologous gene products in bacillus subtilis","Patent: US 4816396-A 3 28-MAR-1989;	Cetus Corporation; Emeryville, CA",NA,NA
"954",269930001,"1  (bases 1 to 465)","Chang,S.",NA,"Method and vector organism for controlled accumulation of	heterologous gene products in bacillus subtilis","Patent: US 4816396-A 4 28-MAR-1989;	Cetus Corporation; Emeryville, CA",NA,NA
"955",269932001,"1  (bases 1 to 31)","Boss,M.A., Kenten,J.H., Emtage,J.S. and Wood,C.R.",NA,"Multichain polypeptides or proteins and processes for their	production","Patent: US 4816397-A 1 28-MAR-1989;	Celltech, Limited; Slough;	GB;",NA,NA
"956",269933001,"1  (bases 1 to 51)","Boss,M.A., Kenten,J.H., Emtage,J.S. and Wood,C.R.",NA,"Multichain polypeptides or proteins and processes for their	production","Patent: US 4816397-A 2 28-MAR-1989;	Celltech, Limited; Slough;	GB;",NA,NA
"957",269935001,"1  (bases 1 to 33)","Boss,M.A., Kenten,J.H., Emtage,J.S. and Wood,C.R.",NA,"Multichain polypeptides or proteins and processes for their	production","Patent: US 4816397-A 4 28-MAR-1989;	Celltech, Limited; Slough;	GB;",NA,NA
"958",269936001,"1  (bases 1 to 49)","Jacobs,C.A.",NA,"Anti-arthritic use of interleukin-1 proteins","Patent: US 4816436-A 1 28-MAR-1989;	Immunex Corporation; Seattle, WA",NA,NA
"959",269959001,"1  (bases 1 to 56)","Ellis,R.W., Hagopian,A. and Kniskern,P.J.",NA,"Method for producing hepatitis B virus proteins in yeast","Patent: US 4816564-A 1 28-MAR-1989;	Merck & Co., Inc.; Rahway, NJ",NA,NA
"960",269960001,"1  (bases 1 to 30)","Ellis,R.W., Hagopian,A. and Kniskern,P.J.",NA,"Method for producing hepatitis B virus proteins in yeast","Patent: US 4816564-A 2 28-MAR-1989;	Merck & Co., Inc.; Rahway, NJ",NA,NA
"961",269961001,"1  (bases 1 to 27)","Ellis,R.W., Hagopian,A. and Kniskern,P.J.",NA,"Method for producing hepatitis B virus proteins in yeast","Patent: US 4816564-A 3 28-MAR-1989;	Merck & Co., Inc.; Rahway, NJ",NA,NA
"962",269962001,"1  (bases 1 to 36)","Ellis,R.W., Hagopian,A. and Kniskern,P.J.",NA,"Method for producing hepatitis B virus proteins in yeast","Patent: US 4816564-A 4 28-MAR-1989;	Merck & Co., Inc.; Rahway, NJ",NA,NA
"963",269964001,"1  (bases 1 to 633)","Honjo,T. and Shimizu,A.",NA,"Interleukin 2 receptor and a method for production thereof","Patent: US 4816565-A 2 28-MAR-1989;	Tasuku Honjo; Toyonaka;	JP;",NA,NA
"964",269966001,"1  (bases 1 to 60)","Honjo,T. and Shimizu,A.",NA,"Interleukin 2 receptor and a method for production thereof","Patent: US 4816565-A 4 28-MAR-1989;	Tasuku Honjo; Toyonaka;	JP;",NA,NA
"965",269968001,"1  (bases 1 to 490)","DeChiara,T.M. and Tarnowski,S.J. Jr.",NA,"Polypeptides having interferon activity","Patent: US 4816566-A 2 28-MAR-1989;	Hoffmann-La Roche, Inc.; Nutley, NJ",NA,NA
"966",269978001,"1  (bases 1 to 32)","Collins,M., Dougherty,J.P., Ellwood,M.S., Fritsch,E.F. and	Jacobs,K.A.",NA,"Method and kit involving displacement and rehybridization of	labeled polynucleotide","Patent: US 4818680-A 1 04-APR-1989;	27 Euclid Ave.; Natick, MA",NA,NA
"967",269979001,"1  (bases 1 to 29)","Collins,M., Dougherty,J.P., Ellwood,M.S., Fritsch,E.F. and	Jacobs,K.A.",NA,"Method and kit involving displacement and rehybridization of	labeled polynucleotide","Patent: US 4818680-A 2 04-APR-1989;	27 Euclid Ave.; Natick, MA",NA,NA
"968",269980001,"1  (bases 1 to 33)","Collins,M., Dougherty,J.P., Ellwood,M.S., Fritsch,E.F. and	Jacobs,K.A.",NA,"Method and kit involving displacement and rehybridization of	labeled polynucleotide","Patent: US 4818680-A 3 04-APR-1989;	27 Euclid Ave.; Natick, MA",NA,NA
"969",269981001,"1  (bases 1 to 27)","Collins,M., Dougherty,J.P., Ellwood,M.S., Fritsch,E.F. and	Jacobs,K.A.",NA,"Method and kit involving displacement and rehybridization of	labeled polynucleotide","Patent: US 4818680-A 4 04-APR-1989;	27 Euclid Ave.; Natick, MA",NA,NA
"970",269982001,"1  (bases 1 to 27)","Collins,M., Dougherty,J.P., Ellwood,M.S., Fritsch,E.F. and	Jacobs,K.A.",NA,"Method and kit involving displacement and rehybridization of	labeled polynucleotide","Patent: US 4818680-A 5 04-APR-1989;	27 Euclid Ave.; Natick, MA",NA,NA
"971",269983001,"1  (bases 1 to 20)","Dattagupta,N.",NA,"Fast and specific immobilization of nucleic acids to solid supports","Patent: US 4818681-A 1 04-APR-1989;	Molecular Diagnostics, Inc.; West Haven, CT",NA,NA
"972",269984001,"1  (bases 1 to 1608)","Watson,R.J., Weis,J.W. and Enquist,L.W.",NA,"Production of herpes simplex viral protein","Patent: US 4818694-A 1 04-APR-1989;	American Cyanamid Company; Stamford, CT",NA,NA
"973",269986001,"1  (bases 1 to 604)","Sagai,H., Takahara,M., Katsuragi,S., Kajiwara,J. and Masujima,H.",NA,"Polypeptides and preparation process thereof","Patent: US 4818698-A 1 04-APR-1989;	Toyo Jozo Co., Ltd.; Shizuoka;	JP;",NA,NA
"974",269994001,"1  (bases 1 to 29)","Lacal,J.C. and Aaronson,S.A.",NA,"Deletion mutants and monoclonal antibodies against ras proteins","Patent: US 4820631-A 1 11-APR-1989;	The United States of America as represented by the Secretary of	the; Washington, DC",NA,NA
"975",269995001,"1  (bases 1 to 29)","Lacal,J.C. and Aaronson,S.A.",NA,"Deletion mutants and monoclonal antibodies against ras proteins","Patent: US 4820631-A 2 11-APR-1989;	The United States of America as represented by the Secretary of	the; Washington, DC",NA,NA
"976",269996001,"1  (bases 1 to 29)","Lacal,J.C. and Aaronson,S.A.",NA,"Deletion mutants and monoclonal antibodies against ras proteins","Patent: US 4820631-A 3 11-APR-1989;	The United States of America as represented by the Secretary of	the; Washington, DC",NA,NA
"977",269997001,"1  (bases 1 to 20)","Lacal,J.C. and Aaronson,S.A.",NA,"Deletion mutants and monoclonal antibodies against ras proteins","Patent: US 4820631-A 4 11-APR-1989;	The United States of America as represented by the Secretary of	the; Washington, DC",NA,NA
"978",269998001,"1  (bases 1 to 24)","Lacal,J.C. and Aaronson,S.A.",NA,"Deletion mutants and monoclonal antibodies against ras proteins","Patent: US 4820631-A 5 11-APR-1989;	The United States of America as represented by the Secretary of	the; Washington, DC",NA,NA
"979",269999001,"1  (bases 1 to 23)","Lacal,J.C. and Aaronson,S.A.",NA,"Deletion mutants and monoclonal antibodies against ras proteins","Patent: US 4820631-A 6 11-APR-1989;	The United States of America as represented by the Secretary of	the; Washington, DC",NA,NA
"980",270000001,"1  (bases 1 to 21)","Lacal,J.C. and Aaronson,S.A.",NA,"Deletion mutants and monoclonal antibodies against ras proteins","Patent: US 4820631-A 7 11-APR-1989;	The United States of America as represented by the Secretary of	the; Washington, DC",NA,NA
"981",270001001,"1  (bases 1 to 23)","Lacal,J.C. and Aaronson,S.A.",NA,"Deletion mutants and monoclonal antibodies against ras proteins","Patent: US 4820631-A 8 11-APR-1989;	The United States of America as represented by the Secretary of	the; Washington, DC",NA,NA
"982",270002001,"1  (bases 1 to 498)","Swetly,P., Dworkin-Rastl,E. and Meindl,P.",NA,"Novel alpha interferon species produced by recombinant means","Patent: US 4820638-A 1 11-APR-1989;	Dr. Karl Thomae GmbH;;	DE;",NA,NA
"983",270004001,"1  (bases 1 to 38)","Gehrke,L.",NA,"Process for enhancing translational efficiency of eukaryotic mRNA","Patent: US 4820639-A 1 11-APR-1989;	Massachusetts Institute of Technology; Cambridge, MA",NA,NA
"984",270005001,"1  (bases 1 to 25)","Gehrke,L.",NA,"Process for enhancing translational efficiency of eukaryotic mRNA","Patent: US 4820639-A 2 11-APR-1989;	Massachusetts Institute of Technology; Cambridge, MA",NA,NA
"985",270006001,"1  (bases 1 to 32)","Gehrke,L.",NA,"Process for enhancing translational efficiency of eukaryotic mRNA","Patent: US 4820639-A 3 11-APR-1989;	Massachusetts Institute of Technology; Cambridge, MA",NA,NA
"986",270007001,"1  (bases 1 to 22)","Gehrke,L.",NA,"Process for enhancing translational efficiency of eukaryotic mRNA","Patent: US 4820639-A 4 11-APR-1989;	Massachusetts Institute of Technology; Cambridge, MA",NA,NA
"987",270008001,"1  (bases 1 to 86)","Gehrke,L.",NA,"Process for enhancing translational efficiency of eukaryotic mRNA","Patent: US 4820639-A 5 11-APR-1989;	Massachusetts Institute of Technology; Cambridge, MA",NA,NA
"988",270019001,"1  (bases 1 to 60)","Watson,R.M., Sheldon,E.L. III and Snead,R.M.",NA,"Process for labeling single-stranded nucleic acids and	hybridizaiton probes","Patent: US 4822731-A 2 18-APR-1989;	Cetus Corporation; Emeryville, CA",NA,NA
"989",270021001,"1  (bases 1 to 75)","Watson,R.M., Sheldon,E.L. III and Snead,R.M.",NA,"Process for labeling single-stranded nucleic acids and	hybridizaiton probes","Patent: US 4822731-A 4 18-APR-1989;	Cetus Corporation; Emeryville, CA",NA,NA
"990",270022001,"1  (bases 1 to 1099)","Watson,R.M., Sheldon,E.L. III and Snead,R.M.",NA,"Process for labeling single-stranded nucleic acids and	hybridizaiton probes","Patent: US 4822731-A 5 18-APR-1989;	Cetus Corporation; Emeryville, CA",NA,NA
"991",270023001,"1  (bases 1 to 1201)","Watson,R.M., Sheldon,E.L. III and Snead,R.M.",NA,"Process for labeling single-stranded nucleic acids and	hybridizaiton probes","Patent: US 4822731-A 6 18-APR-1989;	Cetus Corporation; Emeryville, CA",NA,NA
"992",270024001,"1  (bases 1 to 352)","Chang,S.",NA,"Partition proficiency in genetically engineered plasmids for	transforming gram-positive organisms","Patent: US 4822739-A 1 18-APR-1989;	Cetus Corporation; Emeryville, CA",NA,NA
"993",270026001,"1  (bases 1 to 1040)","Kit,M. and Kit,S.",NA,"Thymidine kinase deletion mutants of bovine herpesvirus-1, vaccines	against infectious bovine rhinotracheitis containing same and	methods for the production and use of same","Patent: US 4824667-A 1 25-APR-1989;	NovaGene, Inc.; Houston, TX",NA,NA
"994",270027001,"1  (bases 1 to 1773)","Kit,M. and Kit,S.",NA,"Thymidine kinase deletion mutants of bovine herpesvirus-1, vaccines	against infectious bovine rhinotracheitis containing same and	methods for the production and use of same","Patent: US 4824667-A 2 25-APR-1989;	NovaGene, Inc.; Houston, TX",NA,NA
"995",270029001,"1  (bases 1 to 40)","Kit,M. and Kit,S.",NA,"Thymidine kinase deletion mutants of bovine herpesvirus-1, vaccines	against infectious bovine rhinotracheitis containing same and	methods for the production and use of same","Patent: US 4824667-A 4 25-APR-1989;	NovaGene, Inc.; Houston, TX",NA,NA
"996",270030001,"1  (bases 1 to 1707)","Furutani,Y., Tomioka,N., Honjo,M., Manabe,K. and Shimada,H.",NA,"DNA base sequence, method for preparing a recombinant plasmid	including the DNA base sequence, and breeding method for enhancing	the protein-secreting ability of a microorganism by introducing	thereinto the recombinant plasmid","Patent: US 4824782-A 1 25-APR-1989;	Agency of Industrial Science and Technology; both of;	JP;",NA,NA
"997",270038001,"1  (bases 1 to 100)","Norris,K., Thim,L., Norris,F., Hansen,M.T. and Moody,A.J.",NA,"Process for preparing glucagon or fragments or derivatives thereof	in yeast","Patent: US 4826763-A 2 02-MAY-1989;	Novo Industri A/S; Bagsvaerd;	DK;",NA,NA
"998",270039001,"1  (bases 1 to 36)","Sebald,W.",NA,"Enhancing the translational initiation frequency of a gene","Patent: US 4826764-A 1 02-MAY-1989;	Gesellschaft fur Biotechnologische Forschung mbH; Brunswick;	DE;",NA,NA
"999",270040001,"1  (bases 1 to 1919)","Greene,F.C., Stiles,J.I., Neill,J.D., Anderson,O.D. and Litts,J.C.",NA,"Yeast strains genetically engineered to produce wheat gluten	proteins","Patent: US 4826765-A 1 02-MAY-1989;	The United States of America as represented by the Secretary of	the; Washington, DC",NA,NA
"1000",270041001,"1  (bases 1 to 2000)","Greene,F.C., Stiles,J.I., Neill,J.D., Anderson,O.D. and Litts,J.C.",NA,"Yeast strains genetically engineered to produce wheat gluten	proteins","Patent: US 4826765-A 2 02-MAY-1989;	The United States of America as represented by the Secretary of	the; Washington, DC",NA,NA
